id	sid	tid	token	lemma	pos
aiua-6844	1	1	197archivio	197archivio	PROPN
aiua-6844	1	2	italiano	italiano	NOUN
aiua-6844	1	3	di	di	X
aiua-6844	1	4	urologia	urologia	PROPN
aiua-6844	1	5	e	e	PROPN
aiua-6844	1	6	andrologia	andrologia	NOUN
aiua-6844	1	7	2017	2017	NUM
aiua-6844	1	8	;	;	PUNCT
aiua-6844	1	9	89	89	NUM
aiua-6844	1	10	,	,	PUNCT
aiua-6844	1	11	3	3	NUM
aiua-6844	1	12	original	original	ADJ
aiua-6844	1	13	paper	paper	NOUN
aiua-6844	1	14	effect	effect	NOUN
aiua-6844	1	15	of	of	ADP
aiua-6844	1	16	green	green	ADJ
aiua-6844	1	17	tea	tea	NOUN
aiua-6844	1	18	catechins	catechin	NOUN
aiua-6844	1	19	in	in	ADP
aiua-6844	1	20	patients	patient	NOUN
aiua-6844	1	21	with	with	ADP
aiua-6844	1	22	high	high	ADJ
aiua-6844	1	23	-	-	PUNCT
aiua-6844	1	24	grade	grade	NOUN
aiua-6844	1	25	prostatic	prostatic	ADJ
aiua-6844	1	26	intraepithelial	intraepithelial	ADJ
aiua-6844	1	27	neoplasia	neoplasia	NOUN
aiua-6844	1	28	:	:	PUNCT
aiua-6844	1	29	results	result	NOUN
aiua-6844	1	30	of	of	ADP
aiua-6844	1	31	a	a	DET
aiua-6844	1	32	short	short	ADJ
aiua-6844	1	33	-	-	PUNCT
aiua-6844	1	34	term	term	NOUN
aiua-6844	1	35	double	double	ADJ
aiua-6844	1	36	-	-	PUNCT
aiua-6844	1	37	blind	blind	ADJ
aiua-6844	1	38	placebo	placebo	NOUN
aiua-6844	1	39	controlled	control	VERB
aiua-6844	1	40	phase	phase	NOUN
aiua-6844	1	41	ii	ii	NOUN
aiua-6844	1	42	clinical	clinical	ADJ
aiua-6844	1	43	trial	trial	NOUN
aiua-6844	1	44	salvatore	salvatore	NOUN
aiua-6844	1	45	micali	micali	PROPN
aiua-6844	1	46	1	1	NUM
aiua-6844	1	47	,	,	PUNCT
aiua-6844	1	48	angelo	angelo	PROPN
aiua-6844	1	49	territo	territo	PROPN
aiua-6844	1	50	1	1	NUM
aiua-6844	1	51	,	,	PUNCT
aiua-6844	1	52	giacomo	giacomo	PROPN
aiua-6844	1	53	maria	maria	PROPN
aiua-6844	1	54	pirola	pirola	PROPN
aiua-6844	1	55	1	1	NUM
aiua-6844	1	56	,	,	PUNCT
aiua-6844	1	57	nancy	nancy	PROPN
aiua-6844	1	58	ferrari	ferrari	PROPN
aiua-6844	1	59	1	1	NUM
aiua-6844	1	60	,	,	PUNCT
aiua-6844	1	61	maria	maria	PROPN
aiua-6844	1	62	chiara	chiara	PROPN
aiua-6844	1	63	sighinolfi	sighinolfi	PROPN
aiua-6844	1	64	1	1	NUM
aiua-6844	1	65	,	,	PUNCT
aiua-6844	1	66	eugenio	eugenio	PROPN
aiua-6844	1	67	martorana	martorana	PROPN
aiua-6844	1	68	1	1	NUM
aiua-6844	1	69	,	,	PUNCT
aiua-6844	1	70	michele	michele	PROPN
aiua-6844	1	71	navarra	navarra	PROPN
aiua-6844	1	72	2	2	NUM
aiua-6844	1	73	,	,	PUNCT
aiua-6844	1	74	giampaolo	giampaolo	ADJ
aiua-6844	1	75	bianchi	bianchi	NOUN
aiua-6844	1	76	1	1	NUM
aiua-6844	1	77	1	1	NUM
aiua-6844	1	78	department	department	NOUN
aiua-6844	1	79	of	of	ADP
aiua-6844	1	80	urology	urology	NOUN
aiua-6844	1	81	,	,	PUNCT
aiua-6844	1	82	bagiovara	bagiovara	NOUN
aiua-6844	1	83	hospital	hospital	NOUN
aiua-6844	1	84	,	,	PUNCT
aiua-6844	1	85	university	university	NOUN
aiua-6844	1	86	of	of	ADP
aiua-6844	1	87	modena	modena	PROPN
aiua-6844	1	88	and	and	CCONJ
aiua-6844	1	89	reggio	reggio	PROPN
aiua-6844	1	90	emilia	emilia	PROPN
aiua-6844	1	91	,	,	PUNCT
aiua-6844	1	92	italy	italy	PROPN
aiua-6844	1	93	;	;	PUNCT
aiua-6844	1	94	2	2	NUM
aiua-6844	1	95	department	department	NOUN
aiua-6844	1	96	of	of	ADP
aiua-6844	1	97	chemical	chemical	PROPN
aiua-6844	1	98	,	,	PUNCT
aiua-6844	1	99	biological	biological	ADJ
aiua-6844	1	100	,	,	PUNCT
aiua-6844	1	101	pharmaceutical	pharmaceutical	ADJ
aiua-6844	1	102	and	and	CCONJ
aiua-6844	1	103	environmental	environmental	ADJ
aiua-6844	1	104	sciences	science	NOUN
aiua-6844	1	105	,	,	PUNCT
aiua-6844	1	106	university	university	PROPN
aiua-6844	1	107	of	of	ADP
aiua-6844	1	108	messina	messina	PROPN
aiua-6844	1	109	,	,	PUNCT
aiua-6844	1	110	italy	italy	PROPN
aiua-6844	1	111	.	.	PUNCT
aiua-6844	2	1	background	background	NOUN
aiua-6844	2	2	and	and	CCONJ
aiua-6844	2	3	study	study	NOUN
aiua-6844	2	4	objective	objective	NOUN
aiua-6844	2	5	:	:	PUNCT
aiua-6844	2	6	several	several	ADJ
aiua-6844	2	7	studies	study	NOUN
aiua-6844	2	8	suggest	suggest	VERB
aiua-6844	2	9	a	a	DET
aiua-6844	2	10	protective	protective	ADJ
aiua-6844	2	11	role	role	NOUN
aiua-6844	2	12	of	of	ADP
aiua-6844	2	13	green	green	ADJ
aiua-6844	2	14	tea	tea	NOUN
aiua-6844	2	15	catechins	catechin	NOUN
aiua-6844	2	16	against	against	ADP
aiua-6844	2	17	prostate	prostate	NOUN
aiua-6844	2	18	cancer	cancer	NOUN
aiua-6844	2	19	(	(	PUNCT
aiua-6844	2	20	pca	pca	PROPN
aiua-6844	2	21	)	)	PUNCT
aiua-6844	2	22	.	.	PUNCT
aiua-6844	3	1	in	in	ADP
aiua-6844	3	2	order	order	NOUN
aiua-6844	3	3	to	to	PART
aiua-6844	3	4	evaluate	evaluate	VERB
aiua-6844	3	5	the	the	DET
aiua-6844	3	6	efficacy	efficacy	NOUN
aiua-6844	3	7	of	of	ADP
aiua-6844	3	8	green	green	ADJ
aiua-6844	3	9	tea	tea	NOUN
aiua-6844	3	10	catechins	catechin	NOUN
aiua-6844	3	11	for	for	ADP
aiua-6844	3	12	chemoprevention	chemoprevention	NOUN
aiua-6844	3	13	of	of	ADP
aiua-6844	3	14	pca	pca	PROPN
aiua-6844	3	15	in	in	ADP
aiua-6844	3	16	patients	patient	NOUN
aiua-6844	3	17	with	with	ADP
aiua-6844	3	18	high	high	ADJ
aiua-6844	3	19	-	-	PUNCT
aiua-6844	3	20	grade	grade	NOUN
aiua-6844	3	21	prostate	prostate	NOUN
aiua-6844	3	22	intraepithelial	intraepithelial	ADJ
aiua-6844	3	23	neoplasia	neoplasia	NOUN
aiua-6844	3	24	(	(	PUNCT
aiua-6844	3	25	hg	hg	NOUN
aiua-6844	3	26	-	-	NOUN
aiua-6844	3	27	pin	pin	NOUN
aiua-6844	3	28	)	)	PUNCT
aiua-6844	3	29	we	we	PRON
aiua-6844	3	30	performed	perform	VERB
aiua-6844	3	31	a	a	DET
aiua-6844	3	32	phase	phase	NOUN
aiua-6844	3	33	ii	ii	NOUN
aiua-6844	3	34	clinical	clinical	ADJ
aiua-6844	3	35	trial	trial	NOUN
aiua-6844	3	36	.	.	PUNCT
aiua-6844	4	1	methods	method	NOUN
aiua-6844	4	2	:	:	PUNCT
aiua-6844	4	3	sixty	sixty	NUM
aiua-6844	4	4	volunteers	volunteer	NOUN
aiua-6844	4	5	with	with	ADP
aiua-6844	4	6	hg	hg	NOUN
aiua-6844	4	7	-	-	NOUN
aiua-6844	4	8	pin	pin	NOUN
aiua-6844	4	9	were	be	AUX
aiua-6844	4	10	enrolled	enrol	VERB
aiua-6844	4	11	to	to	PART
aiua-6844	4	12	carry	carry	VERB
aiua-6844	4	13	out	out	ADP
aiua-6844	4	14	a	a	DET
aiua-6844	4	15	double	double	ADJ
aiua-6844	4	16	-	-	PUNCT
aiua-6844	4	17	blind	blind	ADJ
aiua-6844	4	18	randomized	randomized	ADJ
aiua-6844	4	19	placebo	placebo	NOUN
aiua-6844	4	20	-	-	PUNCT
aiua-6844	4	21	controlled	control	VERB
aiua-6844	4	22	phase	phase	NOUN
aiua-6844	4	23	ii	ii	NOUN
aiua-6844	4	24	clinical	clinical	ADJ
aiua-6844	4	25	trial	trial	NOUN
aiua-6844	4	26	.	.	PUNCT
aiua-6844	5	1	treated	treat	VERB
aiua-6844	5	2	group	group	NOUN
aiua-6844	5	3	took	take	VERB
aiua-6844	5	4	daily	daily	ADV
aiua-6844	5	5	600	600	NUM
aiua-6844	5	6	mg	mg	NOUN
aiua-6844	5	7	of	of	ADP
aiua-6844	5	8	green	green	ADJ
aiua-6844	5	9	tea	tea	NOUN
aiua-6844	5	10	catechins	catechin	NOUN
aiua-6844	5	11	(	(	PUNCT
aiua-6844	5	12	categ	categ	NOUN
aiua-6844	5	13	plus	plus	CCONJ
aiua-6844	5	14	®	®	NOUN
aiua-6844	5	15	)	)	PUNCT
aiua-6844	5	16	for	for	ADP
aiua-6844	5	17	1	1	NUM
aiua-6844	5	18	year	year	NOUN
aiua-6844	5	19	.	.	PUNCT
aiua-6844	6	1	patients	patient	NOUN
aiua-6844	6	2	were	be	AUX
aiua-6844	6	3	screened	screen	VERB
aiua-6844	6	4	at	at	ADP
aiua-6844	6	5	6	6	NUM
aiua-6844	6	6	and	and	CCONJ
aiua-6844	6	7	12	12	NUM
aiua-6844	6	8	months	month	NOUN
aiua-6844	6	9	through	through	ADP
aiua-6844	6	10	prostatic	prostatic	ADJ
aiua-6844	6	11	biopsy	biopsy	NOUN
aiua-6844	6	12	and	and	CCONJ
aiua-6844	6	13	measurements	measurement	NOUN
aiua-6844	6	14	of	of	ADP
aiua-6844	6	15	prostate	prostate	NOUN
aiua-6844	6	16	-	-	PUNCT
aiua-6844	6	17	specific	specific	ADJ
aiua-6844	6	18	antigen	antigen	NOUN
aiua-6844	6	19	(	(	PUNCT
aiua-6844	6	20	psa	psa	NOUN
aiua-6844	6	21	)	)	PUNCT
aiua-6844	6	22	.	.	PUNCT
aiua-6844	7	1	results	result	NOUN
aiua-6844	7	2	:	:	PUNCT
aiua-6844	7	3	despite	despite	SCONJ
aiua-6844	7	4	the	the	DET
aiua-6844	7	5	statistically	statistically	ADV
aiua-6844	7	6	significant	significant	ADJ
aiua-6844	7	7	reduction	reduction	NOUN
aiua-6844	7	8	of	of	ADP
aiua-6844	7	9	psa	psa	NOUN
aiua-6844	7	10	observed	observe	VERB
aiua-6844	7	11	in	in	ADP
aiua-6844	7	12	subjects	subject	NOUN
aiua-6844	7	13	who	who	PRON
aiua-6844	7	14	received	receive	VERB
aiua-6844	7	15	green	green	ADJ
aiua-6844	7	16	tea	tea	NOUN
aiua-6844	7	17	catechins	catechin	NOUN
aiua-6844	7	18	for	for	ADP
aiua-6844	7	19	6	6	NUM
aiua-6844	7	20	and	and	CCONJ
aiua-6844	7	21	12	12	NUM
aiua-6844	7	22	months	month	NOUN
aiua-6844	7	23	,	,	PUNCT
aiua-6844	7	24	we	we	PRON
aiua-6844	7	25	did	do	AUX
aiua-6844	7	26	not	not	PART
aiua-6844	7	27	find	find	VERB
aiua-6844	7	28	any	any	DET
aiua-6844	7	29	statistical	statistical	ADJ
aiua-6844	7	30	difference	difference	NOUN
aiua-6844	7	31	in	in	ADP
aiua-6844	7	32	pca	pca	NOUN
aiua-6844	7	33	incidence	incidence	NOUN
aiua-6844	7	34	between	between	ADP
aiua-6844	7	35	the	the	DET
aiua-6844	7	36	experimental	experimental	ADJ
aiua-6844	7	37	groups	group	NOUN
aiua-6844	7	38	neither	neither	CCONJ
aiua-6844	7	39	after	after	ADP
aiua-6844	7	40	6	6	NUM
aiua-6844	7	41	nor	nor	CCONJ
aiua-6844	7	42	after	after	ADP
aiua-6844	7	43	12	12	NUM
aiua-6844	7	44	months	month	NOUN
aiua-6844	7	45	.	.	PUNCT
aiua-6844	8	1	however	however	ADV
aiua-6844	8	2	,	,	PUNCT
aiua-6844	8	3	throughout	throughout	ADP
aiua-6844	8	4	the	the	DET
aiua-6844	8	5	one	one	NUM
aiua-6844	8	6	-	-	PUNCT
aiua-6844	8	7	year	year	NOUN
aiua-6844	8	8	follow	follow	NOUN
aiua-6844	8	9	-	-	PUNCT
aiua-6844	8	10	up	up	NOUN
aiua-6844	8	11	we	we	PRON
aiua-6844	8	12	observed	observe	VERB
aiua-6844	8	13	very	very	ADV
aiua-6844	8	14	limited	limited	ADJ
aiua-6844	8	15	adverse	adverse	ADJ
aiua-6844	8	16	effects	effect	NOUN
aiua-6844	8	17	induced	induce	VERB
aiua-6844	8	18	by	by	ADP
aiua-6844	8	19	green	green	ADJ
aiua-6844	8	20	tea	tea	NOUN
aiua-6844	8	21	catechins	catechin	NOUN
aiua-6844	8	22	and	and	CCONJ
aiua-6844	8	23	a	a	DET
aiua-6844	8	24	not	not	PART
aiua-6844	8	25	significant	significant	ADJ
aiua-6844	8	26	improvement	improvement	NOUN
aiua-6844	8	27	in	in	ADP
aiua-6844	8	28	lower	low	ADJ
aiua-6844	8	29	urinary	urinary	ADJ
aiua-6844	8	30	tract	tract	NOUN
aiua-6844	8	31	symptoms	symptom	NOUN
aiua-6844	8	32	and	and	CCONJ
aiua-6844	8	33	quality	quality	NOUN
aiua-6844	8	34	of	of	ADP
aiua-6844	8	35	life	life	NOUN
aiua-6844	8	36	.	.	PUNCT
aiua-6844	9	1	conclusions	conclusion	NOUN
aiua-6844	9	2	:	:	PUNCT
aiua-6844	9	3	although	although	SCONJ
aiua-6844	9	4	the	the	DET
aiua-6844	9	5	small	small	ADJ
aiua-6844	9	6	number	number	NOUN
aiua-6844	9	7	of	of	ADP
aiua-6844	9	8	patients	patient	NOUN
aiua-6844	9	9	enrolled	enrol	VERB
aiua-6844	9	10	in	in	ADP
aiua-6844	9	11	our	our	PRON
aiua-6844	9	12	study	study	NOUN
aiua-6844	9	13	and	and	CCONJ
aiua-6844	9	14	the	the	DET
aiua-6844	9	15	relatively	relatively	ADV
aiua-6844	9	16	short	short	ADJ
aiua-6844	9	17	duration	duration	NOUN
aiua-6844	9	18	of	of	ADP
aiua-6844	9	19	intervention	intervention	NOUN
aiua-6844	9	20	,	,	PUNCT
aiua-6844	9	21	our	our	PRON
aiua-6844	9	22	findings	finding	NOUN
aiua-6844	9	23	seems	seem	VERB
aiua-6844	9	24	to	to	PART
aiua-6844	9	25	deny	deny	VERB
aiua-6844	9	26	the	the	DET
aiua-6844	9	27	efficacy	efficacy	NOUN
aiua-6844	9	28	of	of	ADP
aiua-6844	9	29	green	green	ADJ
aiua-6844	9	30	tea	tea	NOUN
aiua-6844	9	31	catechins	catechin	NOUN
aiua-6844	9	32	.	.	PUNCT
aiua-6844	10	1	however	however	ADV
aiua-6844	10	2	,	,	PUNCT
aiua-6844	10	3	results	result	NOUN
aiua-6844	10	4	of	of	ADP
aiua-6844	10	5	our	our	PRON
aiua-6844	10	6	clinical	clinical	ADJ
aiua-6844	10	7	study	study	NOUN
aiua-6844	10	8	,	,	PUNCT
aiua-6844	10	9	mainly	mainly	ADV
aiua-6844	10	10	for	for	ADP
aiua-6844	10	11	its	its	PRON
aiua-6844	10	12	low	low	ADJ
aiua-6844	10	13	statistical	statistical	ADJ
aiua-6844	10	14	strength	strength	NOUN
aiua-6844	10	15	,	,	PUNCT
aiua-6844	10	16	suggest	suggest	VERB
aiua-6844	10	17	that	that	SCONJ
aiua-6844	10	18	the	the	DET
aiua-6844	10	19	effectiveness	effectiveness	NOUN
aiua-6844	10	20	of	of	ADP
aiua-6844	10	21	green	green	ADJ
aiua-6844	10	22	tea	tea	NOUN
aiua-6844	10	23	catechins	catechin	NOUN
aiua-6844	10	24	should	should	AUX
aiua-6844	10	25	be	be	AUX
aiua-6844	10	26	evaluated	evaluate	VERB
aiua-6844	10	27	in	in	ADP
aiua-6844	10	28	both	both	CCONJ
aiua-6844	10	29	a	a	DET
aiua-6844	10	30	larger	large	ADJ
aiua-6844	10	31	cohort	cohort	NOUN
aiua-6844	10	32	of	of	ADP
aiua-6844	10	33	men	man	NOUN
aiua-6844	10	34	and	and	CCONJ
aiua-6844	10	35	longer	long	ADJ
aiua-6844	10	36	trial	trial	NOUN
aiua-6844	10	37	.	.	PUNCT
aiua-6844	11	1	key	key	ADJ
aiua-6844	11	2	words	word	NOUN
aiua-6844	11	3	:	:	PUNCT
aiua-6844	11	4	prostate	prostate	NOUN
aiua-6844	11	5	cancer	cancer	NOUN
aiua-6844	11	6	;	;	PUNCT
aiua-6844	11	7	green	green	ADJ
aiua-6844	11	8	tea	tea	NOUN
aiua-6844	11	9	catechins	catechin	NOUN
aiua-6844	11	10	;	;	PUNCT
aiua-6844	11	11	high	high	ADJ
aiua-6844	11	12	-	-	PUNCT
aiua-6844	11	13	grade	grade	NOUN
aiua-6844	11	14	intra	intra	ADJ
aiua-6844	11	15	-	-	ADJ
aiua-6844	11	16	epithelial	epithelial	ADJ
aiua-6844	11	17	neoplasia	neoplasia	NOUN
aiua-6844	11	18	(	(	PUNCT
aiua-6844	11	19	hg	hg	NOUN
aiua-6844	11	20	-	-	NOUN
aiua-6844	11	21	pin	pin	NOUN
aiua-6844	11	22	)	)	PUNCT
aiua-6844	11	23	;	;	PUNCT
aiua-6844	11	24	herbal	herbal	ADJ
aiua-6844	11	25	medicines	medicine	NOUN
aiua-6844	11	26	;	;	PUNCT
aiua-6844	11	27	psa	psa	NOUN
aiua-6844	11	28	;	;	PUNCT
aiua-6844	11	29	complementary	complementary	ADJ
aiua-6844	11	30	therapies	therapy	NOUN
aiua-6844	11	31	.	.	PUNCT
aiua-6844	11	32	submitted	submit	VERB
aiua-6844	11	33	9	9	NUM
aiua-6844	11	34	june	june	PROPN
aiua-6844	11	35	2017	2017	NUM
aiua-6844	11	36	;	;	PUNCT
aiua-6844	11	37	accepted	accept	VERB
aiua-6844	11	38	3	3	NUM
aiua-6844	11	39	august	august	PROPN
aiua-6844	11	40	2017	2017	NUM
aiua-6844	11	41	summary	summary	NOUN
aiua-6844	11	42	funding	funding	NOUN
aiua-6844	11	43	and	and	CCONJ
aiua-6844	11	44	competing	compete	VERB
aiua-6844	11	45	interests	interest	NOUN
aiua-6844	11	46	:	:	PUNCT
aiua-6844	11	47	this	this	DET
aiua-6844	11	48	clinical	clinical	ADJ
aiua-6844	11	49	trial	trial	NOUN
aiua-6844	11	50	received	receive	VERB
aiua-6844	11	51	no	no	DET
aiua-6844	11	52	specific	specific	ADJ
aiua-6844	11	53	funding	funding	NOUN
aiua-6844	11	54	.	.	PUNCT
aiua-6844	12	1	the	the	DET
aiua-6844	12	2	authors	author	NOUN
aiua-6844	12	3	declare	declare	VERB
aiua-6844	12	4	that	that	SCONJ
aiua-6844	12	5	there	there	PRON
aiua-6844	12	6	is	be	VERB
aiua-6844	12	7	no	no	DET
aiua-6844	12	8	conflict	conflict	NOUN
aiua-6844	12	9	of	of	ADP
aiua-6844	12	10	interest	interest	NOUN
aiua-6844	12	11	regarding	regard	VERB
aiua-6844	12	12	the	the	DET
aiua-6844	12	13	publication	publication	NOUN
aiua-6844	12	14	of	of	ADP
aiua-6844	12	15	this	this	DET
aiua-6844	12	16	paper	paper	NOUN
aiua-6844	12	17	.	.	PUNCT
aiua-6844	13	1	sofar	sofar	PROPN
aiua-6844	13	2	s.p.a	s.p.a	PROPN
aiua-6844	13	3	,	,	PUNCT
aiua-6844	13	4	milan	milan	PROPN
aiua-6844	13	5	provided	provide	VERB
aiua-6844	13	6	free	free	ADJ
aiua-6844	13	7	samples	sample	NOUN
aiua-6844	13	8	of	of	ADP
aiua-6844	13	9	categ	categ	NOUN
aiua-6844	13	10	plus	plus	NOUN
aiua-6844	13	11	®	®	NOUN
aiua-6844	13	12	employed	employ	VERB
aiua-6844	13	13	in	in	ADP
aiua-6844	13	14	this	this	DET
aiua-6844	13	15	study	study	NOUN
aiua-6844	13	16	,	,	PUNCT
aiua-6844	13	17	without	without	ADP
aiua-6844	13	18	any	any	DET
aiua-6844	13	19	role	role	NOUN
aiua-6844	13	20	in	in	ADP
aiua-6844	13	21	data	datum	NOUN
aiua-6844	13	22	collection	collection	NOUN
aiua-6844	13	23	and	and	CCONJ
aiua-6844	13	24	analysis	analysis	NOUN
aiua-6844	13	25	,	,	PUNCT
aiua-6844	13	26	decision	decision	NOUN
aiua-6844	13	27	to	to	PART
aiua-6844	13	28	publish	publish	VERB
aiua-6844	13	29	,	,	PUNCT
aiua-6844	13	30	or	or	CCONJ
aiua-6844	13	31	preparation	preparation	NOUN
aiua-6844	13	32	of	of	ADP
aiua-6844	13	33	the	the	DET
aiua-6844	13	34	paper	paper	NOUN
aiua-6844	13	35	.	.	PUNCT
aiua-6844	14	1	usually	usually	ADV
aiua-6844	14	2	,	,	PUNCT
aiua-6844	14	3	requires	require	VERB
aiua-6844	14	4	more	more	ADJ
aiua-6844	14	5	than	than	ADP
aiua-6844	14	6	two	two	NUM
aiua-6844	14	7	decades	decade	NOUN
aiua-6844	14	8	for	for	ADP
aiua-6844	14	9	its	its	PRON
aiua-6844	14	10	development	development	NOUN
aiua-6844	14	11	.	.	PUNCT
aiua-6844	15	1	thus	thus	ADV
aiua-6844	15	2	,	,	PUNCT
aiua-6844	15	3	it	it	PRON
aiua-6844	15	4	can	can	AUX
aiua-6844	15	5	be	be	AUX
aiua-6844	15	6	considered	consider	VERB
aiua-6844	15	7	as	as	ADP
aiua-6844	15	8	an	an	DET
aiua-6844	15	9	important	important	ADJ
aiua-6844	15	10	chance	chance	NOUN
aiua-6844	15	11	for	for	ADP
aiua-6844	15	12	early	early	ADJ
aiua-6844	15	13	prediction	prediction	NOUN
aiua-6844	15	14	or	or	CCONJ
aiua-6844	15	15	chemoprevention	chemoprevention	NOUN
aiua-6844	15	16	through	through	ADP
aiua-6844	15	17	therapeutic	therapeutic	ADJ
aiua-6844	15	18	or	or	CCONJ
aiua-6844	15	19	nutritional	nutritional	ADJ
aiua-6844	15	20	interventions	intervention	NOUN
aiua-6844	15	21	,	,	PUNCT
aiua-6844	15	22	especially	especially	ADV
aiua-6844	15	23	in	in	ADP
aiua-6844	15	24	the	the	DET
aiua-6844	15	25	case	case	NOUN
aiua-6844	15	26	of	of	ADP
aiua-6844	15	27	pre	pre	ADJ
aiua-6844	15	28	-	-	ADJ
aiua-6844	15	29	malignant	malignant	ADJ
aiua-6844	15	30	lesions	lesion	NOUN
aiua-6844	15	31	such	such	ADJ
aiua-6844	15	32	as	as	ADP
aiua-6844	15	33	high	high	ADJ
aiua-6844	15	34	-	-	PUNCT
aiua-6844	15	35	grade	grade	NOUN
aiua-6844	15	36	prostate	prostate	NOUN
aiua-6844	15	37	intraepithelial	intraepithelial	ADJ
aiua-6844	15	38	neoplasia	neoplasia	NOUN
aiua-6844	15	39	(	(	PUNCT
aiua-6844	15	40	hg	hg	NOUN
aiua-6844	15	41	-	-	NOUN
aiua-6844	15	42	pin	pin	NOUN
aiua-6844	15	43	)	)	PUNCT
aiua-6844	15	44	(	(	PUNCT
aiua-6844	15	45	1	1	NUM
aiua-6844	15	46	)	)	PUNCT
aiua-6844	15	47	.	.	PUNCT
aiua-6844	16	1	a	a	DET
aiua-6844	16	2	chemoprevention	chemoprevention	NOUN
aiua-6844	16	3	approach	approach	NOUN
aiua-6844	16	4	in	in	ADP
aiua-6844	16	5	patients	patient	NOUN
aiua-6844	16	6	with	with	ADP
aiua-6844	16	7	high	high	ADJ
aiua-6844	16	8	risk	risk	NOUN
aiua-6844	16	9	of	of	ADP
aiua-6844	16	10	pca	pca	NOUN
aiua-6844	16	11	can	can	AUX
aiua-6844	16	12	be	be	AUX
aiua-6844	16	13	proposed	propose	VERB
aiua-6844	16	14	in	in	ADP
aiua-6844	16	15	order	order	NOUN
aiua-6844	16	16	to	to	PART
aiua-6844	16	17	reduce	reduce	VERB
aiua-6844	16	18	the	the	DET
aiua-6844	16	19	disease	disease	NOUN
aiua-6844	16	20	progression	progression	NOUN
aiua-6844	16	21	rate	rate	NOUN
aiua-6844	16	22	.	.	PUNCT
aiua-6844	17	1	it	it	PRON
aiua-6844	17	2	is	be	AUX
aiua-6844	17	3	known	know	VERB
aiua-6844	17	4	that	that	SCONJ
aiua-6844	17	5	natural	natural	ADJ
aiua-6844	17	6	product	product	NOUN
aiua-6844	17	7	can	can	AUX
aiua-6844	17	8	be	be	AUX
aiua-6844	17	9	used	use	VERB
aiua-6844	17	10	to	to	PART
aiua-6844	17	11	prevent	prevent	VERB
aiua-6844	17	12	and/or	and/or	CCONJ
aiua-6844	17	13	alleviate	alleviate	VERB
aiua-6844	17	14	several	several	ADJ
aiua-6844	17	15	health	health	NOUN
aiua-6844	17	16	disorders	disorder	NOUN
aiua-6844	17	17	(	(	PUNCT
aiua-6844	17	18	2	2	NUM
aiua-6844	17	19	-	-	SYM
aiua-6844	17	20	4	4	NUM
aiua-6844	17	21	)	)	PUNCT
aiua-6844	17	22	,	,	PUNCT
aiua-6844	17	23	including	include	VERB
aiua-6844	17	24	those	those	PRON
aiua-6844	17	25	affecting	affect	VERB
aiua-6844	17	26	the	the	DET
aiua-6844	17	27	urinary	urinary	ADJ
aiua-6844	17	28	tract	tract	NOUN
aiua-6844	17	29	(	(	PUNCT
aiua-6844	17	30	5	5	NUM
aiua-6844	17	31	)	)	PUNCT
aiua-6844	17	32	.	.	PUNCT
aiua-6844	18	1	moreover	moreover	ADV
aiua-6844	18	2	,	,	PUNCT
aiua-6844	18	3	regular	regular	ADJ
aiua-6844	18	4	dietary	dietary	ADJ
aiua-6844	18	5	habits	habit	NOUN
aiua-6844	18	6	coupled	couple	VERB
aiua-6844	18	7	with	with	ADP
aiua-6844	18	8	a	a	DET
aiua-6844	18	9	healthy	healthy	ADJ
aiua-6844	18	10	lifestyle	lifestyle	NOUN
aiua-6844	18	11	may	may	AUX
aiua-6844	18	12	protect	protect	VERB
aiua-6844	18	13	against	against	ADP
aiua-6844	18	14	certain	certain	ADJ
aiua-6844	18	15	types	type	NOUN
aiua-6844	18	16	of	of	ADP
aiua-6844	18	17	cancer	cancer	NOUN
aiua-6844	18	18	(	(	PUNCT
aiua-6844	18	19	6	6	NUM
aiua-6844	18	20	,	,	PUNCT
aiua-6844	18	21	7	7	NUM
aiua-6844	18	22	)	)	PUNCT
aiua-6844	18	23	,	,	PUNCT
aiua-6844	18	24	including	include	VERB
aiua-6844	18	25	pca	pca	PROPN
aiua-6844	18	26	.	.	PUNCT
aiua-6844	19	1	in	in	ADP
aiua-6844	19	2	particular	particular	ADJ
aiua-6844	19	3	,	,	PUNCT
aiua-6844	19	4	epidemiological	epidemiological	ADJ
aiua-6844	19	5	studies	study	NOUN
aiua-6844	19	6	have	have	AUX
aiua-6844	19	7	shown	show	VERB
aiua-6844	19	8	that	that	SCONJ
aiua-6844	19	9	asiatic	asiatic	ADJ
aiua-6844	19	10	populations	population	NOUN
aiua-6844	19	11	have	have	VERB
aiua-6844	19	12	lower	low	ADJ
aiua-6844	19	13	rates	rate	NOUN
aiua-6844	19	14	of	of	ADP
aiua-6844	19	15	pca	pca	NOUN
aiua-6844	19	16	compared	compare	VERB
aiua-6844	19	17	to	to	ADP
aiua-6844	19	18	others	other	NOUN
aiua-6844	19	19	races	race	NOUN
aiua-6844	19	20	and	and	CCONJ
aiua-6844	19	21	that	that	SCONJ
aiua-6844	19	22	asian	asian	ADJ
aiua-6844	19	23	men	man	NOUN
aiua-6844	19	24	who	who	PRON
aiua-6844	19	25	adopt	adopt	VERB
aiua-6844	19	26	a	a	DET
aiua-6844	19	27	lifestyle	lifestyle	NOUN
aiua-6844	19	28	typical	typical	ADJ
aiua-6844	19	29	of	of	ADP
aiua-6844	19	30	western	western	ADJ
aiua-6844	19	31	countries	country	NOUN
aiua-6844	19	32	because	because	SCONJ
aiua-6844	19	33	of	of	ADP
aiua-6844	19	34	migration	migration	NOUN
aiua-6844	19	35	to	to	ADP
aiua-6844	19	36	the	the	DET
aiua-6844	19	37	united	united	PROPN
aiua-6844	19	38	states	states	PROPN
aiua-6844	19	39	,	,	PUNCT
aiua-6844	19	40	have	have	VERB
aiua-6844	19	41	a	a	DET
aiua-6844	19	42	significantly	significantly	ADV
aiua-6844	19	43	higher	high	ADJ
aiua-6844	19	44	risk	risk	NOUN
aiua-6844	19	45	of	of	ADP
aiua-6844	19	46	pca	pca	PROPN
aiua-6844	19	47	when	when	SCONJ
aiua-6844	19	48	compared	compare	VERB
aiua-6844	19	49	to	to	ADP
aiua-6844	19	50	their	their	PRON
aiua-6844	19	51	native	native	ADJ
aiua-6844	19	52	asian	asian	ADJ
aiua-6844	19	53	counterparts	counterpart	NOUN
aiua-6844	19	54	(	(	PUNCT
aiua-6844	19	55	8)	8)	NUM
aiua-6844	19	56	.	.	PUNCT
aiua-6844	20	1	these	these	DET
aiua-6844	20	2	findings	finding	NOUN
aiua-6844	20	3	strengthen	strengthen	VERB
aiua-6844	20	4	the	the	DET
aiua-6844	20	5	hypothesis	hypothesis	NOUN
aiua-6844	20	6	that	that	PRON
aiua-6844	20	7	environmental	environmental	ADJ
aiua-6844	20	8	factors	factor	NOUN
aiua-6844	20	9	may	may	AUX
aiua-6844	20	10	contribute	contribute	VERB
aiua-6844	20	11	to	to	ADP
aiua-6844	20	12	pca	pca	NOUN
aiua-6844	20	13	development	development	NOUN
aiua-6844	20	14	and	and	CCONJ
aiua-6844	20	15	that	that	SCONJ
aiua-6844	20	16	the	the	DET
aiua-6844	20	17	use	use	NOUN
aiua-6844	20	18	of	of	ADP
aiua-6844	20	19	dietary	dietary	ADJ
aiua-6844	20	20	agents	agent	NOUN
aiua-6844	20	21	such	such	ADJ
aiua-6844	20	22	as	as	ADP
aiua-6844	20	23	green	green	ADJ
aiua-6844	20	24	tea	tea	NOUN
aiua-6844	20	25	may	may	AUX
aiua-6844	20	26	be	be	AUX
aiua-6844	20	27	an	an	DET
aiua-6844	20	28	important	important	ADJ
aiua-6844	20	29	way	way	NOUN
aiua-6844	20	30	to	to	PART
aiua-6844	20	31	prevent	prevent	VERB
aiua-6844	20	32	or	or	CCONJ
aiua-6844	20	33	slow	slow	VERB
aiua-6844	20	34	down	down	ADP
aiua-6844	20	35	the	the	DET
aiua-6844	20	36	process	process	NOUN
aiua-6844	20	37	of	of	ADP
aiua-6844	20	38	carcinogenesis	carcinogenesis	NOUN
aiua-6844	20	39	,	,	PUNCT
aiua-6844	20	40	hence	hence	ADV
aiua-6844	20	41	the	the	DET
aiua-6844	20	42	growing	grow	VERB
aiua-6844	20	43	interest	interest	NOUN
aiua-6844	20	44	toward	toward	ADP
aiua-6844	20	45	both	both	DET
aiua-6844	20	46	dietary	dietary	ADJ
aiua-6844	20	47	supplements	supplement	NOUN
aiua-6844	20	48	and	and	CCONJ
aiua-6844	20	49	complementary	complementary	ADJ
aiua-6844	20	50	and	and	CCONJ
aiua-6844	20	51	alternative	alternative	ADJ
aiua-6844	20	52	medicine	medicine	NOUN
aiua-6844	20	53	.	.	PUNCT
aiua-6844	21	1	in	in	ADP
aiua-6844	21	2	such	such	ADJ
aiua-6844	21	3	context	context	NOUN
aiua-6844	21	4	,	,	PUNCT
aiua-6844	21	5	diet	diet	NOUN
aiua-6844	21	6	-	-	PUNCT
aiua-6844	21	7	derived	derive	VERB
aiua-6844	21	8	polyphenols	polyphenol	NOUN
aiua-6844	21	9	have	have	AUX
aiua-6844	21	10	received	receive	VERB
aiua-6844	21	11	great	great	ADJ
aiua-6844	21	12	attention	attention	NOUN
aiua-6844	21	13	among	among	ADP
aiua-6844	21	14	nutritionists	nutritionist	NOUN
aiua-6844	21	15	,	,	PUNCT
aiua-6844	21	16	food	food	NOUN
aiua-6844	21	17	scientists	scientist	NOUN
aiua-6844	21	18	,	,	PUNCT
aiua-6844	21	19	and	and	CCONJ
aiua-6844	21	20	consumers	consumer	NOUN
aiua-6844	21	21	for	for	ADP
aiua-6844	21	22	their	their	PRON
aiua-6844	21	23	health	health	NOUN
aiua-6844	21	24	-	-	PUNCT
aiua-6844	21	25	promoting	promote	VERB
aiua-6844	21	26	effects	effect	NOUN
aiua-6844	21	27	,	,	PUNCT
aiua-6844	21	28	including	include	VERB
aiua-6844	21	29	their	their	PRON
aiua-6844	21	30	use	use	NOUN
aiua-6844	21	31	in	in	ADP
aiua-6844	21	32	the	the	DET
aiua-6844	21	33	chemoprevention	chemoprevention	NOUN
aiua-6844	21	34	of	of	ADP
aiua-6844	21	35	pca	pca	PROPN
aiua-6844	21	36	(	(	PUNCT
aiua-6844	21	37	9	9	NUM
aiua-6844	21	38	)	)	PUNCT
aiua-6844	21	39	,	,	PUNCT
aiua-6844	21	40	because	because	SCONJ
aiua-6844	21	41	oxidative	oxidative	ADJ
aiua-6844	21	42	stress	stress	NOUN
aiua-6844	21	43	has	have	AUX
aiua-6844	21	44	been	be	AUX
aiua-6844	21	45	implicated	implicate	VERB
aiua-6844	21	46	in	in	ADP
aiua-6844	21	47	the	the	DET
aiua-6844	21	48	aetiopathogenesis	aetiopathogenesis	NOUN
aiua-6844	21	49	of	of	ADP
aiua-6844	21	50	pca	pca	PROPN
aiua-6844	21	51	(	(	PUNCT
aiua-6844	21	52	10	10	NUM
aiua-6844	21	53	)	)	PUNCT
aiua-6844	21	54	.	.	PUNCT
aiua-6844	22	1	regardless	regardless	ADV
aiua-6844	22	2	,	,	PUNCT
aiua-6844	22	3	unresolved	unresolved	ADJ
aiua-6844	22	4	issues	issue	NOUN
aiua-6844	22	5	still	still	ADV
aiua-6844	22	6	linger	linger	VERB
aiua-6844	22	7	.	.	PUNCT
aiua-6844	23	1	tea	tea	NOUN
aiua-6844	23	2	is	be	AUX
aiua-6844	23	3	the	the	DET
aiua-6844	23	4	most	most	ADV
aiua-6844	23	5	consumed	consume	VERB
aiua-6844	23	6	beverage	beverage	NOUN
aiua-6844	23	7	worldwide	worldwide	ADV
aiua-6844	23	8	,	,	PUNCT
aiua-6844	23	9	second	second	ADJ
aiua-6844	23	10	only	only	ADV
aiua-6844	23	11	to	to	PART
aiua-6844	23	12	water	water	VERB
aiua-6844	23	13	in	in	ADP
aiua-6844	23	14	terms	term	NOUN
aiua-6844	23	15	of	of	ADP
aiua-6844	23	16	popularity	popularity	NOUN
aiua-6844	23	17	.	.	PUNCT
aiua-6844	24	1	it	it	PRON
aiua-6844	24	2	is	be	AUX
aiua-6844	24	3	prepared	prepare	VERB
aiua-6844	24	4	by	by	ADP
aiua-6844	24	5	infusion	infusion	NOUN
aiua-6844	24	6	of	of	ADP
aiua-6844	24	7	the	the	DET
aiua-6844	24	8	camelia	camelia	PROPN
aiua-6844	24	9	sinensis	sinensis	NOUN
aiua-6844	24	10	l.	l.	PROPN
aiua-6844	24	11	(	(	PUNCT
aiua-6844	24	12	theaceae	theaceae	PROPN
aiua-6844	24	13	)	)	PUNCT
aiua-6844	24	14	leaves	leave	NOUN
aiua-6844	24	15	.	.	PUNCT
aiua-6844	25	1	on	on	ADP
aiua-6844	25	2	the	the	DET
aiua-6844	25	3	basis	basis	NOUN
aiua-6844	25	4	of	of	ADP
aiua-6844	25	5	both	both	CCONJ
aiua-6844	25	6	the	the	DET
aiua-6844	25	7	differences	difference	NOUN
aiua-6844	25	8	in	in	ADP
aiua-6844	25	9	the	the	DET
aiua-6844	25	10	processing	processing	NOUN
aiua-6844	25	11	methods	method	NOUN
aiua-6844	25	12	and	and	CCONJ
aiua-6844	25	13	chemical	chemical	NOUN
aiua-6844	25	14	composition	composition	NOUN
aiua-6844	25	15	,	,	PUNCT
aiua-6844	25	16	it	it	PRON
aiua-6844	25	17	could	could	AUX
aiua-6844	25	18	be	be	AUX
aiua-6844	25	19	classified	classify	VERB
aiua-6844	25	20	in	in	ADP
aiua-6844	25	21	three	three	NUM
aiua-6844	25	22	main	main	ADJ
aiua-6844	25	23	types	type	NOUN
aiua-6844	25	24	,	,	PUNCT
aiua-6844	25	25	the	the	DET
aiua-6844	25	26	green	green	ADJ
aiua-6844	25	27	tea	tea	NOUN
aiua-6844	25	28	(	(	PUNCT
aiua-6844	25	29	unfermented	unfermented	ADJ
aiua-6844	25	30	)	)	PUNCT
aiua-6844	25	31	,	,	PUNCT
aiua-6844	25	32	the	the	DET
aiua-6844	25	33	oolong	oolong	PROPN
aiua-6844	25	34	tea	tea	NOUN
aiua-6844	25	35	(	(	PUNCT
aiua-6844	25	36	partially	partially	ADV
aiua-6844	25	37	fermented	ferment	VERB
aiua-6844	25	38	)	)	PUNCT
aiua-6844	25	39	and	and	CCONJ
aiua-6844	25	40	the	the	DET
aiua-6844	25	41	black	black	ADJ
aiua-6844	25	42	tea	tea	NOUN
aiua-6844	25	43	(	(	PUNCT
aiua-6844	25	44	fully	fully	ADV
aiua-6844	25	45	fermented	ferment	VERB
aiua-6844	25	46	)	)	PUNCT
aiua-6844	25	47	.	.	PUNCT
aiua-6844	26	1	habitual	habitual	ADJ
aiua-6844	26	2	green	green	ADJ
aiua-6844	26	3	tea	tea	NOUN
aiua-6844	26	4	consumption	consumption	NOUN
aiua-6844	26	5	has	have	AUX
aiua-6844	26	6	long	long	ADV
aiua-6844	26	7	been	be	AUX
aiua-6844	26	8	associated	associate	VERB
aiua-6844	26	9	with	with	ADP
aiua-6844	26	10	preventive	preventive	ADJ
aiua-6844	26	11	effects	effect	NOUN
aiua-6844	26	12	against	against	ADP
aiua-6844	26	13	chronic	chronic	ADJ
aiua-6844	26	14	pathologies	pathology	NOUN
aiua-6844	26	15	including	include	VERB
aiua-6844	26	16	both	both	CCONJ
aiua-6844	26	17	heart	heart	NOUN
aiua-6844	26	18	and	and	CCONJ
aiua-6844	26	19	neurodegenerative	neurodegenerative	ADJ
aiua-6844	26	20	disease	disease	NOUN
aiua-6844	26	21	and	and	CCONJ
aiua-6844	26	22	cancer	cancer	NOUN
aiua-6844	26	23	.	.	PUNCT
aiua-6844	27	1	in	in	ADP
aiua-6844	27	2	the	the	DET
aiua-6844	27	3	latter	latter	ADJ
aiua-6844	27	4	field	field	NOUN
aiua-6844	27	5	,	,	PUNCT
aiua-6844	27	6	several	several	ADJ
aiua-6844	27	7	in	in	ADP
aiua-6844	27	8	vitro	vitro	X
aiua-6844	27	9	and	and	CCONJ
aiua-6844	27	10	doi	doi	NOUN
aiua-6844	27	11	:	:	PUNCT
aiua-6844	27	12	10.4081	10.4081	NUM
aiua-6844	27	13	/	/	SYM
aiua-6844	27	14	aiua.2017.3.197	aiua.2017.3.197	NOUN
aiua-6844	27	15	introduction	introduction	NOUN
aiua-6844	27	16	prostate	prostate	NOUN
aiua-6844	27	17	cancer	cancer	NOUN
aiua-6844	27	18	(	(	PUNCT
aiua-6844	27	19	pca	pca	PROPN
aiua-6844	27	20	)	)	PUNCT
aiua-6844	27	21	is	be	AUX
aiua-6844	27	22	a	a	DET
aiua-6844	27	23	leading	lead	VERB
aiua-6844	27	24	cause	cause	NOUN
aiua-6844	27	25	of	of	ADP
aiua-6844	27	26	cancer	cancer	NOUN
aiua-6844	27	27	related	relate	VERB
aiua-6844	27	28	death	death	NOUN
aiua-6844	27	29	among	among	ADP
aiua-6844	27	30	men	man	NOUN
aiua-6844	27	31	in	in	ADP
aiua-6844	27	32	western	western	ADJ
aiua-6844	27	33	countries	country	NOUN
aiua-6844	27	34	,	,	PUNCT
aiua-6844	27	35	representing	represent	VERB
aiua-6844	27	36	a	a	DET
aiua-6844	27	37	major	major	ADJ
aiua-6844	27	38	public	public	ADJ
aiua-6844	27	39	health	health	NOUN
aiua-6844	27	40	problem	problem	NOUN
aiua-6844	27	41	with	with	ADP
aiua-6844	27	42	high	high	ADJ
aiua-6844	27	43	economic	economic	ADJ
aiua-6844	27	44	and	and	CCONJ
aiua-6844	27	45	social	social	ADJ
aiua-6844	27	46	costs	cost	NOUN
aiua-6844	27	47	.	.	PUNCT
aiua-6844	28	1	however	however	ADV
aiua-6844	28	2	,	,	PUNCT
aiua-6844	28	3	it	it	PRON
aiua-6844	28	4	is	be	AUX
aiua-6844	28	5	typically	typically	ADV
aiua-6844	28	6	diagnosed	diagnose	VERB
aiua-6844	28	7	in	in	ADP
aiua-6844	28	8	men	man	NOUN
aiua-6844	28	9	over	over	ADP
aiua-6844	28	10	50	50	NUM
aiua-6844	28	11	years	year	NOUN
aiua-6844	28	12	of	of	ADP
aiua-6844	28	13	age	age	NOUN
aiua-6844	28	14	and	and	CCONJ
aiua-6844	28	15	,	,	PUNCT
aiua-6844	28	16	as	as	ADP
aiua-6844	28	17	clinically	clinically	ADV
aiua-6844	28	18	significant	significant	ADJ
aiua-6844	28	19	pca	pca	NOUN
aiua-6844	28	20	,	,	PUNCT
aiua-6844	28	21	micali_stesura	micali_stesura	NOUN
aiua-6844	28	22	seveso	seveso	VERB
aiua-6844	28	23	28/09/17	28/09/17	PROPN
aiua-6844	28	24	10:18	10:18	NUM
aiua-6844	28	25	pagina	pagina	NOUN
aiua-6844	28	26	197	197	NUM
aiua-6844	28	27	archivio	archivio	NOUN
aiua-6844	28	28	italiano	italiano	NOUN
aiua-6844	28	29	di	di	X
aiua-6844	28	30	urologia	urologia	PROPN
aiua-6844	28	31	e	e	PROPN
aiua-6844	28	32	andrologia	andrologia	NOUN
aiua-6844	28	33	2017	2017	NUM
aiua-6844	28	34	;	;	PUNCT
aiua-6844	28	35	89	89	NUM
aiua-6844	28	36	,	,	PUNCT
aiua-6844	28	37	3	3	NUM
aiua-6844	28	38	s.	s.	PROPN
aiua-6844	28	39	micali	micali	PROPN
aiua-6844	28	40	,	,	PUNCT
aiua-6844	28	41	a.	a.	NOUN
aiua-6844	28	42	territo	territo	PROPN
aiua-6844	28	43	,	,	PUNCT
aiua-6844	28	44	g.m	g.m	PROPN
aiua-6844	28	45	.	.	PROPN
aiua-6844	28	46	pirola	pirola	PROPN
aiua-6844	28	47	,	,	PUNCT
aiua-6844	28	48	n.	n.	PROPN
aiua-6844	28	49	ferrari	ferrari	PROPN
aiua-6844	28	50	,	,	PUNCT
aiua-6844	28	51	m.c	m.c	PROPN
aiua-6844	28	52	.	.	PROPN
aiua-6844	28	53	sighinolfi	sighinolfi	PROPN
aiua-6844	28	54	,	,	PUNCT
aiua-6844	28	55	e.	e.	PROPN
aiua-6844	28	56	martorana	martorana	PROPN
aiua-6844	28	57	,	,	PUNCT
aiua-6844	28	58	m.	m.	NOUN
aiua-6844	28	59	navarra	navarra	PROPN
aiua-6844	28	60	,	,	PUNCT
aiua-6844	28	61	g.	g.	PROPN
aiua-6844	28	62	bianchi	bianchi	PROPN
aiua-6844	28	63	198	198	NUM
aiua-6844	28	64	in	in	ADP
aiua-6844	28	65	vivo	vivo	ADJ
aiua-6844	28	66	studies	study	NOUN
aiua-6844	28	67	showed	show	VERB
aiua-6844	28	68	that	that	SCONJ
aiua-6844	28	69	tea	tea	NOUN
aiua-6844	28	70	and	and	CCONJ
aiua-6844	28	71	its	its	PRON
aiua-6844	28	72	bioactive	bioactive	ADJ
aiua-6844	28	73	molecules	molecule	NOUN
aiua-6844	28	74	might	might	AUX
aiua-6844	28	75	modify	modify	VERB
aiua-6844	28	76	the	the	DET
aiua-6844	28	77	incidence	incidence	NOUN
aiua-6844	28	78	and	and	CCONJ
aiua-6844	28	79	the	the	DET
aiua-6844	28	80	progression	progression	NOUN
aiua-6844	28	81	of	of	ADP
aiua-6844	28	82	pca	pca	PROPN
aiua-6844	28	83	through	through	ADP
aiua-6844	28	84	their	their	PRON
aiua-6844	28	85	antioxidant	antioxidant	ADJ
aiua-6844	28	86	properties	property	NOUN
aiua-6844	28	87	and	and	CCONJ
aiua-6844	28	88	the	the	DET
aiua-6844	28	89	ability	ability	NOUN
aiua-6844	28	90	to	to	PART
aiua-6844	28	91	interact	interact	VERB
aiua-6844	28	92	with	with	ADP
aiua-6844	28	93	specific	specific	ADJ
aiua-6844	28	94	intracellular	intracellular	ADJ
aiua-6844	28	95	targets	target	NOUN
aiua-6844	28	96	in	in	ADP
aiua-6844	28	97	cancerous	cancerous	ADJ
aiua-6844	28	98	cells	cell	NOUN
aiua-6844	28	99	(	(	PUNCT
aiua-6844	28	100	11	11	NUM
aiua-6844	28	101	)	)	PUNCT
aiua-6844	28	102	.	.	PUNCT
aiua-6844	29	1	the	the	DET
aiua-6844	29	2	beneficial	beneficial	ADJ
aiua-6844	29	3	effects	effect	NOUN
aiua-6844	29	4	of	of	ADP
aiua-6844	29	5	green	green	ADJ
aiua-6844	29	6	tea	tea	NOUN
aiua-6844	29	7	are	be	AUX
aiua-6844	29	8	attributed	attribute	VERB
aiua-6844	29	9	especially	especially	ADV
aiua-6844	29	10	to	to	ADP
aiua-6844	29	11	its	its	PRON
aiua-6844	29	12	water	water	NOUN
aiua-6844	29	13	soluble	soluble	ADJ
aiua-6844	29	14	polyphenolic	polyphenolic	ADJ
aiua-6844	29	15	flavonoids	flavonoid	NOUN
aiua-6844	29	16	,	,	PUNCT
aiua-6844	29	17	known	know	VERB
aiua-6844	29	18	as	as	ADP
aiua-6844	29	19	catechins	catechin	NOUN
aiua-6844	29	20	,	,	PUNCT
aiua-6844	29	21	including	include	VERB
aiua-6844	29	22	epicatechin	epicatechin	PROPN
aiua-6844	29	23	(	(	PUNCT
aiua-6844	29	24	ec	ec	PROPN
aiua-6844	29	25	)	)	PUNCT
aiua-6844	29	26	,	,	PUNCT
aiua-6844	29	27	epigallocatechin	epigallocatechin	NOUN
aiua-6844	29	28	(	(	PUNCT
aiua-6844	29	29	egc	egc	PROPN
aiua-6844	29	30	)	)	PUNCT
aiua-6844	29	31	,	,	PUNCT
aiua-6844	29	32	epicatechin-3	epicatechin-3	PROPN
aiua-6844	29	33	-	-	NOUN
aiua-6844	29	34	gallate	gallate	NOUN
aiua-6844	29	35	(	(	PUNCT
aiua-6844	29	36	ecg	ecg	PROPN
aiua-6844	29	37	)	)	PUNCT
aiua-6844	29	38	and	and	CCONJ
aiua-6844	29	39	the	the	DET
aiua-6844	29	40	major	major	ADJ
aiua-6844	29	41	flavonoid	flavonoid	NOUN
aiua-6844	29	42	(	(	PUNCT
aiua-6844	29	43	−)-epigallocatechin-3	−)-epigallocatechin-3	NOUN
aiua-6844	29	44	-	-	NOUN
aiua-6844	29	45	gallate	gallate	NOUN
aiua-6844	29	46	(	(	PUNCT
aiua-6844	29	47	egcg	egcg	NOUN
aiua-6844	29	48	)	)	PUNCT
aiua-6844	29	49	.	.	PUNCT
aiua-6844	30	1	their	their	PRON
aiua-6844	30	2	content	content	NOUN
aiua-6844	30	3	is	be	AUX
aiua-6844	30	4	30	30	NUM
aiua-6844	30	5	-	-	SYM
aiua-6844	30	6	40	40	NUM
aiua-6844	30	7	%	%	NOUN
aiua-6844	30	8	of	of	ADP
aiua-6844	30	9	dry	dry	ADJ
aiua-6844	30	10	green	green	ADJ
aiua-6844	30	11	tea	tea	NOUN
aiua-6844	30	12	weight	weight	NOUN
aiua-6844	30	13	,	,	PUNCT
aiua-6844	30	14	and	and	CCONJ
aiua-6844	30	15	egcg	egcg	NOUN
aiua-6844	30	16	may	may	AUX
aiua-6844	30	17	represent	represent	VERB
aiua-6844	30	18	up	up	ADP
aiua-6844	30	19	to	to	PART
aiua-6844	30	20	50	50	NUM
aiua-6844	30	21	%	%	NOUN
aiua-6844	30	22	of	of	ADP
aiua-6844	30	23	the	the	DET
aiua-6844	30	24	catechins	catechin	NOUN
aiua-6844	30	25	by	by	ADP
aiua-6844	30	26	weight	weight	NOUN
aiua-6844	30	27	.	.	PUNCT
aiua-6844	31	1	however	however	ADV
aiua-6844	31	2	,	,	PUNCT
aiua-6844	31	3	other	other	ADJ
aiua-6844	31	4	polyphenols	polyphenol	NOUN
aiua-6844	31	5	present	present	ADJ
aiua-6844	31	6	in	in	ADP
aiua-6844	31	7	green	green	ADJ
aiua-6844	31	8	tea	tea	NOUN
aiua-6844	31	9	are	be	AUX
aiua-6844	31	10	quercetin	quercetin	NOUN
aiua-6844	31	11	,	,	PUNCT
aiua-6844	31	12	myricitrin	myricitrin	NOUN
aiua-6844	31	13	and	and	CCONJ
aiua-6844	31	14	kaempferol	kaempferol	NOUN
aiua-6844	31	15	.	.	PUNCT
aiua-6844	32	1	bettuzzi	bettuzzi	NOUN
aiua-6844	32	2	et	et	PROPN
aiua-6844	32	3	al	al	PROPN
aiua-6844	32	4	.	.	PUNCT
aiua-6844	33	1	(	(	PUNCT
aiua-6844	33	2	12	12	NUM
aiua-6844	33	3	)	)	PUNCT
aiua-6844	33	4	proposed	propose	VERB
aiua-6844	33	5	the	the	DET
aiua-6844	33	6	green	green	ADJ
aiua-6844	33	7	tea	tea	NOUN
aiua-6844	33	8	catechins	catechin	NOUN
aiua-6844	33	9	as	as	ADP
aiua-6844	33	10	chemopreventive	chemopreventive	ADJ
aiua-6844	33	11	agents	agent	NOUN
aiua-6844	33	12	against	against	ADP
aiua-6844	33	13	prostate	prostate	NOUN
aiua-6844	33	14	cancer	cancer	NOUN
aiua-6844	33	15	in	in	ADP
aiua-6844	33	16	men	man	NOUN
aiua-6844	33	17	with	with	ADP
aiua-6844	33	18	hg	hg	NOUN
aiua-6844	33	19	-	-	NOUN
aiua-6844	33	20	pin	pin	NOUN
aiua-6844	33	21	,	,	PUNCT
aiua-6844	33	22	confirming	confirm	VERB
aiua-6844	33	23	this	this	DET
aiua-6844	33	24	suggestion	suggestion	NOUN
aiua-6844	33	25	in	in	ADP
aiua-6844	33	26	a	a	DET
aiua-6844	33	27	long	long	ADJ
aiua-6844	33	28	term	term	NOUN
aiua-6844	33	29	follow	follow	VERB
aiua-6844	33	30	up	up	ADP
aiua-6844	33	31	study	study	NOUN
aiua-6844	33	32	(	(	PUNCT
aiua-6844	33	33	13	13	NUM
aiua-6844	33	34	)	)	PUNCT
aiua-6844	33	35	.	.	PUNCT
aiua-6844	34	1	however	however	ADV
aiua-6844	34	2	,	,	PUNCT
aiua-6844	34	3	others	other	NOUN
aiua-6844	34	4	studies	study	NOUN
aiua-6844	34	5	(	(	PUNCT
aiua-6844	34	6	14	14	NUM
aiua-6844	34	7	)	)	PUNCT
aiua-6844	34	8	often	often	ADV
aiua-6844	34	9	report	report	VERB
aiua-6844	34	10	conflicting	conflicting	ADJ
aiua-6844	34	11	results	result	NOUN
aiua-6844	34	12	,	,	PUNCT
aiua-6844	34	13	suggesting	suggest	VERB
aiua-6844	34	14	that	that	SCONJ
aiua-6844	34	15	habitual	habitual	ADJ
aiua-6844	34	16	green	green	ADJ
aiua-6844	34	17	tea	tea	NOUN
aiua-6844	34	18	consumption	consumption	NOUN
aiua-6844	34	19	may	may	AUX
aiua-6844	34	20	not	not	PART
aiua-6844	34	21	provide	provide	VERB
aiua-6844	34	22	the	the	DET
aiua-6844	34	23	alleged	allege	VERB
aiua-6844	34	24	protection	protection	NOUN
aiua-6844	34	25	against	against	ADP
aiua-6844	34	26	cancer	cancer	NOUN
aiua-6844	34	27	.	.	PUNCT
aiua-6844	35	1	therefore	therefore	ADV
aiua-6844	35	2	,	,	PUNCT
aiua-6844	35	3	the	the	DET
aiua-6844	35	4	aim	aim	NOUN
aiua-6844	35	5	of	of	ADP
aiua-6844	35	6	the	the	DET
aiua-6844	35	7	study	study	NOUN
aiua-6844	35	8	was	be	AUX
aiua-6844	35	9	to	to	PART
aiua-6844	35	10	evaluate	evaluate	VERB
aiua-6844	35	11	the	the	DET
aiua-6844	35	12	efficacy	efficacy	NOUN
aiua-6844	35	13	of	of	ADP
aiua-6844	35	14	green	green	ADJ
aiua-6844	35	15	tea	tea	NOUN
aiua-6844	35	16	catechins	catechin	NOUN
aiua-6844	35	17	for	for	ADP
aiua-6844	35	18	chemoprevention	chemoprevention	NOUN
aiua-6844	35	19	of	of	ADP
aiua-6844	35	20	pca	pca	PROPN
aiua-6844	35	21	in	in	ADP
aiua-6844	35	22	patients	patient	NOUN
aiua-6844	35	23	with	with	ADP
aiua-6844	35	24	hg	hg	NOUN
aiua-6844	35	25	-	-	NOUN
aiua-6844	35	26	pin	pin	NOUN
aiua-6844	35	27	by	by	ADP
aiua-6844	35	28	a	a	DET
aiua-6844	35	29	double	double	ADJ
aiua-6844	35	30	-	-	PUNCT
aiua-6844	35	31	blind	blind	ADJ
aiua-6844	35	32	randomized	randomized	ADJ
aiua-6844	35	33	placebo	placebo	NOUN
aiua-6844	35	34	-	-	PUNCT
aiua-6844	35	35	controlled	control	VERB
aiua-6844	35	36	phase	phase	NOUN
aiua-6844	35	37	ii	ii	NOUN
aiua-6844	35	38	clinical	clinical	ADJ
aiua-6844	35	39	trial	trial	NOUN
aiua-6844	35	40	.	.	PUNCT
aiua-6844	36	1	methods	method	NOUN
aiua-6844	36	2	study	study	NOUN
aiua-6844	36	3	design	design	NOUN
aiua-6844	36	4	sixty	sixty	NUM
aiua-6844	36	5	volunteers	volunteer	NOUN
aiua-6844	36	6	with	with	ADP
aiua-6844	36	7	hg	hg	NOUN
aiua-6844	36	8	-	-	NOUN
aiua-6844	36	9	pin	pin	NOUN
aiua-6844	36	10	were	be	AUX
aiua-6844	36	11	enrolled	enrol	VERB
aiua-6844	36	12	to	to	PART
aiua-6844	36	13	carry	carry	VERB
aiua-6844	36	14	out	out	ADP
aiua-6844	36	15	a	a	DET
aiua-6844	36	16	double	double	ADJ
aiua-6844	36	17	-	-	PUNCT
aiua-6844	36	18	blind	blind	ADJ
aiua-6844	36	19	randomized	randomized	ADJ
aiua-6844	36	20	placebo	placebo	NOUN
aiua-6844	36	21	-	-	PUNCT
aiua-6844	36	22	controlled	control	VERB
aiua-6844	36	23	phase	phase	NOUN
aiua-6844	36	24	ii	ii	NOUN
aiua-6844	36	25	clinical	clinical	ADJ
aiua-6844	36	26	trial	trial	NOUN
aiua-6844	36	27	in	in	ADP
aiua-6844	36	28	order	order	NOUN
aiua-6844	36	29	to	to	PART
aiua-6844	36	30	investigate	investigate	VERB
aiua-6844	36	31	whether	whether	SCONJ
aiua-6844	36	32	green	green	ADJ
aiua-6844	36	33	tea	tea	NOUN
aiua-6844	36	34	catechins	catechin	NOUN
aiua-6844	36	35	could	could	AUX
aiua-6844	36	36	prevent	prevent	VERB
aiua-6844	36	37	the	the	DET
aiua-6844	36	38	occurrence	occurrence	NOUN
aiua-6844	36	39	of	of	ADP
aiua-6844	36	40	pca	pca	PROPN
aiua-6844	36	41	in	in	ADP
aiua-6844	36	42	men	man	NOUN
aiua-6844	36	43	at	at	ADP
aiua-6844	36	44	high	high	ADJ
aiua-6844	36	45	-	-	PUNCT
aiua-6844	36	46	risk	risk	NOUN
aiua-6844	36	47	.	.	PUNCT
aiua-6844	37	1	ethics	ethic	NOUN
aiua-6844	37	2	approval	approval	NOUN
aiua-6844	37	3	and	and	CCONJ
aiua-6844	37	4	consent	consent	NOUN
aiua-6844	37	5	to	to	PART
aiua-6844	37	6	participate	participate	VERB
aiua-6844	37	7	this	this	DET
aiua-6844	37	8	study	study	NOUN
aiua-6844	37	9	was	be	AUX
aiua-6844	37	10	approved	approve	VERB
aiua-6844	37	11	by	by	ADP
aiua-6844	37	12	the	the	DET
aiua-6844	37	13	modena	modena	PROPN
aiua-6844	37	14	ethic	ethic	PROPN
aiua-6844	37	15	committee	committee	PROPN
aiua-6844	37	16	(	(	PUNCT
aiua-6844	37	17	italy	italy	PROPN
aiua-6844	37	18	)	)	PUNCT
aiua-6844	37	19	on	on	ADP
aiua-6844	37	20	2007	2007	NUM
aiua-6844	37	21	-	-	PUNCT
aiua-6844	37	22	04	04	NUM
aiua-6844	37	23	-	-	SYM
aiua-6844	37	24	10	10	NUM
aiua-6844	37	25	(	(	PUNCT
aiua-6844	37	26	number	number	NOUN
aiua-6844	37	27	23/07	23/07	NUM
aiua-6844	37	28	)	)	PUNCT
aiua-6844	37	29	and	and	CCONJ
aiua-6844	37	30	carried	carry	VERB
aiua-6844	37	31	out	out	ADP
aiua-6844	37	32	in	in	ADP
aiua-6844	37	33	the	the	DET
aiua-6844	37	34	modena	modena	PROPN
aiua-6844	37	35	university	university	PROPN
aiua-6844	37	36	hospital	hospital	PROPN
aiua-6844	37	37	(	(	PUNCT
aiua-6844	37	38	italy	italy	PROPN
aiua-6844	37	39	)	)	PUNCT
aiua-6844	37	40	from	from	ADP
aiua-6844	37	41	may	may	PROPN
aiua-6844	37	42	2007	2007	NUM
aiua-6844	37	43	to	to	ADP
aiua-6844	37	44	february	february	PROPN
aiua-6844	37	45	2011	2011	NUM
aiua-6844	37	46	.	.	PUNCT
aiua-6844	38	1	the	the	DET
aiua-6844	38	2	recommendations	recommendation	NOUN
aiua-6844	38	3	of	of	ADP
aiua-6844	38	4	the	the	DET
aiua-6844	38	5	declaration	declaration	NOUN
aiua-6844	38	6	of	of	ADP
aiua-6844	38	7	helsinki	helsinki	PROPN
aiua-6844	38	8	and	and	CCONJ
aiua-6844	38	9	the	the	DET
aiua-6844	38	10	guidelines	guideline	NOUN
aiua-6844	38	11	of	of	ADP
aiua-6844	38	12	the	the	DET
aiua-6844	38	13	international	international	ADJ
aiua-6844	38	14	conference	conference	NOUN
aiua-6844	38	15	on	on	ADP
aiua-6844	38	16	harmonization	harmonization	NOUN
aiua-6844	38	17	good	good	ADJ
aiua-6844	38	18	clinical	clinical	ADJ
aiua-6844	38	19	practice	practice	NOUN
aiua-6844	38	20	were	be	AUX
aiua-6844	38	21	observed	observe	VERB
aiua-6844	38	22	.	.	PUNCT
aiua-6844	39	1	all	all	DET
aiua-6844	39	2	volunteers	volunteer	NOUN
aiua-6844	39	3	have	have	AUX
aiua-6844	39	4	been	be	AUX
aiua-6844	39	5	properly	properly	ADV
aiua-6844	39	6	informed	inform	VERB
aiua-6844	39	7	about	about	ADP
aiua-6844	39	8	the	the	DET
aiua-6844	39	9	clinical	clinical	ADJ
aiua-6844	39	10	trial	trial	NOUN
aiua-6844	39	11	and	and	CCONJ
aiua-6844	39	12	signed	sign	VERB
aiua-6844	39	13	a	a	DET
aiua-6844	39	14	free	free	ADJ
aiua-6844	39	15	informed	inform	VERB
aiua-6844	39	16	consent	consent	NOUN
aiua-6844	39	17	form	form	NOUN
aiua-6844	39	18	.	.	PUNCT
aiua-6844	40	1	study	study	NOUN
aiua-6844	40	2	objectives	objective	NOUN
aiua-6844	40	3	.	.	PUNCT
aiua-6844	41	1	the	the	DET
aiua-6844	41	2	primary	primary	ADJ
aiua-6844	41	3	objective	objective	NOUN
aiua-6844	41	4	was	be	AUX
aiua-6844	41	5	to	to	PART
aiua-6844	41	6	determine	determine	VERB
aiua-6844	41	7	the	the	DET
aiua-6844	41	8	efficacy	efficacy	NOUN
aiua-6844	41	9	of	of	ADP
aiua-6844	41	10	green	green	ADJ
aiua-6844	41	11	tea	tea	NOUN
aiua-6844	41	12	catechins	catechin	NOUN
aiua-6844	41	13	for	for	ADP
aiua-6844	41	14	chemoprevention	chemoprevention	NOUN
aiua-6844	41	15	of	of	ADP
aiua-6844	41	16	pca	pca	PROPN
aiua-6844	41	17	in	in	ADP
aiua-6844	41	18	patients	patient	NOUN
aiua-6844	41	19	with	with	ADP
aiua-6844	41	20	hg	hg	NOUN
aiua-6844	41	21	-	-	NOUN
aiua-6844	41	22	pin	pin	NOUN
aiua-6844	41	23	.	.	PUNCT
aiua-6844	42	1	therefore	therefore	ADV
aiua-6844	42	2	,	,	PUNCT
aiua-6844	42	3	the	the	DET
aiua-6844	42	4	first	first	ADJ
aiua-6844	42	5	goal	goal	NOUN
aiua-6844	42	6	of	of	ADP
aiua-6844	42	7	our	our	PRON
aiua-6844	42	8	study	study	NOUN
aiua-6844	42	9	was	be	AUX
aiua-6844	42	10	to	to	PART
aiua-6844	42	11	point	point	VERB
aiua-6844	42	12	out	out	ADP
aiua-6844	42	13	pca	pca	NOUN
aiua-6844	42	14	incidence	incidence	NOUN
aiua-6844	42	15	during	during	ADP
aiua-6844	42	16	the	the	DET
aiua-6844	42	17	1	1	NUM
aiua-6844	42	18	-	-	PUNCT
aiua-6844	42	19	year	year	NOUN
aiua-6844	42	20	study	study	NOUN
aiua-6844	42	21	in	in	ADP
aiua-6844	42	22	the	the	DET
aiua-6844	42	23	two	two	NUM
aiua-6844	42	24	arms	arm	NOUN
aiua-6844	42	25	.	.	PUNCT
aiua-6844	43	1	moreover	moreover	ADV
aiua-6844	43	2	,	,	PUNCT
aiua-6844	43	3	during	during	ADP
aiua-6844	43	4	the	the	DET
aiua-6844	43	5	whole	whole	ADJ
aiua-6844	43	6	study	study	NOUN
aiua-6844	43	7	,	,	PUNCT
aiua-6844	43	8	we	we	PRON
aiua-6844	43	9	recorded	record	VERB
aiua-6844	43	10	possible	possible	ADJ
aiua-6844	43	11	changes	change	NOUN
aiua-6844	43	12	in	in	ADP
aiua-6844	43	13	total	total	ADJ
aiua-6844	43	14	serum	serum	NOUN
aiua-6844	43	15	prostate	prostate	NOUN
aiua-6844	43	16	-	-	PUNCT
aiua-6844	43	17	specific	specific	ADJ
aiua-6844	43	18	antigen	antigen	NOUN
aiua-6844	43	19	(	(	PUNCT
aiua-6844	43	20	psa	psa	NOUN
aiua-6844	43	21	)	)	PUNCT
aiua-6844	43	22	values	value	NOUN
aiua-6844	43	23	(	(	PUNCT
aiua-6844	43	24	secondary	secondary	ADJ
aiua-6844	43	25	objective	objective	NOUN
aiua-6844	43	26	)	)	PUNCT
aiua-6844	43	27	,	,	PUNCT
aiua-6844	43	28	together	together	ADV
aiua-6844	43	29	with	with	ADP
aiua-6844	43	30	the	the	DET
aiua-6844	43	31	toxicity	toxicity	NOUN
aiua-6844	43	32	evaluation	evaluation	NOUN
aiua-6844	43	33	as	as	ADV
aiua-6844	43	34	well	well	ADV
aiua-6844	43	35	as	as	ADP
aiua-6844	43	36	the	the	DET
aiua-6844	43	37	patient	patient	NOUN
aiua-6844	43	38	’s	’s	PART
aiua-6844	43	39	lower	low	ADJ
aiua-6844	43	40	urinary	urinary	ADJ
aiua-6844	43	41	tract	tract	NOUN
aiua-6844	43	42	symptoms	symptom	NOUN
aiua-6844	43	43	(	(	PUNCT
aiua-6844	43	44	luts	luts	PROPN
aiua-6844	43	45	)	)	PUNCT
aiua-6844	43	46	and	and	CCONJ
aiua-6844	43	47	quality	quality	NOUN
aiua-6844	43	48	of	of	ADP
aiua-6844	43	49	life	life	NOUN
aiua-6844	43	50	(	(	PUNCT
aiua-6844	43	51	qol	qol	NOUN
aiua-6844	43	52	)	)	PUNCT
aiua-6844	43	53	scores	score	NOUN
aiua-6844	43	54	assessments	assessment	NOUN
aiua-6844	43	55	by	by	ADP
aiua-6844	43	56	questionnaires	questionnaire	NOUN
aiua-6844	43	57	.	.	PUNCT
aiua-6844	44	1	subjects	subject	NOUN
aiua-6844	44	2	who	who	PRON
aiua-6844	44	3	were	be	AUX
aiua-6844	44	4	detected	detect	VERB
aiua-6844	44	5	pca	pca	PROPN
aiua-6844	44	6	during	during	ADP
aiua-6844	44	7	the	the	DET
aiua-6844	44	8	clinical	clinical	ADJ
aiua-6844	44	9	trial	trial	NOUN
aiua-6844	44	10	were	be	AUX
aiua-6844	44	11	excluded	exclude	VERB
aiua-6844	44	12	from	from	ADP
aiua-6844	44	13	the	the	DET
aiua-6844	44	14	study	study	NOUN
aiua-6844	44	15	and	and	CCONJ
aiua-6844	44	16	subjected	subject	VERB
aiua-6844	44	17	to	to	ADP
aiua-6844	44	18	chemotherapy	chemotherapy	NOUN
aiua-6844	44	19	.	.	PUNCT
aiua-6844	45	1	study	study	NOUN
aiua-6844	45	2	population	population	NOUN
aiua-6844	45	3	.	.	PUNCT
aiua-6844	46	1	eligibility	eligibility	NOUN
aiua-6844	46	2	criteria	criterion	NOUN
aiua-6844	46	3	for	for	ADP
aiua-6844	46	4	enrolment	enrolment	NOUN
aiua-6844	46	5	included	include	VERB
aiua-6844	46	6	:	:	PUNCT
aiua-6844	46	7	caucasian	caucasian	ADJ
aiua-6844	46	8	men	man	NOUN
aiua-6844	46	9	aged	age	VERB
aiua-6844	46	10	between	between	ADP
aiua-6844	46	11	55	55	NUM
aiua-6844	46	12	to	to	PART
aiua-6844	46	13	65	65	NUM
aiua-6844	46	14	years	year	NOUN
aiua-6844	46	15	old	old	ADJ
aiua-6844	46	16	with	with	ADP
aiua-6844	46	17	hg	hg	NOUN
aiua-6844	46	18	-	-	NOUN
aiua-6844	46	19	pin	pin	NOUN
aiua-6844	46	20	,	,	PUNCT
aiua-6844	46	21	as	as	SCONJ
aiua-6844	46	22	assessed	assess	VERB
aiua-6844	46	23	by	by	ADP
aiua-6844	46	24	prostate	prostate	NOUN
aiua-6844	46	25	biopsy	biopsy	NOUN
aiua-6844	46	26	.	.	PUNCT
aiua-6844	47	1	all	all	DET
aiua-6844	47	2	volunteers	volunteer	NOUN
aiua-6844	47	3	were	be	AUX
aiua-6844	47	4	properly	properly	ADV
aiua-6844	47	5	advised	advise	VERB
aiua-6844	47	6	about	about	ADP
aiua-6844	47	7	the	the	DET
aiua-6844	47	8	clinical	clinical	ADJ
aiua-6844	47	9	trial	trial	NOUN
aiua-6844	47	10	and	and	CCONJ
aiua-6844	47	11	signed	sign	VERB
aiua-6844	47	12	a	a	DET
aiua-6844	47	13	free	free	ADJ
aiua-6844	47	14	informed	inform	VERB
aiua-6844	47	15	consent	consent	NOUN
aiua-6844	47	16	form	form	NOUN
aiua-6844	47	17	.	.	PUNCT
aiua-6844	48	1	exclusion	exclusion	NOUN
aiua-6844	48	2	criteria	criterion	NOUN
aiua-6844	48	3	included	include	VERB
aiua-6844	48	4	:	:	PUNCT
aiua-6844	48	5	men	man	NOUN
aiua-6844	48	6	aged	age	VERB
aiua-6844	48	7	>	>	X
aiua-6844	48	8	65	65	NUM
aiua-6844	48	9	years	year	NOUN
aiua-6844	48	10	,	,	PUNCT
aiua-6844	48	11	previous	previous	ADJ
aiua-6844	48	12	malignancies	malignancy	NOUN
aiua-6844	48	13	,	,	PUNCT
aiua-6844	48	14	cancer	cancer	NOUN
aiua-6844	48	15	diagnosis	diagnosis	NOUN
aiua-6844	48	16	,	,	PUNCT
aiua-6844	48	17	antiandrogenic	antiandrogenic	ADJ
aiua-6844	48	18	or	or	CCONJ
aiua-6844	48	19	chemoprevention	chemoprevention	NOUN
aiua-6844	48	20	therapies	therapy	NOUN
aiua-6844	48	21	,	,	PUNCT
aiua-6844	48	22	obesity	obesity	NOUN
aiua-6844	48	23	,	,	PUNCT
aiua-6844	48	24	diabetes	diabetes	NOUN
aiua-6844	48	25	or	or	CCONJ
aiua-6844	48	26	other	other	ADJ
aiua-6844	48	27	endocrinologic	endocrinologic	ADJ
aiua-6844	48	28	diseases	disease	NOUN
aiua-6844	48	29	.	.	PUNCT
aiua-6844	49	1	the	the	DET
aiua-6844	49	2	subjects	subject	NOUN
aiua-6844	49	3	enrolled	enrol	VERB
aiua-6844	49	4	in	in	ADP
aiua-6844	49	5	the	the	DET
aiua-6844	49	6	trial	trial	NOUN
aiua-6844	49	7	were	be	AUX
aiua-6844	49	8	instructed	instruct	VERB
aiua-6844	49	9	to	to	PART
aiua-6844	49	10	abstain	abstain	VERB
aiua-6844	49	11	from	from	ADP
aiua-6844	49	12	green	green	ADJ
aiua-6844	49	13	tea	tea	NOUN
aiua-6844	49	14	and	and	CCONJ
aiua-6844	49	15	its	its	PRON
aiua-6844	49	16	derivatives	derivative	NOUN
aiua-6844	49	17	,	,	PUNCT
aiua-6844	49	18	antioxidants	antioxidant	NOUN
aiua-6844	49	19	or	or	CCONJ
aiua-6844	49	20	nutritional	nutritional	ADJ
aiua-6844	49	21	supplements	supplement	NOUN
aiua-6844	49	22	and	and	CCONJ
aiua-6844	49	23	herbal	herbal	ADJ
aiua-6844	49	24	therapies	therapy	NOUN
aiua-6844	49	25	.	.	PUNCT
aiua-6844	50	1	study	study	NOUN
aiua-6844	50	2	procedures	procedure	NOUN
aiua-6844	50	3	during	during	ADP
aiua-6844	50	4	the	the	DET
aiua-6844	50	5	initial	initial	ADJ
aiua-6844	50	6	visit	visit	NOUN
aiua-6844	50	7	,	,	PUNCT
aiua-6844	50	8	volunteers	volunteer	NOUN
aiua-6844	50	9	underwent	undergo	VERB
aiua-6844	50	10	an	an	DET
aiua-6844	50	11	interview	interview	NOUN
aiua-6844	50	12	to	to	PART
aiua-6844	50	13	obtain	obtain	VERB
aiua-6844	50	14	medical	medical	ADJ
aiua-6844	50	15	history	history	NOUN
aiua-6844	50	16	as	as	ADV
aiua-6844	50	17	well	well	ADV
aiua-6844	50	18	as	as	ADP
aiua-6844	50	19	a	a	DET
aiua-6844	50	20	brief	brief	ADJ
aiua-6844	50	21	physical	physical	ADJ
aiua-6844	50	22	assessment	assessment	NOUN
aiua-6844	50	23	including	include	VERB
aiua-6844	50	24	a	a	DET
aiua-6844	50	25	digital	digital	ADJ
aiua-6844	50	26	rectal	rectal	ADJ
aiua-6844	50	27	examination	examination	NOUN
aiua-6844	50	28	.	.	PUNCT
aiua-6844	51	1	moreover	moreover	ADV
aiua-6844	51	2	,	,	PUNCT
aiua-6844	51	3	blood	blood	NOUN
aiua-6844	51	4	samples	sample	NOUN
aiua-6844	51	5	were	be	AUX
aiua-6844	51	6	collected	collect	VERB
aiua-6844	51	7	for	for	ADP
aiua-6844	51	8	complete	complete	ADJ
aiua-6844	51	9	blood	blood	NOUN
aiua-6844	51	10	count	count	NOUN
aiua-6844	51	11	and	and	CCONJ
aiua-6844	51	12	serum	serum	NOUN
aiua-6844	51	13	psa	psa	NOUN
aiua-6844	51	14	levels	level	NOUN
aiua-6844	51	15	.	.	PUNCT
aiua-6844	52	1	finally	finally	ADV
aiua-6844	52	2	,	,	PUNCT
aiua-6844	52	3	baseline	baseline	ADJ
aiua-6844	52	4	assessments	assessment	NOUN
aiua-6844	52	5	of	of	ADP
aiua-6844	52	6	luts	luts	PROPN
aiua-6844	52	7	and	and	CCONJ
aiua-6844	52	8	qol	qol	PROPN
aiua-6844	52	9	,	,	PUNCT
aiua-6844	52	10	were	be	AUX
aiua-6844	52	11	obtained	obtain	VERB
aiua-6844	52	12	.	.	PUNCT
aiua-6844	53	1	upon	upon	SCONJ
aiua-6844	53	2	determination	determination	NOUN
aiua-6844	53	3	of	of	ADP
aiua-6844	53	4	eligibility	eligibility	NOUN
aiua-6844	53	5	,	,	PUNCT
aiua-6844	53	6	a	a	DET
aiua-6844	53	7	total	total	NOUN
aiua-6844	53	8	of	of	ADP
aiua-6844	53	9	60	60	NUM
aiua-6844	53	10	patients	patient	NOUN
aiua-6844	53	11	participating	participate	VERB
aiua-6844	53	12	to	to	ADP
aiua-6844	53	13	the	the	DET
aiua-6844	53	14	clinical	clinical	ADJ
aiua-6844	53	15	trial	trial	NOUN
aiua-6844	53	16	were	be	AUX
aiua-6844	53	17	randomized	randomize	VERB
aiua-6844	53	18	(	(	PUNCT
aiua-6844	53	19	1:1	1:1	NUM
aiua-6844	53	20	)	)	PUNCT
aiua-6844	53	21	to	to	PART
aiua-6844	53	22	receive	receive	VERB
aiua-6844	53	23	daily	daily	ADJ
aiua-6844	53	24	green	green	ADJ
aiua-6844	53	25	tea	tea	NOUN
aiua-6844	53	26	catechins	catechin	NOUN
aiua-6844	53	27	600	600	NUM
aiua-6844	53	28	mg	mg	NOUN
aiua-6844	53	29	(	(	PUNCT
aiua-6844	53	30	2	2	NUM
aiua-6844	53	31	tablets	tablet	NOUN
aiua-6844	53	32	of	of	ADP
aiua-6844	53	33	300	300	NUM
aiua-6844	53	34	mg	mg	NOUN
aiua-6844	53	35	of	of	ADP
aiua-6844	53	36	categ	categ	PROPN
aiua-6844	53	37	plus	plus	PROPN
aiua-6844	53	38	®	®	PROPN
aiua-6844	53	39	,	,	PUNCT
aiua-6844	53	40	sofar	sofar	ADV
aiua-6844	53	41	s.p.a	s.p.a	PROPN
aiua-6844	53	42	,	,	PUNCT
aiua-6844	53	43	milan	milan	PROPN
aiua-6844	53	44	,	,	PUNCT
aiua-6844	53	45	italy	italy	PROPN
aiua-6844	53	46	)	)	PUNCT
aiua-6844	53	47	or	or	CCONJ
aiua-6844	53	48	placebo	placebo	NOUN
aiua-6844	53	49	for	for	ADP
aiua-6844	53	50	1	1	NUM
aiua-6844	53	51	year	year	NOUN
aiua-6844	53	52	.	.	PUNCT
aiua-6844	54	1	the	the	DET
aiua-6844	54	2	random	random	ADJ
aiua-6844	54	3	allocation	allocation	NOUN
aiua-6844	54	4	sequence	sequence	NOUN
aiua-6844	54	5	was	be	AUX
aiua-6844	54	6	obtained	obtain	VERB
aiua-6844	54	7	by	by	ADP
aiua-6844	54	8	means	mean	NOUN
aiua-6844	54	9	of	of	ADP
aiua-6844	54	10	“	"	PUNCT
aiua-6844	54	11	easy	easy	ADJ
aiua-6844	54	12	random	random	ADJ
aiua-6844	54	13	picker	picker	NOUN
aiua-6844	54	14	”	"	PUNCT
aiua-6844	54	15	software	software	NOUN
aiua-6844	54	16	(	(	PUNCT
aiua-6844	54	17	trustfm	trustfm	NOUN
aiua-6844	54	18	©	©	PROPN
aiua-6844	54	19	19982016	19982016	NUM
aiua-6844	54	20	)	)	PUNCT
aiua-6844	54	21	.	.	PUNCT
aiua-6844	55	1	both	both	DET
aiua-6844	55	2	participants	participant	NOUN
aiua-6844	55	3	and	and	CCONJ
aiua-6844	55	4	care	care	NOUN
aiua-6844	55	5	providers	provider	NOUN
aiua-6844	55	6	were	be	AUX
aiua-6844	55	7	blinded	blind	VERB
aiua-6844	55	8	after	after	ADP
aiua-6844	55	9	assignment	assignment	NOUN
aiua-6844	55	10	to	to	ADP
aiua-6844	55	11	interventions	intervention	NOUN
aiua-6844	55	12	,	,	PUNCT
aiua-6844	55	13	in	in	ADP
aiua-6844	55	14	order	order	NOUN
aiua-6844	55	15	to	to	PART
aiua-6844	55	16	avoid	avoid	VERB
aiua-6844	55	17	any	any	DET
aiua-6844	55	18	bias	bias	NOUN
aiua-6844	55	19	.	.	PUNCT
aiua-6844	56	1	two	two	NUM
aiua-6844	56	2	capsules	capsule	NOUN
aiua-6844	56	3	of	of	ADP
aiua-6844	56	4	categ	categ	NOUN
aiua-6844	56	5	plus	plus	CCONJ
aiua-6844	56	6	®	®	NOUN
aiua-6844	56	7	or	or	CCONJ
aiua-6844	56	8	placebo	placebo	NOUN
aiua-6844	56	9	per	per	ADP
aiua-6844	56	10	day	day	NOUN
aiua-6844	56	11	were	be	AUX
aiua-6844	56	12	given	give	VERB
aiua-6844	56	13	to	to	ADP
aiua-6844	56	14	all	all	DET
aiua-6844	56	15	subjects	subject	NOUN
aiua-6844	56	16	by	by	ADP
aiua-6844	56	17	the	the	DET
aiua-6844	56	18	clinical	clinical	ADJ
aiua-6844	56	19	trial	trial	NOUN
aiua-6844	56	20	investigators	investigator	NOUN
aiua-6844	56	21	,	,	PUNCT
aiua-6844	56	22	according	accord	VERB
aiua-6844	56	23	to	to	ADP
aiua-6844	56	24	the	the	DET
aiua-6844	56	25	double	double	ADJ
aiua-6844	56	26	blind	blind	ADJ
aiua-6844	56	27	method	method	NOUN
aiua-6844	56	28	.	.	PUNCT
aiua-6844	57	1	follow	follow	VERB
aiua-6844	57	2	up	up	ADP
aiua-6844	57	3	was	be	AUX
aiua-6844	57	4	carried	carry	VERB
aiua-6844	57	5	out	out	ADP
aiua-6844	57	6	at	at	ADP
aiua-6844	57	7	6	6	NUM
aiua-6844	57	8	and	and	CCONJ
aiua-6844	57	9	12	12	NUM
aiua-6844	57	10	months	month	NOUN
aiua-6844	57	11	with	with	ADP
aiua-6844	57	12	toxicity	toxicity	NOUN
aiua-6844	57	13	assessment	assessment	NOUN
aiua-6844	57	14	(	(	PUNCT
aiua-6844	57	15	side	side	NOUN
aiua-6844	57	16	effects	effect	NOUN
aiua-6844	57	17	)	)	PUNCT
aiua-6844	57	18	,	,	PUNCT
aiua-6844	57	19	luts	luts	PROPN
aiua-6844	57	20	and	and	CCONJ
aiua-6844	57	21	qol	qol	PROPN
aiua-6844	57	22	evaluation	evaluation	NOUN
aiua-6844	57	23	,	,	PUNCT
aiua-6844	57	24	medical	medical	ADJ
aiua-6844	57	25	examination	examination	NOUN
aiua-6844	57	26	,	,	PUNCT
aiua-6844	57	27	rectal	rectal	ADJ
aiua-6844	57	28	inspection	inspection	NOUN
aiua-6844	57	29	,	,	PUNCT
aiua-6844	57	30	serum	serum	NOUN
aiua-6844	57	31	psa	psa	NOUN
aiua-6844	57	32	levels	level	NOUN
aiua-6844	57	33	and	and	CCONJ
aiua-6844	57	34	prostate	prostate	NOUN
aiua-6844	57	35	biopsy	biopsy	NOUN
aiua-6844	57	36	.	.	PUNCT
aiua-6844	58	1	psa	psa	VERB
aiua-6844	58	2	measurements	measurement	NOUN
aiua-6844	58	3	as	as	ADV
aiua-6844	58	4	well	well	ADV
aiua-6844	58	5	as	as	ADP
aiua-6844	58	6	immunohistochemistry	immunohistochemistry	NOUN
aiua-6844	58	7	evaluation	evaluation	NOUN
aiua-6844	58	8	of	of	ADP
aiua-6844	58	9	prostatic	prostatic	ADJ
aiua-6844	58	10	biopsies	biopsy	NOUN
aiua-6844	58	11	were	be	AUX
aiua-6844	58	12	performed	perform	VERB
aiua-6844	58	13	in	in	ADP
aiua-6844	58	14	the	the	DET
aiua-6844	58	15	same	same	ADJ
aiua-6844	58	16	hospital	hospital	NOUN
aiua-6844	58	17	’s	’s	PART
aiua-6844	58	18	central	central	ADJ
aiua-6844	58	19	laboratory	laboratory	NOUN
aiua-6844	58	20	where	where	SCONJ
aiua-6844	58	21	was	be	AUX
aiua-6844	58	22	carried	carry	VERB
aiua-6844	58	23	out	out	ADP
aiua-6844	58	24	the	the	DET
aiua-6844	58	25	clinical	clinical	ADJ
aiua-6844	58	26	trial	trial	NOUN
aiua-6844	58	27	(	(	PUNCT
aiua-6844	58	28	modena	modena	PROPN
aiua-6844	58	29	university	university	PROPN
aiua-6844	58	30	hospital	hospital	NOUN
aiua-6844	58	31	,	,	PUNCT
aiua-6844	58	32	italy	italy	PROPN
aiua-6844	58	33	)	)	PUNCT
aiua-6844	58	34	.	.	PUNCT
aiua-6844	59	1	possible	possible	ADJ
aiua-6844	59	2	changes	change	NOUN
aiua-6844	59	3	in	in	ADP
aiua-6844	59	4	luts	luts	PROPN
aiua-6844	59	5	,	,	PUNCT
aiua-6844	59	6	using	use	VERB
aiua-6844	59	7	the	the	DET
aiua-6844	59	8	international	international	ADJ
aiua-6844	59	9	prostate	prostate	NOUN
aiua-6844	59	10	symptom	symptom	NOUN
aiua-6844	59	11	score	score	NOUN
aiua-6844	59	12	(	(	PUNCT
aiua-6844	59	13	ipss	ipss	PROPN
aiua-6844	59	14	)	)	PUNCT
aiua-6844	59	15	,	,	PUNCT
aiua-6844	59	16	and	and	CCONJ
aiua-6844	59	17	qol	qol	PROPN
aiua-6844	59	18	were	be	AUX
aiua-6844	59	19	evaluated	evaluate	VERB
aiua-6844	59	20	as	as	ADP
aiua-6844	59	21	described	describe	VERB
aiua-6844	59	22	(	(	PUNCT
aiua-6844	59	23	15	15	NUM
aiua-6844	59	24	,	,	PUNCT
aiua-6844	59	25	16	16	NUM
aiua-6844	59	26	)	)	PUNCT
aiua-6844	59	27	.	.	PUNCT
aiua-6844	60	1	statistical	statistical	ADJ
aiua-6844	60	2	analysis	analysis	NOUN
aiua-6844	60	3	statistical	statistical	ADJ
aiua-6844	60	4	analyses	analysis	NOUN
aiua-6844	60	5	of	of	ADP
aiua-6844	60	6	results	result	NOUN
aiua-6844	60	7	were	be	AUX
aiua-6844	60	8	performed	perform	VERB
aiua-6844	60	9	using	use	VERB
aiua-6844	60	10	the	the	DET
aiua-6844	60	11	student	student	NOUN
aiua-6844	60	12	’s	’s	PART
aiua-6844	60	13	t	t	PROPN
aiua-6844	60	14	test	test	NOUN
aiua-6844	60	15	.	.	PUNCT
aiua-6844	61	1	p	p	X
aiua-6844	61	2	-	-	PUNCT
aiua-6844	61	3	values	value	NOUN
aiua-6844	61	4	<	<	X
aiua-6844	61	5	0.05	0.05	NUM
aiua-6844	61	6	were	be	AUX
aiua-6844	61	7	considered	consider	VERB
aiua-6844	61	8	statistically	statistically	ADV
aiua-6844	61	9	significant	significant	ADJ
aiua-6844	61	10	.	.	PUNCT
aiua-6844	62	1	results	result	NOUN
aiua-6844	62	2	first	first	ADV
aiua-6844	62	3	,	,	PUNCT
aiua-6844	62	4	we	we	PRON
aiua-6844	62	5	have	have	AUX
aiua-6844	62	6	ensured	ensure	VERB
aiua-6844	62	7	that	that	SCONJ
aiua-6844	62	8	the	the	DET
aiua-6844	62	9	randomization	randomization	NOUN
aiua-6844	62	10	of	of	ADP
aiua-6844	62	11	volunteers	volunteer	NOUN
aiua-6844	62	12	in	in	ADP
aiua-6844	62	13	the	the	DET
aiua-6844	62	14	two	two	NUM
aiua-6844	62	15	arms	arm	NOUN
aiua-6844	62	16	of	of	ADP
aiua-6844	62	17	the	the	DET
aiua-6844	62	18	clinical	clinical	ADJ
aiua-6844	62	19	trial	trial	NOUN
aiua-6844	62	20	had	have	AUX
aiua-6844	62	21	resulted	result	VERB
aiua-6844	62	22	in	in	ADP
aiua-6844	62	23	two	two	NUM
aiua-6844	62	24	homogeneous	homogeneous	ADJ
aiua-6844	62	25	groups	group	NOUN
aiua-6844	62	26	with	with	ADP
aiua-6844	62	27	one	one	NUM
aiua-6844	62	28	another	another	DET
aiua-6844	62	29	.	.	PUNCT
aiua-6844	63	1	a	a	DET
aiua-6844	63	2	consort	consort	NOUN
aiua-6844	63	3	flow	flow	NOUN
aiua-6844	63	4	diagram	diagram	NOUN
aiua-6844	63	5	of	of	ADP
aiua-6844	63	6	the	the	DET
aiua-6844	63	7	study	study	NOUN
aiua-6844	63	8	is	be	AUX
aiua-6844	63	9	shown	show	VERB
aiua-6844	63	10	in	in	ADP
aiua-6844	63	11	figure	figure	NOUN
aiua-6844	63	12	1	1	NUM
aiua-6844	63	13	.	.	PUNCT
aiua-6844	64	1	in	in	ADP
aiua-6844	64	2	particular	particular	ADJ
aiua-6844	64	3	,	,	PUNCT
aiua-6844	64	4	at	at	ADP
aiua-6844	64	5	the	the	DET
aiua-6844	64	6	time	time	NOUN
aiua-6844	64	7	of	of	ADP
aiua-6844	64	8	enrollment	enrollment	NOUN
aiua-6844	64	9	the	the	DET
aiua-6844	64	10	age	age	NOUN
aiua-6844	64	11	of	of	ADP
aiua-6844	64	12	subject	subject	NOUN
aiua-6844	64	13	,	,	PUNCT
aiua-6844	64	14	their	their	PRON
aiua-6844	64	15	weight	weight	NOUN
aiua-6844	64	16	,	,	PUNCT
aiua-6844	64	17	the	the	DET
aiua-6844	64	18	psa	psa	NOUN
aiua-6844	64	19	value	value	NOUN
aiua-6844	64	20	and	and	CCONJ
aiua-6844	64	21	the	the	DET
aiua-6844	64	22	prostate	prostate	NOUN
aiua-6844	64	23	volume	volume	NOUN
aiua-6844	64	24	were	be	AUX
aiua-6844	64	25	recorded	record	VERB
aiua-6844	64	26	and	and	CCONJ
aiua-6844	64	27	statistically	statistically	ADV
aiua-6844	64	28	analyzed	analyze	VERB
aiua-6844	64	29	.	.	PUNCT
aiua-6844	65	1	in	in	ADP
aiua-6844	65	2	table	table	NOUN
aiua-6844	65	3	1	1	NUM
aiua-6844	65	4	are	be	AUX
aiua-6844	65	5	reported	report	VERB
aiua-6844	65	6	their	their	PRON
aiua-6844	65	7	mean	mean	ADJ
aiua-6844	65	8	values	value	NOUN
aiua-6844	65	9	.	.	PUNCT
aiua-6844	66	1	none	none	NOUN
aiua-6844	66	2	of	of	ADP
aiua-6844	66	3	the	the	DET
aiua-6844	66	4	variables	variable	NOUN
aiua-6844	66	5	considered	consider	VERB
aiua-6844	66	6	were	be	AUX
aiua-6844	66	7	significantly	significantly	ADV
aiua-6844	66	8	different	different	ADJ
aiua-6844	66	9	in	in	ADP
aiua-6844	66	10	the	the	DET
aiua-6844	66	11	two	two	NUM
aiua-6844	66	12	arms	arm	NOUN
aiua-6844	66	13	(	(	PUNCT
aiua-6844	66	14	age	age	NOUN
aiua-6844	66	15	,	,	PUNCT
aiua-6844	66	16	p	p	NOUN
aiua-6844	66	17	=	=	NOUN
aiua-6844	66	18	0.8	0.8	NUM
aiua-6844	66	19	;	;	PUNCT
aiua-6844	66	20	psa	psa	NOUN
aiua-6844	66	21	value	value	NOUN
aiua-6844	66	22	,	,	PUNCT
aiua-6844	66	23	p	p	X
aiua-6844	66	24	=	=	SYM
aiua-6844	66	25	0.16	0.16	NUM
aiua-6844	66	26	;	;	PUNCT
aiua-6844	66	27	prostate	prostate	NOUN
aiua-6844	66	28	volume	volume	NOUN
aiua-6844	66	29	,	,	PUNCT
aiua-6844	66	30	p	p	X
aiua-6844	66	31	=	=	NOUN
aiua-6844	66	32	0.23	0.23	NUM
aiua-6844	66	33	)	)	PUNCT
aiua-6844	66	34	.	.	PUNCT
aiua-6844	67	1	the	the	DET
aiua-6844	67	2	two	two	NUM
aiua-6844	67	3	groups	group	NOUN
aiua-6844	67	4	were	be	AUX
aiua-6844	67	5	statistically	statistically	ADV
aiua-6844	67	6	analyzed	analyze	VERB
aiua-6844	67	7	to	to	PART
aiua-6844	67	8	ensure	ensure	VERB
aiua-6844	67	9	homogeneity	homogeneity	NOUN
aiua-6844	67	10	between	between	ADP
aiua-6844	67	11	the	the	DET
aiua-6844	67	12	two	two	NUM
aiua-6844	67	13	groups	group	NOUN
aiua-6844	67	14	by	by	ADP
aiua-6844	67	15	the	the	DET
aiua-6844	67	16	t	t	PROPN
aiua-6844	67	17	test	test	NOUN
aiua-6844	67	18	of	of	ADP
aiua-6844	67	19	student	student	NOUN
aiua-6844	67	20	(	(	PUNCT
aiua-6844	67	21	age	age	NOUN
aiua-6844	67	22	,	,	PUNCT
aiua-6844	67	23	p	p	NOUN
aiua-6844	67	24	=	=	NOUN
aiua-6844	67	25	0.580	0.580	NUM
aiua-6844	67	26	;	;	PUNCT
aiua-6844	67	27	psa	psa	NOUN
aiua-6844	67	28	value	value	NOUN
aiua-6844	67	29	,	,	PUNCT
aiua-6844	67	30	p	p	X
aiua-6844	67	31	=	=	NOUN
aiua-6844	67	32	0.790	0.790	NUM
aiua-6844	67	33	;	;	PUNCT
aiua-6844	67	34	prostate	prostate	NOUN
aiua-6844	67	35	volume	volume	NOUN
aiua-6844	67	36	,	,	PUNCT
aiua-6844	67	37	p	p	X
aiua-6844	67	38	=	=	NOUN
aiua-6844	67	39	0.738	0.738	NUM
aiua-6844	67	40	)	)	PUNCT
aiua-6844	67	41	.	.	PUNCT
aiua-6844	68	1	among	among	ADP
aiua-6844	68	2	the	the	DET
aiua-6844	68	3	60	60	NUM
aiua-6844	68	4	patients	patient	NOUN
aiua-6844	68	5	that	that	PRON
aiua-6844	68	6	entered	enter	VERB
aiua-6844	68	7	the	the	DET
aiua-6844	68	8	study	study	NOUN
aiua-6844	68	9	,	,	PUNCT
aiua-6844	68	10	44	44	NUM
aiua-6844	68	11	subjects	subject	NOUN
aiua-6844	68	12	completed	complete	VERB
aiua-6844	68	13	the	the	DET
aiua-6844	68	14	study	study	NOUN
aiua-6844	68	15	(	(	PUNCT
aiua-6844	68	16	22	22	NUM
aiua-6844	68	17	cases	case	NOUN
aiua-6844	68	18	and	and	CCONJ
aiua-6844	68	19	22	22	NUM
aiua-6844	68	20	controls	control	NOUN
aiua-6844	68	21	)	)	PUNCT
aiua-6844	68	22	with	with	ADP
aiua-6844	68	23	a	a	DET
aiua-6844	68	24	drop	drop	NOUN
aiua-6844	68	25	out	out	ADP
aiua-6844	68	26	of	of	ADP
aiua-6844	68	27	26.7	26.7	NUM
aiua-6844	68	28	%	%	NOUN
aiua-6844	68	29	,	,	PUNCT
aiua-6844	68	30	whereas	whereas	SCONJ
aiua-6844	68	31	minimal	minimal	ADJ
aiua-6844	68	32	side	side	NOUN
aiua-6844	68	33	effects	effect	NOUN
aiua-6844	68	34	were	be	AUX
aiua-6844	68	35	recorded	record	VERB
aiua-6844	68	36	.	.	PUNCT
aiua-6844	69	1	indeed	indeed	ADV
aiua-6844	69	2	,	,	PUNCT
aiua-6844	69	3	although	although	SCONJ
aiua-6844	69	4	the	the	DET
aiua-6844	69	5	majority	majority	NOUN
aiua-6844	69	6	of	of	ADP
aiua-6844	69	7	patients	patient	NOUN
aiua-6844	69	8	tolerated	tolerate	VERB
aiua-6844	69	9	the	the	DET
aiua-6844	69	10	green	green	ADJ
aiua-6844	69	11	tea	tea	NOUN
aiua-6844	69	12	relatively	relatively	ADV
aiua-6844	69	13	well	well	ADV
aiua-6844	69	14	,	,	PUNCT
aiua-6844	69	15	8	8	NUM
aiua-6844	69	16	patients	patient	NOUN
aiua-6844	69	17	withmicali_stesura	withmicali_stesura	PROPN
aiua-6844	69	18	seveso	seveso	VERB
aiua-6844	69	19	28/09/17	28/09/17	PROPN
aiua-6844	69	20	10:18	10:18	NUM
aiua-6844	69	21	pagina	pagina	NOUN
aiua-6844	69	22	198	198	NUM
aiua-6844	69	23	drew	draw	VERB
aiua-6844	69	24	from	from	ADP
aiua-6844	69	25	the	the	DET
aiua-6844	69	26	clinical	clinical	ADJ
aiua-6844	69	27	study	study	NOUN
aiua-6844	69	28	because	because	SCONJ
aiua-6844	69	29	one	one	NUM
aiua-6844	69	30	selves	self	NOUN
aiua-6844	69	31	’	’	PART
aiua-6844	69	32	decision	decision	NOUN
aiua-6844	69	33	.	.	PUNCT
aiua-6844	70	1	when	when	SCONJ
aiua-6844	70	2	toxicity	toxicity	NOUN
aiua-6844	70	3	did	do	AUX
aiua-6844	70	4	occur	occur	VERB
aiua-6844	70	5	,	,	PUNCT
aiua-6844	70	6	it	it	PRON
aiua-6844	70	7	was	be	AUX
aiua-6844	70	8	of	of	ADP
aiua-6844	70	9	grade	grade	NOUN
aiua-6844	70	10	1	1	NUM
aiua-6844	70	11	or	or	CCONJ
aiua-6844	70	12	2	2	NUM
aiua-6844	70	13	,	,	PUNCT
aiua-6844	70	14	including	include	VERB
aiua-6844	70	15	the	the	DET
aiua-6844	70	16	following	follow	VERB
aiua-6844	70	17	symptoms	symptom	NOUN
aiua-6844	70	18	:	:	PUNCT
aiua-6844	70	19	nausea	nausea	NOUN
aiua-6844	70	20	,	,	PUNCT
aiua-6844	70	21	emesis	emesis	NOUN
aiua-6844	70	22	,	,	PUNCT
aiua-6844	70	23	abdominal	abdominal	ADJ
aiua-6844	70	24	pain	pain	NOUN
aiua-6844	70	25	,	,	PUNCT
aiua-6844	70	26	insomnia	insomnia	NOUN
aiua-6844	70	27	,	,	PUNCT
aiua-6844	70	28	fatigue	fatigue	NOUN
aiua-6844	70	29	and	and	CCONJ
aiua-6844	70	30	diarrhea	diarrhea	NOUN
aiua-6844	70	31	.	.	PUNCT
aiua-6844	71	1	figure	figure	NOUN
aiua-6844	71	2	2a	2a	PROPN
aiua-6844	71	3	shows	show	VERB
aiua-6844	71	4	that	that	SCONJ
aiua-6844	71	5	the	the	DET
aiua-6844	71	6	incidence	incidence	NOUN
aiua-6844	71	7	of	of	ADP
aiua-6844	71	8	new	new	ADJ
aiua-6844	71	9	diagnoses	diagnosis	NOUN
aiua-6844	71	10	of	of	ADP
aiua-6844	71	11	pca	pca	PROPN
aiua-6844	71	12	at	at	ADP
aiua-6844	71	13	6	6	NUM
aiua-6844	71	14	months	month	NOUN
aiua-6844	71	15	was	be	AUX
aiua-6844	71	16	9	9	NUM
aiua-6844	71	17	%	%	NOUN
aiua-6844	71	18	(	(	PUNCT
aiua-6844	71	19	2/22	2/22	NUM
aiua-6844	71	20	)	)	PUNCT
aiua-6844	71	21	in	in	ADP
aiua-6844	71	22	the	the	DET
aiua-6844	71	23	green	green	ADJ
aiua-6844	71	24	tea	tea	NOUN
aiua-6844	71	25	catechins	catechin	NOUN
aiua-6844	71	26	-	-	PUNCT
aiua-6844	71	27	treated	treat	VERB
aiua-6844	71	28	arm	arm	NOUN
aiua-6844	71	29	,	,	PUNCT
aiua-6844	71	30	and	and	CCONJ
aiua-6844	71	31	18.1	18.1	NUM
aiua-6844	71	32	%	%	NOUN
aiua-6844	71	33	(	(	PUNCT
aiua-6844	71	34	4/22	4/22	NUM
aiua-6844	71	35	)	)	PUNCT
aiua-6844	71	36	in	in	ADP
aiua-6844	71	37	the	the	DET
aiua-6844	71	38	placebo	placebo	NOUN
aiua-6844	71	39	group	group	NOUN
aiua-6844	71	40	;	;	PUNCT
aiua-6844	71	41	although	although	SCONJ
aiua-6844	71	42	these	these	DET
aiua-6844	71	43	values	value	NOUN
aiua-6844	71	44	are	be	AUX
aiua-6844	71	45	the	the	DET
aiua-6844	71	46	one	one	NUM
aiua-6844	71	47	of	of	ADP
aiua-6844	71	48	the	the	DET
aiua-6844	71	49	other	other	ADJ
aiua-6844	71	50	half	half	NOUN
aiua-6844	71	51	,	,	PUNCT
aiua-6844	71	52	the	the	DET
aiua-6844	71	53	difference	difference	NOUN
aiua-6844	71	54	between	between	ADP
aiua-6844	71	55	green	green	ADJ
aiua-6844	71	56	tea	tea	NOUN
aiua-6844	71	57	-	-	PUNCT
aiua-6844	71	58	treated	treat	VERB
aiua-6844	71	59	and	and	CCONJ
aiua-6844	71	60	placebo	placebo	NOUN
aiua-6844	71	61	groups	group	NOUN
aiua-6844	71	62	has	have	AUX
aiua-6844	71	63	not	not	PART
aiua-6844	71	64	reached	reach	VERB
aiua-6844	71	65	the	the	DET
aiua-6844	71	66	statistical	statistical	ADJ
aiua-6844	71	67	significance	significance	NOUN
aiua-6844	71	68	(	(	PUNCT
aiua-6844	71	69	p	p	NOUN
aiua-6844	71	70	=	=	NOUN
aiua-6844	71	71	0.5	0.5	NUM
aiua-6844	71	72	)	)	PUNCT
aiua-6844	71	73	.	.	PUNCT
aiua-6844	72	1	moreover	moreover	ADV
aiua-6844	72	2	,	,	PUNCT
aiua-6844	72	3	at	at	ADP
aiua-6844	72	4	12	12	NUM
aiua-6844	72	5	months	month	NOUN
aiua-6844	72	6	follow	follow	VERB
aiua-6844	72	7	up	up	ADP
aiua-6844	72	8	,	,	PUNCT
aiua-6844	72	9	two	two	NUM
aiua-6844	72	10	more	more	ADJ
aiua-6844	72	11	cases	case	NOUN
aiua-6844	72	12	of	of	ADP
aiua-6844	72	13	pca	pca	NOUN
aiua-6844	72	14	were	be	AUX
aiua-6844	72	15	diagnosed	diagnose	VERB
aiua-6844	72	16	in	in	ADP
aiua-6844	72	17	the	the	DET
aiua-6844	72	18	green	green	ADJ
aiua-6844	72	19	tea	tea	NOUN
aiua-6844	72	20	catechins	catechin	NOUN
aiua-6844	72	21	group	group	NOUN
aiua-6844	72	22	,	,	PUNCT
aiua-6844	72	23	reaching	reach	VERB
aiua-6844	72	24	a	a	DET
aiua-6844	72	25	18	18	NUM
aiua-6844	72	26	%	%	NOUN
aiua-6844	72	27	of	of	ADP
aiua-6844	72	28	pca	pca	NOUN
aiua-6844	72	29	incidence	incidence	NOUN
aiua-6844	72	30	also	also	ADV
aiua-6844	72	31	in	in	ADP
aiua-6844	72	32	the	the	DET
aiua-6844	72	33	treated	treat	VERB
aiua-6844	72	34	arm	arm	NOUN
aiua-6844	72	35	(	(	PUNCT
aiua-6844	72	36	figure	figure	NOUN
aiua-6844	72	37	2b	2b	NOUN
aiua-6844	72	38	)	)	PUNCT
aiua-6844	72	39	.	.	PUNCT
aiua-6844	73	1	in	in	ADP
aiua-6844	73	2	the	the	DET
aiua-6844	73	3	green	green	ADJ
aiua-6844	73	4	tea	tea	NOUN
aiua-6844	73	5	catechins	catechin	NOUN
aiua-6844	73	6	group	group	NOUN
aiua-6844	73	7	we	we	PRON
aiua-6844	73	8	observed	observe	VERB
aiua-6844	73	9	a	a	DET
aiua-6844	73	10	progressive	progressive	ADJ
aiua-6844	73	11	reduction	reduction	NOUN
aiua-6844	73	12	of	of	ADP
aiua-6844	73	13	the	the	DET
aiua-6844	73	14	psa	psa	NOUN
aiua-6844	73	15	value	value	NOUN
aiua-6844	73	16	throughout	throughout	ADP
aiua-6844	73	17	the	the	DET
aiua-6844	73	18	1	1	NUM
aiua-6844	73	19	-	-	PUNCT
aiua-6844	73	20	year	year	NOUN
aiua-6844	73	21	study	study	NOUN
aiua-6844	73	22	,	,	PUNCT
aiua-6844	73	23	as	as	ADV
aiua-6844	73	24	well	well	ADV
aiua-6844	73	25	as	as	SCONJ
aiua-6844	73	26	we	we	PRON
aiua-6844	73	27	found	find	VERB
aiua-6844	73	28	a	a	DET
aiua-6844	73	29	deceleration	deceleration	NOUN
aiua-6844	73	30	of	of	ADP
aiua-6844	73	31	the	the	DET
aiua-6844	73	32	psa	psa	NOUN
aiua-6844	73	33	rise	rise	NOUN
aiua-6844	73	34	in	in	ADP
aiua-6844	73	35	the	the	DET
aiua-6844	73	36	green	green	ADJ
aiua-6844	73	37	tea	tea	NOUN
aiua-6844	73	38	catechins	catechin	NOUN
aiua-6844	73	39	group	group	NOUN
aiua-6844	73	40	with	with	ADP
aiua-6844	73	41	respect	respect	NOUN
aiua-6844	73	42	to	to	ADP
aiua-6844	73	43	the	the	DET
aiua-6844	73	44	placebo	placebo	NOUN
aiua-6844	73	45	ones	one	NOUN
aiua-6844	73	46	,	,	PUNCT
aiua-6844	73	47	however	however	ADV
aiua-6844	73	48	without	without	ADP
aiua-6844	73	49	reaching	reach	VERB
aiua-6844	73	50	statistical	statistical	ADJ
aiua-6844	73	51	significance	significance	NOUN
aiua-6844	73	52	(	(	PUNCT
aiua-6844	73	53	table	table	NOUN
aiua-6844	73	54	2	2	NUM
aiua-6844	73	55	)	)	PUNCT
aiua-6844	73	56	.	.	PUNCT
aiua-6844	74	1	interestingly	interestingly	ADV
aiua-6844	74	2	,	,	PUNCT
aiua-6844	74	3	after	after	ADP
aiua-6844	74	4	12	12	NUM
aiua-6844	74	5	months	month	NOUN
aiua-6844	74	6	of	of	ADP
aiua-6844	74	7	treatment	treatment	NOUN
aiua-6844	74	8	we	we	PRON
aiua-6844	74	9	found	find	VERB
aiua-6844	74	10	a	a	DET
aiua-6844	74	11	significant	significant	ADJ
aiua-6844	74	12	reduction	reduction	NOUN
aiua-6844	74	13	of	of	ADP
aiua-6844	74	14	psa	psa	NOUN
aiua-6844	74	15	values	value	NOUN
aiua-6844	74	16	in	in	ADP
aiua-6844	74	17	the	the	DET
aiua-6844	74	18	green	green	ADJ
aiua-6844	74	19	tea	tea	NOUN
aiua-6844	74	20	catechins	catechin	NOUN
aiua-6844	74	21	group	group	NOUN
aiua-6844	74	22	with	with	ADP
aiua-6844	74	23	respect	respect	NOUN
aiua-6844	74	24	to	to	ADP
aiua-6844	74	25	the	the	DET
aiua-6844	74	26	placebo	placebo	NOUN
aiua-6844	74	27	ones	one	NOUN
aiua-6844	74	28	(	(	PUNCT
aiua-6844	74	29	3.85	3.85	NUM
aiua-6844	74	30	±	±	NUM
aiua-6844	74	31	1.8	1.8	NUM
aiua-6844	74	32	ng	ng	PROPN
aiua-6844	74	33	/	/	SYM
aiua-6844	74	34	dl	dl	PROPN
aiua-6844	74	35	and	and	CCONJ
aiua-6844	74	36	5.83	5.83	NUM
aiua-6844	74	37	±	±	NUM
aiua-6844	74	38	2.65	2.65	NUM
aiua-6844	74	39	,	,	PUNCT
aiua-6844	74	40	respectively	respectively	ADV
aiua-6844	74	41	;	;	PUNCT
aiua-6844	74	42	p	p	X
aiua-6844	74	43	<	<	X
aiua-6844	74	44	0.05	0.05	NUM
aiua-6844	74	45	;	;	PUNCT
aiua-6844	74	46	table	table	NOUN
aiua-6844	74	47	2	2	NUM
aiua-6844	74	48	)	)	PUNCT
aiua-6844	74	49	.	.	PUNCT
aiua-6844	75	1	finally	finally	ADV
aiua-6844	75	2	,	,	PUNCT
aiua-6844	75	3	a	a	DET
aiua-6844	75	4	certain	certain	ADJ
aiua-6844	75	5	improvement	improvement	NOUN
aiua-6844	75	6	in	in	ADP
aiua-6844	75	7	luts	luts	PROPN
aiua-6844	75	8	and	and	CCONJ
aiua-6844	75	9	qol	qol	PROPN
aiua-6844	75	10	scores	score	NOUN
aiua-6844	75	11	was	be	AUX
aiua-6844	75	12	found	find	VERB
aiua-6844	75	13	by	by	ADP
aiua-6844	75	14	analyzing	analyze	VERB
aiua-6844	75	15	the	the	DET
aiua-6844	75	16	patient	patient	NOUN
aiua-6844	75	17	’s	’s	PART
aiua-6844	75	18	questionnaires	questionnaire	NOUN
aiua-6844	75	19	filled	fill	VERB
aiua-6844	75	20	by	by	ADP
aiua-6844	75	21	the	the	DET
aiua-6844	75	22	subjects	subject	NOUN
aiua-6844	75	23	belonging	belong	VERB
aiua-6844	75	24	to	to	ADP
aiua-6844	75	25	green	green	ADJ
aiua-6844	75	26	tea	tea	NOUN
aiua-6844	75	27	catechins	catechin	NOUN
aiua-6844	75	28	group	group	NOUN
aiua-6844	75	29	throughout	throughout	ADP
aiua-6844	75	30	the	the	DET
aiua-6844	75	31	1	1	NUM
aiua-6844	75	32	-	-	PUNCT
aiua-6844	75	33	year	year	NOUN
aiua-6844	75	34	study	study	NOUN
aiua-6844	75	35	.	.	PUNCT
aiua-6844	76	1	however	however	ADV
aiua-6844	76	2	,	,	PUNCT
aiua-6844	76	3	no	no	DET
aiua-6844	76	4	significant	significant	ADJ
aiua-6844	76	5	differences	difference	NOUN
aiua-6844	76	6	between	between	ADP
aiua-6844	76	7	the	the	DET
aiua-6844	76	8	treatment	treatment	NOUN
aiua-6844	76	9	and	and	CCONJ
aiua-6844	76	10	placebo	placebo	NOUN
aiua-6844	76	11	arms	arm	NOUN
aiua-6844	76	12	were	be	AUX
aiua-6844	76	13	observed	observe	VERB
aiua-6844	76	14	from	from	ADP
aiua-6844	76	15	baseline	baseline	NOUN
aiua-6844	76	16	to	to	ADP
aiua-6844	76	17	end	end	NOUN
aiua-6844	76	18	of	of	ADP
aiua-6844	76	19	study	study	NOUN
aiua-6844	76	20	(	(	PUNCT
aiua-6844	76	21	data	datum	NOUN
aiua-6844	76	22	not	not	PART
aiua-6844	76	23	shown	show	VERB
aiua-6844	76	24	)	)	PUNCT
aiua-6844	76	25	.	.	PUNCT
aiua-6844	77	1	discussion	discussion	NOUN
aiua-6844	77	2	pca	pca	PROPN
aiua-6844	77	3	is	be	AUX
aiua-6844	77	4	considered	consider	VERB
aiua-6844	77	5	the	the	DET
aiua-6844	77	6	most	most	ADV
aiua-6844	77	7	common	common	ADJ
aiua-6844	77	8	malignancy	malignancy	NOUN
aiua-6844	77	9	and	and	CCONJ
aiua-6844	77	10	the	the	DET
aiua-6844	77	11	second	second	ADJ
aiua-6844	77	12	leading	leading	ADJ
aiua-6844	77	13	cause	cause	NOUN
aiua-6844	77	14	of	of	ADP
aiua-6844	77	15	cancer	cancer	NOUN
aiua-6844	77	16	death	death	NOUN
aiua-6844	77	17	among	among	ADP
aiua-6844	77	18	men	man	NOUN
aiua-6844	77	19	in	in	ADP
aiua-6844	77	20	united	united	PROPN
aiua-6844	77	21	states	states	PROPN
aiua-6844	77	22	and	and	CCONJ
aiua-6844	77	23	europe	europe	PROPN
aiua-6844	77	24	.	.	PUNCT
aiua-6844	78	1	during	during	ADP
aiua-6844	78	2	its	its	PRON
aiua-6844	78	3	progression	progression	NOUN
aiua-6844	78	4	,	,	PUNCT
aiua-6844	78	5	cell	cell	NOUN
aiua-6844	78	6	phenotype	phenotype	NOUN
aiua-6844	78	7	changes	change	VERB
aiua-6844	78	8	from	from	ADP
aiua-6844	78	9	normal	normal	ADJ
aiua-6844	78	10	to	to	ADP
aiua-6844	78	11	severe	severe	ADJ
aiua-6844	78	12	dysplasia	dysplasia	NOUN
aiua-6844	78	13	(	(	PUNCT
aiua-6844	78	14	high	high	ADJ
aiua-6844	78	15	-	-	PUNCT
aiua-6844	78	16	grade	grade	NOUN
aiua-6844	78	17	prostatic	prostatic	ADJ
aiua-6844	78	18	intraepithelial	intraepithelial	ADJ
aiua-6844	78	19	neoplasia	neoplasia	NOUN
aiua-6844	78	20	)	)	PUNCT
aiua-6844	78	21	,	,	PUNCT
aiua-6844	78	22	to	to	ADP
aiua-6844	78	23	early	early	ADJ
aiua-6844	78	24	(	(	PUNCT
aiua-6844	78	25	superficial	superficial	ADJ
aiua-6844	78	26	)	)	PUNCT
aiua-6844	78	27	cancers	cancer	NOUN
aiua-6844	78	28	,	,	PUNCT
aiua-6844	78	29	and	and	CCONJ
aiua-6844	78	30	finally	finally	ADV
aiua-6844	78	31	to	to	PART
aiua-6844	78	32	metastatic	metastatic	ADJ
aiua-6844	78	33	disease	disease	NOUN
aiua-6844	78	34	.	.	PUNCT
aiua-6844	79	1	the	the	DET
aiua-6844	79	2	occurrence	occurrence	NOUN
aiua-6844	79	3	of	of	ADP
aiua-6844	79	4	latent	latent	NOUN
aiua-6844	79	5	pca	pca	PROPN
aiua-6844	79	6	is	be	AUX
aiua-6844	79	7	consistently	consistently	ADV
aiua-6844	79	8	distributed	distribute	VERB
aiua-6844	79	9	,	,	PUNCT
aiua-6844	79	10	suggesting	suggest	VERB
aiua-6844	79	11	that	that	SCONJ
aiua-6844	79	12	external	external	ADJ
aiua-6844	79	13	issues	issue	NOUN
aiua-6844	79	14	such	such	ADJ
aiua-6844	79	15	as	as	ADP
aiua-6844	79	16	diet	diet	NOUN
aiua-6844	79	17	,	,	PUNCT
aiua-6844	79	18	physical	physical	ADJ
aiua-6844	79	19	199archivio	199archivio	PROPN
aiua-6844	79	20	italiano	italiano	NOUN
aiua-6844	79	21	di	di	X
aiua-6844	79	22	urologia	urologia	PROPN
aiua-6844	79	23	e	e	PROPN
aiua-6844	79	24	andrologia	andrologia	NOUN
aiua-6844	79	25	2017	2017	NUM
aiua-6844	79	26	;	;	PUNCT
aiua-6844	79	27	89	89	NUM
aiua-6844	79	28	,	,	PUNCT
aiua-6844	79	29	3	3	NUM
aiua-6844	79	30	green	green	ADJ
aiua-6844	79	31	tea	tea	NOUN
aiua-6844	79	32	catechins	catechin	NOUN
aiua-6844	79	33	in	in	ADP
aiua-6844	79	34	hg	hg	ADJ
aiua-6844	79	35	-	-	ADJ
aiua-6844	79	36	pin	pin	ADJ
aiua-6844	79	37	patients	patient	NOUN
aiua-6844	79	38	table	table	VERB
aiua-6844	79	39	1	1	NUM
aiua-6844	79	40	.	.	PUNCT
aiua-6844	80	1	patient	patient	ADJ
aiua-6844	80	2	characteristics	characteristic	NOUN
aiua-6844	80	3	at	at	ADP
aiua-6844	80	4	the	the	DET
aiua-6844	80	5	time	time	NOUN
aiua-6844	80	6	of	of	ADP
aiua-6844	80	7	enrollment	enrollment	NOUN
aiua-6844	80	8	(	(	PUNCT
aiua-6844	80	9	mean	mean	PROPN
aiua-6844	80	10	±	±	NUM
aiua-6844	80	11	sd	sd	NOUN
aiua-6844	80	12	)	)	PUNCT
aiua-6844	80	13	.	.	PUNCT
aiua-6844	81	1	mean	mean	VERB
aiua-6844	81	2	weight	weight	NOUN
aiua-6844	81	3	prostate	prostate	NOUN
aiua-6844	81	4	psa	psa	NOUN
aiua-6844	81	5	age	age	NOUN
aiua-6844	81	6	(	(	PUNCT
aiua-6844	81	7	kg	kg	NOUN
aiua-6844	81	8	)	)	PUNCT
aiua-6844	81	9	volume	volume	NOUN
aiua-6844	81	10	(	(	PUNCT
aiua-6844	81	11	ml	ml	NOUN
aiua-6844	81	12	)	)	PUNCT
aiua-6844	81	13	value	value	NOUN
aiua-6844	81	14	total	total	ADJ
aiua-6844	81	15	population	population	NOUN
aiua-6844	81	16	enrolled	enrol	VERB
aiua-6844	81	17	64.34	64.34	NUM
aiua-6844	81	18	±	±	NUM
aiua-6844	81	19	8.4	8.4	NUM
aiua-6844	81	20	82.77	82.77	NUM
aiua-6844	81	21	±	±	NUM
aiua-6844	81	22	6.6	6.6	NUM
aiua-6844	81	23	44.74	44.74	NUM
aiua-6844	81	24	±	±	NUM
aiua-6844	81	25	16	16	NUM
aiua-6844	81	26	5.31	5.31	NUM
aiua-6844	81	27	±	±	NUM
aiua-6844	81	28	2.5	2.5	NUM
aiua-6844	81	29	placebo	placebo	NOUN
aiua-6844	81	30	arm	arm	NOUN
aiua-6844	81	31	64.4	64.4	NUM
aiua-6844	81	32	±	±	NUM
aiua-6844	81	33	8.9	8.9	NUM
aiua-6844	81	34	80.9	80.9	NUM
aiua-6844	81	35	±	±	NUM
aiua-6844	81	36	6.4	6.4	NUM
aiua-6844	81	37	42.15	42.15	NUM
aiua-6844	81	38	±	±	NUM
aiua-6844	81	39	15	15	NUM
aiua-6844	81	40	4.7	4.7	NUM
aiua-6844	81	41	±	±	NUM
aiua-6844	81	42	2.5	2.5	NUM
aiua-6844	81	43	green	green	ADJ
aiua-6844	81	44	tea	tea	NOUN
aiua-6844	81	45	catechinstreated	catechinstreate	VERB
aiua-6844	81	46	arm	arm	NOUN
aiua-6844	81	47	64.27	64.27	NUM
aiua-6844	81	48	±	±	NUM
aiua-6844	81	49	8	8	NUM
aiua-6844	81	50	84.64	84.64	NUM
aiua-6844	81	51	±	±	NUM
aiua-6844	81	52	6	6	NUM
aiua-6844	81	53	46.,87	46.,87	NUM
aiua-6844	81	54	±	±	NUM
aiua-6844	81	55	17.8	17.8	NUM
aiua-6844	81	56	5.95	5.95	NUM
aiua-6844	81	57	±	±	NUM
aiua-6844	81	58	2.3	2.3	NUM
aiua-6844	81	59	table	table	NOUN
aiua-6844	81	60	2	2	NUM
aiua-6844	81	61	.	.	PUNCT
aiua-6844	82	1	psa	psa	NOUN
aiua-6844	82	2	values	value	NOUN
aiua-6844	82	3	(	(	PUNCT
aiua-6844	82	4	ng	ng	NOUN
aiua-6844	82	5	/	/	SYM
aiua-6844	82	6	ml	ml	PROPN
aiua-6844	82	7	)	)	PUNCT
aiua-6844	82	8	throughout	throughout	ADP
aiua-6844	82	9	the	the	DET
aiua-6844	82	10	1	1	NUM
aiua-6844	82	11	-	-	PUNCT
aiua-6844	82	12	year	year	NOUN
aiua-6844	82	13	study	study	NOUN
aiua-6844	82	14	(	(	PUNCT
aiua-6844	82	15	mean	mean	PROPN
aiua-6844	82	16	±	±	NUM
aiua-6844	82	17	sd	sd	NOUN
aiua-6844	82	18	)	)	PUNCT
aiua-6844	82	19	.	.	PUNCT
aiua-6844	83	1	green	green	ADJ
aiua-6844	83	2	tea	tea	NOUN
aiua-6844	83	3	placebo	placebo	NOUN
aiua-6844	83	4	p	p	NOUN
aiua-6844	83	5	catechins	catechin	NOUN
aiua-6844	83	6	-	-	PUNCT
aiua-6844	83	7	treated	treat	VERB
aiua-6844	83	8	arm	arm	NOUN
aiua-6844	83	9	group	group	NOUN
aiua-6844	83	10	value	value	NOUN
aiua-6844	83	11	time	time	NOUN
aiua-6844	83	12	of	of	ADP
aiua-6844	83	13	enrolment	enrolment	NOUN
aiua-6844	83	14	5.9	5.9	NUM
aiua-6844	83	15	±	±	NOUN
aiua-6844	83	16	2.3	2.3	NUM
aiua-6844	83	17	4.7	4.7	NUM
aiua-6844	83	18	±	±	NUM
aiua-6844	83	19	2.5	2.5	NUM
aiua-6844	83	20	6	6	NUM
aiua-6844	83	21	months	month	NOUN
aiua-6844	83	22	4.9	4.9	NUM
aiua-6844	83	23	±	±	NUM
aiua-6844	83	24	1.9	1.9	NUM
aiua-6844	83	25	5.2	5.2	NUM
aiua-6844	83	26	±	±	NUM
aiua-6844	83	27	2.1	2.1	NUM
aiua-6844	83	28	n.s	n.s	PROPN
aiua-6844	83	29	.	.	PROPN
aiua-6844	83	30	12	12	NUM
aiua-6844	83	31	months	month	NOUN
aiua-6844	83	32	3.8	3.8	NUM
aiua-6844	83	33	±	±	NUM
aiua-6844	83	34	1.8	1.8	NUM
aiua-6844	83	35	5.8	5.8	NUM
aiua-6844	83	36	±	±	NUM
aiua-6844	83	37	2.6	2.6	NUM
aiua-6844	83	38	<	<	X
aiua-6844	83	39	0.05	0.05	NUM
aiua-6844	83	40	figure	figure	NOUN
aiua-6844	83	41	1	1	NUM
aiua-6844	83	42	.	.	PUNCT
aiua-6844	83	43	consort	consort	NOUN
aiua-6844	83	44	flow	flow	PROPN
aiua-6844	83	45	diagram	diagram	PROPN
aiua-6844	83	46	.	.	PUNCT
aiua-6844	84	1	figure	figure	NOUN
aiua-6844	84	2	2	2	NUM
aiua-6844	84	3	.	.	PUNCT
aiua-6844	85	1	incidence	incidence	NOUN
aiua-6844	85	2	of	of	ADP
aiua-6844	85	3	new	new	ADJ
aiua-6844	85	4	diagnosis	diagnosis	NOUN
aiua-6844	85	5	of	of	ADP
aiua-6844	85	6	pca	pca	NOUN
aiua-6844	85	7	at	at	ADP
aiua-6844	85	8	6	6	NUM
aiua-6844	85	9	(	(	PUNCT
aiua-6844	85	10	a	a	NOUN
aiua-6844	85	11	)	)	PUNCT
aiua-6844	85	12	and	and	CCONJ
aiua-6844	85	13	12	12	NUM
aiua-6844	85	14	(	(	PUNCT
aiua-6844	85	15	b	b	NOUN
aiua-6844	85	16	)	)	PUNCT
aiua-6844	85	17	months	month	NOUN
aiua-6844	85	18	’	'	PUNCT
aiua-6844	85	19	follow	follow	VERB
aiua-6844	85	20	up	up	ADP
aiua-6844	85	21	.	.	PUNCT
aiua-6844	86	1	micali_stesura	micali_stesura	NOUN
aiua-6844	86	2	seveso	seveso	VERB
aiua-6844	86	3	28/09/17	28/09/17	PROPN
aiua-6844	86	4	10:18	10:18	NUM
aiua-6844	86	5	pagina	pagina	NOUN
aiua-6844	86	6	199	199	NUM
aiua-6844	86	7	archivio	archivio	NOUN
aiua-6844	86	8	italiano	italiano	X
aiua-6844	86	9	di	di	X
aiua-6844	86	10	urologia	urologia	PROPN
aiua-6844	86	11	e	e	PROPN
aiua-6844	86	12	andrologia	andrologia	NOUN
aiua-6844	86	13	2017	2017	NUM
aiua-6844	86	14	;	;	PUNCT
aiua-6844	86	15	89	89	NUM
aiua-6844	86	16	,	,	PUNCT
aiua-6844	86	17	3	3	NUM
aiua-6844	86	18	s.	s.	PROPN
aiua-6844	86	19	micali	micali	PROPN
aiua-6844	86	20	,	,	PUNCT
aiua-6844	86	21	a.	a.	NOUN
aiua-6844	86	22	territo	territo	PROPN
aiua-6844	86	23	,	,	PUNCT
aiua-6844	86	24	g.m	g.m	PROPN
aiua-6844	86	25	.	.	PROPN
aiua-6844	86	26	pirola	pirola	PROPN
aiua-6844	86	27	,	,	PUNCT
aiua-6844	86	28	n.	n.	PROPN
aiua-6844	86	29	ferrari	ferrari	PROPN
aiua-6844	86	30	,	,	PUNCT
aiua-6844	86	31	m.c	m.c	PROPN
aiua-6844	86	32	.	.	PROPN
aiua-6844	86	33	sighinolfi	sighinolfi	PROPN
aiua-6844	86	34	,	,	PUNCT
aiua-6844	86	35	e.	e.	PROPN
aiua-6844	86	36	martorana	martorana	PROPN
aiua-6844	86	37	,	,	PUNCT
aiua-6844	86	38	m.	m.	NOUN
aiua-6844	86	39	navarra	navarra	PROPN
aiua-6844	86	40	,	,	PUNCT
aiua-6844	86	41	g.	g.	PROPN
aiua-6844	86	42	bianchi	bianchi	PROPN
aiua-6844	86	43	200	200	NUM
aiua-6844	86	44	activity	activity	NOUN
aiua-6844	86	45	,	,	PUNCT
aiua-6844	86	46	and	and	CCONJ
aiua-6844	86	47	other	other	ADJ
aiua-6844	86	48	lifestyle	lifestyle	NOUN
aiua-6844	86	49	factors	factor	NOUN
aiua-6844	86	50	may	may	AUX
aiua-6844	86	51	be	be	AUX
aiua-6844	86	52	important	important	ADJ
aiua-6844	86	53	in	in	ADP
aiua-6844	86	54	the	the	DET
aiua-6844	86	55	evolution	evolution	NOUN
aiua-6844	86	56	into	into	ADP
aiua-6844	86	57	aggressive	aggressive	ADJ
aiua-6844	86	58	clinical	clinical	ADJ
aiua-6844	86	59	diseases	disease	NOUN
aiua-6844	86	60	(	(	PUNCT
aiua-6844	86	61	17	17	NUM
aiua-6844	86	62	)	)	PUNCT
aiua-6844	86	63	.	.	PUNCT
aiua-6844	87	1	hg	hg	X
aiua-6844	87	2	-	-	PUNCT
aiua-6844	87	3	pin	pin	NOUN
aiua-6844	87	4	is	be	AUX
aiua-6844	87	5	a	a	DET
aiua-6844	87	6	premalignant	premalignant	ADJ
aiua-6844	87	7	condition	condition	NOUN
aiua-6844	87	8	,	,	PUNCT
aiua-6844	87	9	defined	define	VERB
aiua-6844	87	10	by	by	ADP
aiua-6844	87	11	neoplastic	neoplastic	ADJ
aiua-6844	87	12	development	development	NOUN
aiua-6844	87	13	of	of	ADP
aiua-6844	87	14	epithelial	epithelial	ADJ
aiua-6844	87	15	cells	cell	NOUN
aiua-6844	87	16	among	among	ADP
aiua-6844	87	17	pre	pre	ADJ
aiua-6844	87	18	-	-	ADJ
aiua-6844	87	19	existing	exist	VERB
aiua-6844	87	20	benign	benign	ADJ
aiua-6844	87	21	prostatic	prostatic	ADJ
aiua-6844	87	22	acini	acini	NOUN
aiua-6844	87	23	or	or	CCONJ
aiua-6844	87	24	ducts	duct	NOUN
aiua-6844	87	25	,	,	PUNCT
aiua-6844	87	26	appearing	appear	VERB
aiua-6844	87	27	as	as	ADP
aiua-6844	87	28	a	a	DET
aiua-6844	87	29	sort	sort	NOUN
aiua-6844	87	30	of	of	ADP
aiua-6844	87	31	intermediate	intermediate	ADJ
aiua-6844	87	32	stage	stage	NOUN
aiua-6844	87	33	between	between	ADP
aiua-6844	87	34	benign	benign	ADJ
aiua-6844	87	35	epithelium	epithelium	NOUN
aiua-6844	87	36	and	and	CCONJ
aiua-6844	87	37	malignant	malignant	ADJ
aiua-6844	87	38	carcinoma	carcinoma	NOUN
aiua-6844	87	39	.	.	PUNCT
aiua-6844	88	1	histologically	histologically	ADV
aiua-6844	88	2	,	,	PUNCT
aiua-6844	88	3	the	the	DET
aiua-6844	88	4	main	main	ADJ
aiua-6844	88	5	difference	difference	NOUN
aiua-6844	88	6	with	with	ADP
aiua-6844	88	7	the	the	DET
aiua-6844	88	8	prostate	prostate	NOUN
aiua-6844	88	9	carcinoma	carcinoma	NOUN
aiua-6844	88	10	is	be	AUX
aiua-6844	88	11	the	the	DET
aiua-6844	88	12	conservation	conservation	NOUN
aiua-6844	88	13	of	of	ADP
aiua-6844	88	14	the	the	DET
aiua-6844	88	15	basement	basement	NOUN
aiua-6844	88	16	membrane	membrane	NOUN
aiua-6844	88	17	,	,	PUNCT
aiua-6844	88	18	which	which	PRON
aiua-6844	88	19	orients	orient	VERB
aiua-6844	88	20	pathologists	pathologist	NOUN
aiua-6844	88	21	in	in	ADP
aiua-6844	88	22	indicating	indicate	VERB
aiua-6844	88	23	an	an	DET
aiua-6844	88	24	hg	hg	NOUN
aiua-6844	88	25	-	-	NOUN
aiua-6844	88	26	pin	pin	NOUN
aiua-6844	88	27	.	.	PUNCT
aiua-6844	89	1	on	on	ADP
aiua-6844	89	2	the	the	DET
aiua-6844	89	3	other	other	ADJ
aiua-6844	89	4	hand	hand	NOUN
aiua-6844	89	5	,	,	PUNCT
aiua-6844	89	6	cellular	cellular	ADJ
aiua-6844	89	7	parameters	parameter	NOUN
aiua-6844	89	8	can	can	AUX
aiua-6844	89	9	be	be	AUX
aiua-6844	89	10	mismatched	mismatch	VERB
aiua-6844	89	11	with	with	ADP
aiua-6844	89	12	a	a	DET
aiua-6844	89	13	carcinoma	carcinoma	NOUN
aiua-6844	89	14	,	,	PUNCT
aiua-6844	89	15	like	like	ADP
aiua-6844	89	16	the	the	DET
aiua-6844	89	17	prominent	prominent	ADJ
aiua-6844	89	18	and	and	CCONJ
aiua-6844	89	19	abnormal	abnormal	ADJ
aiua-6844	89	20	nuclei	nucleus	NOUN
aiua-6844	89	21	,	,	PUNCT
aiua-6844	89	22	that	that	PRON
aiua-6844	89	23	are	be	AUX
aiua-6844	89	24	also	also	ADV
aiua-6844	89	25	characteristic	characteristic	ADJ
aiua-6844	89	26	in	in	ADP
aiua-6844	89	27	hg	hg	NOUN
aiua-6844	89	28	-	-	NOUN
aiua-6844	89	29	pin	pin	NOUN
aiua-6844	89	30	(	(	PUNCT
aiua-6844	89	31	18	18	NUM
aiua-6844	89	32	)	)	PUNCT
aiua-6844	89	33	.	.	PUNCT
aiua-6844	90	1	the	the	DET
aiua-6844	90	2	incidence	incidence	NOUN
aiua-6844	90	3	of	of	ADP
aiua-6844	90	4	hg	hg	NOUN
aiua-6844	90	5	-	-	NOUN
aiua-6844	90	6	pin	pin	NOUN
aiua-6844	90	7	on	on	ADP
aiua-6844	90	8	prostatic	prostatic	ADJ
aiua-6844	90	9	biopsy	biopsy	NOUN
aiua-6844	90	10	averages	average	NOUN
aiua-6844	90	11	approximately	approximately	ADV
aiua-6844	90	12	15	15	NUM
aiua-6844	90	13	%	%	NOUN
aiua-6844	90	14	,	,	PUNCT
aiua-6844	90	15	increasing	increase	VERB
aiua-6844	90	16	with	with	ADP
aiua-6844	90	17	patient	patient	NOUN
aiua-6844	90	18	’s	’s	PART
aiua-6844	90	19	age	age	NOUN
aiua-6844	90	20	.	.	PUNCT
aiua-6844	91	1	moreover	moreover	ADV
aiua-6844	91	2	,	,	PUNCT
aiua-6844	91	3	some	some	DET
aiua-6844	91	4	areas	area	NOUN
aiua-6844	91	5	of	of	ADP
aiua-6844	91	6	hg	hg	NOUN
aiua-6844	91	7	-	-	NOUN
aiua-6844	91	8	pin	pin	NOUN
aiua-6844	91	9	are	be	AUX
aiua-6844	91	10	frequently	frequently	ADV
aiua-6844	91	11	found	find	VERB
aiua-6844	91	12	around	around	ADP
aiua-6844	91	13	prostatic	prostatic	ADJ
aiua-6844	91	14	cancerous	cancerous	ADJ
aiua-6844	91	15	lesions	lesion	NOUN
aiua-6844	91	16	and	and	CCONJ
aiua-6844	91	17	evolution	evolution	NOUN
aiua-6844	91	18	into	into	ADP
aiua-6844	91	19	carcinoma	carcinoma	NOUN
aiua-6844	91	20	is	be	AUX
aiua-6844	91	21	estimated	estimate	VERB
aiua-6844	91	22	in	in	ADP
aiua-6844	91	23	about	about	ADV
aiua-6844	91	24	30	30	NUM
aiua-6844	91	25	%	%	NOUN
aiua-6844	91	26	of	of	ADP
aiua-6844	91	27	cases	case	NOUN
aiua-6844	91	28	(	(	PUNCT
aiua-6844	91	29	19	19	NUM
aiua-6844	91	30	)	)	PUNCT
aiua-6844	91	31	.	.	PUNCT
aiua-6844	92	1	recent	recent	ADJ
aiua-6844	92	2	literature	literature	NOUN
aiua-6844	92	3	states	state	VERB
aiua-6844	92	4	that	that	SCONJ
aiua-6844	92	5	30	30	NUM
aiua-6844	92	6	%	%	NOUN
aiua-6844	92	7	of	of	ADP
aiua-6844	92	8	men	man	NOUN
aiua-6844	92	9	with	with	ADP
aiua-6844	92	10	hg	hg	NOUN
aiua-6844	92	11	-	-	NOUN
aiua-6844	92	12	pin	pin	NOUN
aiua-6844	92	13	would	would	AUX
aiua-6844	92	14	develop	develop	VERB
aiua-6844	92	15	prostate	prostate	NOUN
aiua-6844	92	16	cancer	cancer	NOUN
aiua-6844	92	17	within	within	ADP
aiua-6844	92	18	1	1	NUM
aiua-6844	92	19	year	year	NOUN
aiua-6844	92	20	after	after	ADP
aiua-6844	92	21	repeated	repeat	VERB
aiua-6844	92	22	biopsy	biopsy	NOUN
aiua-6844	92	23	(	(	PUNCT
aiua-6844	92	24	1	1	NUM
aiua-6844	92	25	)	)	PUNCT
aiua-6844	92	26	.	.	PUNCT
aiua-6844	93	1	in	in	ADP
aiua-6844	93	2	this	this	DET
aiua-6844	93	3	contest	contest	NOUN
aiua-6844	93	4	,	,	PUNCT
aiua-6844	93	5	the	the	DET
aiua-6844	93	6	chemoprevention	chemoprevention	NOUN
aiua-6844	93	7	(	(	PUNCT
aiua-6844	93	8	the	the	DET
aiua-6844	93	9	administration	administration	NOUN
aiua-6844	93	10	of	of	ADP
aiua-6844	93	11	agents	agent	NOUN
aiua-6844	93	12	to	to	PART
aiua-6844	93	13	prevent	prevent	VERB
aiua-6844	93	14	the	the	DET
aiua-6844	93	15	induction	induction	NOUN
aiua-6844	93	16	or	or	CCONJ
aiua-6844	93	17	to	to	PART
aiua-6844	93	18	delay	delay	VERB
aiua-6844	93	19	the	the	DET
aiua-6844	93	20	progression	progression	NOUN
aiua-6844	93	21	of	of	ADP
aiua-6844	93	22	cancers	cancer	NOUN
aiua-6844	93	23	)	)	PUNCT
aiua-6844	93	24	play	play	VERB
aiua-6844	93	25	an	an	DET
aiua-6844	93	26	important	important	ADJ
aiua-6844	93	27	role	role	NOUN
aiua-6844	93	28	,	,	PUNCT
aiua-6844	93	29	trying	try	VERB
aiua-6844	93	30	to	to	PART
aiua-6844	93	31	stop	stop	VERB
aiua-6844	93	32	multistage	multistage	NOUN
aiua-6844	93	33	carcinogenesis	carcinogenesis	NOUN
aiua-6844	93	34	before	before	ADP
aiua-6844	93	35	its	its	PRON
aiua-6844	93	36	development	development	NOUN
aiua-6844	93	37	in	in	ADP
aiua-6844	93	38	malignancy	malignancy	NOUN
aiua-6844	93	39	.	.	PUNCT
aiua-6844	94	1	pca	pca	NOUN
aiua-6844	94	2	with	with	ADP
aiua-6844	94	3	its	its	PRON
aiua-6844	94	4	high	high	ADJ
aiua-6844	94	5	prevalence	prevalence	NOUN
aiua-6844	94	6	and	and	CCONJ
aiua-6844	94	7	long	long	ADJ
aiua-6844	94	8	latency	latency	NOUN
aiua-6844	94	9	provides	provide	VERB
aiua-6844	94	10	a	a	DET
aiua-6844	94	11	promising	promising	ADJ
aiua-6844	94	12	approach	approach	NOUN
aiua-6844	94	13	for	for	ADP
aiua-6844	94	14	evaluating	evaluate	VERB
aiua-6844	94	15	agents	agent	NOUN
aiua-6844	94	16	for	for	ADP
aiua-6844	94	17	chemoprevention	chemoprevention	NOUN
aiua-6844	94	18	.	.	PUNCT
aiua-6844	95	1	it	it	PRON
aiua-6844	95	2	is	be	AUX
aiua-6844	95	3	known	know	VERB
aiua-6844	95	4	that	that	SCONJ
aiua-6844	95	5	the	the	DET
aiua-6844	95	6	possible	possible	ADJ
aiua-6844	95	7	protective	protective	ADJ
aiua-6844	95	8	action	action	NOUN
aiua-6844	95	9	of	of	ADP
aiua-6844	95	10	green	green	ADJ
aiua-6844	95	11	tea	tea	NOUN
aiua-6844	95	12	on	on	ADP
aiua-6844	95	13	pca	pca	PROPN
aiua-6844	95	14	is	be	AUX
aiua-6844	95	15	due	due	ADJ
aiua-6844	95	16	to	to	ADP
aiua-6844	95	17	the	the	DET
aiua-6844	95	18	presence	presence	NOUN
aiua-6844	95	19	of	of	ADP
aiua-6844	95	20	catechins	catechin	NOUN
aiua-6844	95	21	,	,	PUNCT
aiua-6844	95	22	above	above	ADP
aiua-6844	95	23	all	all	DET
aiua-6844	95	24	egcg	egcg	NOUN
aiua-6844	95	25	,	,	PUNCT
aiua-6844	95	26	since	since	SCONJ
aiua-6844	95	27	black	black	ADJ
aiua-6844	95	28	tea	tea	NOUN
aiua-6844	95	29	,	,	PUNCT
aiua-6844	95	30	poor	poor	ADJ
aiua-6844	95	31	of	of	ADP
aiua-6844	95	32	these	these	DET
aiua-6844	95	33	compounds	compound	NOUN
aiua-6844	95	34	,	,	PUNCT
aiua-6844	95	35	does	do	AUX
aiua-6844	95	36	not	not	PART
aiua-6844	95	37	play	play	VERB
aiua-6844	95	38	a	a	DET
aiua-6844	95	39	role	role	NOUN
aiua-6844	95	40	in	in	ADP
aiua-6844	95	41	prevention	prevention	NOUN
aiua-6844	95	42	from	from	ADP
aiua-6844	95	43	pca	pca	PROPN
aiua-6844	95	44	(	(	PUNCT
aiua-6844	95	45	20	20	NUM
aiua-6844	95	46	)	)	PUNCT
aiua-6844	95	47	.	.	PUNCT
aiua-6844	96	1	an	an	DET
aiua-6844	96	2	important	important	ADJ
aiua-6844	96	3	clinical	clinical	ADJ
aiua-6844	96	4	trial	trial	NOUN
aiua-6844	96	5	investigating	investigate	VERB
aiua-6844	96	6	the	the	DET
aiua-6844	96	7	effectiveness	effectiveness	NOUN
aiua-6844	96	8	of	of	ADP
aiua-6844	96	9	green	green	ADJ
aiua-6844	96	10	tea	tea	NOUN
aiua-6844	96	11	catechins	catechin	NOUN
aiua-6844	96	12	on	on	ADP
aiua-6844	96	13	pca	pca	PROPN
aiua-6844	96	14	was	be	AUX
aiua-6844	96	15	carried	carry	VERB
aiua-6844	96	16	out	out	ADP
aiua-6844	96	17	by	by	ADP
aiua-6844	96	18	bettuzzi	bettuzzi	PROPN
aiua-6844	96	19	et	et	PROPN
aiua-6844	96	20	al	al	PROPN
aiua-6844	96	21	.	.	PUNCT
aiua-6844	97	1	(	(	PUNCT
aiua-6844	97	2	12	12	NUM
aiua-6844	97	3	)	)	PUNCT
aiua-6844	97	4	,	,	PUNCT
aiua-6844	97	5	suggesting	suggest	VERB
aiua-6844	97	6	that	that	SCONJ
aiua-6844	97	7	green	green	ADJ
aiua-6844	97	8	tea	tea	NOUN
aiua-6844	97	9	polyphenols	polyphenol	NOUN
aiua-6844	97	10	may	may	AUX
aiua-6844	97	11	be	be	AUX
aiua-6844	97	12	effective	effective	ADJ
aiua-6844	97	13	for	for	ADP
aiua-6844	97	14	treating	treat	VERB
aiua-6844	97	15	premalignant	premalignant	ADJ
aiua-6844	97	16	lesions	lesion	NOUN
aiua-6844	97	17	before	before	SCONJ
aiua-6844	97	18	pca	pca	NOUN
aiua-6844	97	19	develops	develop	VERB
aiua-6844	97	20	.	.	PUNCT
aiua-6844	98	1	in	in	ADP
aiua-6844	98	2	this	this	DET
aiua-6844	98	3	prospective	prospective	ADJ
aiua-6844	98	4	,	,	PUNCT
aiua-6844	98	5	randomized	randomize	VERB
aiua-6844	98	6	,	,	PUNCT
aiua-6844	98	7	double	double	ADJ
aiua-6844	98	8	-	-	PUNCT
aiua-6844	98	9	blind	blind	ADJ
aiua-6844	98	10	,	,	PUNCT
aiua-6844	98	11	placebo	placebo	NOUN
aiua-6844	98	12	-	-	PUNCT
aiua-6844	98	13	controlled	control	VERB
aiua-6844	98	14	clinical	clinical	ADJ
aiua-6844	98	15	trial	trial	NOUN
aiua-6844	98	16	,	,	PUNCT
aiua-6844	98	17	60	60	NUM
aiua-6844	98	18	volunteers	volunteer	NOUN
aiua-6844	98	19	with	with	ADP
aiua-6844	98	20	hgpin	hgpin	NOUN
aiua-6844	98	21	received	receive	VERB
aiua-6844	98	22	orally	orally	ADV
aiua-6844	98	23	600	600	NUM
aiua-6844	98	24	mg	mg	NOUN
aiua-6844	98	25	per	per	ADP
aiua-6844	98	26	day	day	NOUN
aiua-6844	98	27	of	of	ADP
aiua-6844	98	28	green	green	ADJ
aiua-6844	98	29	tea	tea	NOUN
aiua-6844	98	30	catechins	catechin	NOUN
aiua-6844	98	31	or	or	CCONJ
aiua-6844	98	32	placebo	placebo	NOUN
aiua-6844	98	33	for	for	ADP
aiua-6844	98	34	one	one	NUM
aiua-6844	98	35	year	year	NOUN
aiua-6844	98	36	,	,	PUNCT
aiua-6844	98	37	and	and	CCONJ
aiua-6844	98	38	were	be	AUX
aiua-6844	98	39	subjected	subject	VERB
aiua-6844	98	40	to	to	ADP
aiua-6844	98	41	medical	medical	ADJ
aiua-6844	98	42	examinations	examination	NOUN
aiua-6844	98	43	and	and	CCONJ
aiua-6844	98	44	prostate	prostate	NOUN
aiua-6844	98	45	biopsies	biopsy	NOUN
aiua-6844	98	46	at	at	ADP
aiua-6844	98	47	6	6	NUM
aiua-6844	98	48	at	at	ADP
aiua-6844	98	49	12	12	NUM
aiua-6844	98	50	months	month	NOUN
aiua-6844	98	51	.	.	PUNCT
aiua-6844	99	1	authors	author	NOUN
aiua-6844	99	2	concluded	conclude	VERB
aiua-6844	99	3	that	that	SCONJ
aiua-6844	99	4	green	green	ADJ
aiua-6844	99	5	tea	tea	NOUN
aiua-6844	99	6	catechins	catechin	NOUN
aiua-6844	99	7	might	might	AUX
aiua-6844	99	8	provide	provide	VERB
aiua-6844	99	9	a	a	DET
aiua-6844	99	10	90	90	NUM
aiua-6844	99	11	%	%	NOUN
aiua-6844	99	12	of	of	ADP
aiua-6844	99	13	chemoprevention	chemoprevention	NOUN
aiua-6844	99	14	efficacy	efficacy	NOUN
aiua-6844	99	15	.	.	PUNCT
aiua-6844	100	1	following	follow	VERB
aiua-6844	100	2	the	the	DET
aiua-6844	100	3	same	same	ADJ
aiua-6844	100	4	hg	hg	ADJ
aiua-6844	100	5	-	-	ADJ
aiua-6844	100	6	pin	pin	ADJ
aiua-6844	100	7	cohort	cohort	NOUN
aiua-6844	100	8	of	of	ADP
aiua-6844	100	9	subject	subject	NOUN
aiua-6844	100	10	for	for	ADP
aiua-6844	100	11	two	two	NUM
aiua-6844	100	12	years	year	NOUN
aiua-6844	100	13	(	(	PUNCT
aiua-6844	100	14	despite	despite	SCONJ
aiua-6844	100	15	a	a	DET
aiua-6844	100	16	considerable	considerable	ADJ
aiua-6844	100	17	dropout	dropout	NOUN
aiua-6844	100	18	rate	rate	NOUN
aiua-6844	100	19	)	)	PUNCT
aiua-6844	100	20	,	,	PUNCT
aiua-6844	100	21	the	the	DET
aiua-6844	100	22	reduction	reduction	NOUN
aiua-6844	100	23	of	of	ADP
aiua-6844	100	24	pca	pca	NOUN
aiua-6844	100	25	incidence	incidence	NOUN
aiua-6844	100	26	in	in	ADP
aiua-6844	100	27	the	the	DET
aiua-6844	100	28	green	green	ADJ
aiua-6844	100	29	tea	tea	NOUN
aiua-6844	100	30	catechins	catechin	NOUN
aiua-6844	100	31	arm	arm	NOUN
aiua-6844	100	32	still	still	ADV
aiua-6844	100	33	remained	remain	VERB
aiua-6844	100	34	significant	significant	ADJ
aiua-6844	100	35	,	,	PUNCT
aiua-6844	100	36	thus	thus	ADV
aiua-6844	100	37	suggesting	suggest	VERB
aiua-6844	100	38	a	a	DET
aiua-6844	100	39	long	long	ADV
aiua-6844	100	40	lasting	last	VERB
aiua-6844	100	41	inhibition	inhibition	NOUN
aiua-6844	100	42	of	of	ADP
aiua-6844	100	43	cancer	cancer	NOUN
aiua-6844	100	44	development	development	NOUN
aiua-6844	100	45	achieved	achieve	VERB
aiua-6844	100	46	with	with	ADP
aiua-6844	100	47	one	one	NUM
aiua-6844	100	48	-	-	PUNCT
aiua-6844	100	49	year	year	NOUN
aiua-6844	100	50	therapy	therapy	NOUN
aiua-6844	100	51	(	(	PUNCT
aiua-6844	100	52	13	13	NUM
aiua-6844	100	53	)	)	PUNCT
aiua-6844	100	54	.	.	PUNCT
aiua-6844	101	1	in	in	ADP
aiua-6844	101	2	our	our	PRON
aiua-6844	101	3	study	study	NOUN
aiua-6844	101	4	,	,	PUNCT
aiua-6844	101	5	we	we	PRON
aiua-6844	101	6	failed	fail	VERB
aiua-6844	101	7	to	to	PART
aiua-6844	101	8	confirm	confirm	VERB
aiua-6844	101	9	a	a	DET
aiua-6844	101	10	clear	clear	ADJ
aiua-6844	101	11	association	association	NOUN
aiua-6844	101	12	between	between	ADP
aiua-6844	101	13	green	green	ADJ
aiua-6844	101	14	tea	tea	NOUN
aiua-6844	101	15	catechins	catechin	NOUN
aiua-6844	101	16	and	and	CCONJ
aiua-6844	101	17	pca	pca	NOUN
aiua-6844	101	18	chemoprevention	chemoprevention	NOUN
aiua-6844	101	19	,	,	PUNCT
aiua-6844	101	20	suggesting	suggest	VERB
aiua-6844	101	21	that	that	SCONJ
aiua-6844	101	22	the	the	DET
aiua-6844	101	23	lack	lack	NOUN
aiua-6844	101	24	of	of	ADP
aiua-6844	101	25	effectiveness	effectiveness	NOUN
aiua-6844	101	26	we	we	PRON
aiua-6844	101	27	described	describe	VERB
aiua-6844	101	28	could	could	AUX
aiua-6844	101	29	be	be	AUX
aiua-6844	101	30	due	due	ADJ
aiua-6844	101	31	to	to	ADP
aiua-6844	101	32	the	the	DET
aiua-6844	101	33	somewhat	somewhat	ADV
aiua-6844	101	34	small	small	ADJ
aiua-6844	101	35	number	number	NOUN
aiua-6844	101	36	of	of	ADP
aiua-6844	101	37	enrolled	enrol	VERB
aiua-6844	101	38	volunteers	volunteer	NOUN
aiua-6844	101	39	as	as	ADV
aiua-6844	101	40	well	well	ADV
aiua-6844	101	41	as	as	ADP
aiua-6844	101	42	to	to	ADP
aiua-6844	101	43	limited	limited	ADJ
aiua-6844	101	44	length	length	NOUN
aiua-6844	101	45	of	of	ADP
aiua-6844	101	46	the	the	DET
aiua-6844	101	47	study	study	NOUN
aiua-6844	101	48	.	.	PUNCT
aiua-6844	102	1	however	however	ADV
aiua-6844	102	2	,	,	PUNCT
aiua-6844	102	3	results	result	NOUN
aiua-6844	102	4	of	of	ADP
aiua-6844	102	5	our	our	PRON
aiua-6844	102	6	clinical	clinical	ADJ
aiua-6844	102	7	trial	trial	NOUN
aiua-6844	102	8	are	be	AUX
aiua-6844	102	9	consistent	consistent	ADJ
aiua-6844	102	10	with	with	ADP
aiua-6844	102	11	studies	study	NOUN
aiua-6844	102	12	supporting	support	VERB
aiua-6844	102	13	the	the	DET
aiua-6844	102	14	notion	notion	NOUN
aiua-6844	102	15	that	that	SCONJ
aiua-6844	102	16	green	green	ADJ
aiua-6844	102	17	tea	tea	NOUN
aiua-6844	102	18	intake	intake	NOUN
aiua-6844	102	19	does	do	AUX
aiua-6844	102	20	not	not	PART
aiua-6844	102	21	protect	protect	VERB
aiua-6844	102	22	against	against	ADP
aiua-6844	102	23	prostate	prostate	NOUN
aiua-6844	102	24	cancer	cancer	NOUN
aiua-6844	102	25	.	.	PUNCT
aiua-6844	103	1	for	for	ADP
aiua-6844	103	2	instance	instance	NOUN
aiua-6844	103	3	,	,	PUNCT
aiua-6844	103	4	a	a	DET
aiua-6844	103	5	prospective	prospective	ADJ
aiua-6844	103	6	cohort	cohort	NOUN
aiua-6844	103	7	study	study	NOUN
aiua-6844	103	8	performed	perform	VERB
aiua-6844	103	9	using	use	VERB
aiua-6844	103	10	data	datum	NOUN
aiua-6844	103	11	from	from	ADP
aiua-6844	103	12	a	a	DET
aiua-6844	103	13	follow	follow	VERB
aiua-6844	103	14	-	-	PUNCT
aiua-6844	103	15	up	up	ADP
aiua-6844	103	16	database	database	NOUN
aiua-6844	103	17	of	of	ADP
aiua-6844	103	18	27.293	27.293	NUM
aiua-6844	103	19	of	of	ADP
aiua-6844	103	20	singapore	singapore	PROPN
aiua-6844	103	21	chinese	chinese	ADJ
aiua-6844	103	22	men	man	NOUN
aiua-6844	103	23	,	,	PUNCT
aiua-6844	103	24	concluded	conclude	VERB
aiua-6844	103	25	that	that	SCONJ
aiua-6844	103	26	there	there	PRON
aiua-6844	103	27	was	be	VERB
aiua-6844	103	28	no	no	DET
aiua-6844	103	29	association	association	NOUN
aiua-6844	103	30	between	between	ADP
aiua-6844	103	31	daily	daily	ADJ
aiua-6844	103	32	green	green	ADJ
aiua-6844	103	33	tea	tea	NOUN
aiua-6844	103	34	intake	intake	NOUN
aiua-6844	103	35	and	and	CCONJ
aiua-6844	103	36	prostate	prostate	NOUN
aiua-6844	103	37	cancer	cancer	NOUN
aiua-6844	103	38	risk	risk	NOUN
aiua-6844	103	39	,	,	PUNCT
aiua-6844	103	40	compared	compare	VERB
aiua-6844	103	41	with	with	ADP
aiua-6844	103	42	no	no	DET
aiua-6844	103	43	green	green	ADJ
aiua-6844	103	44	tea	tea	NOUN
aiua-6844	103	45	intake	intake	NOUN
aiua-6844	103	46	(	(	PUNCT
aiua-6844	103	47	21	21	NUM
aiua-6844	103	48	)	)	PUNCT
aiua-6844	103	49	.	.	PUNCT
aiua-6844	104	1	moreover	moreover	ADV
aiua-6844	104	2	,	,	PUNCT
aiua-6844	104	3	results	result	NOUN
aiua-6844	104	4	of	of	ADP
aiua-6844	104	5	a	a	DET
aiua-6844	104	6	prospective	prospective	ADJ
aiua-6844	104	7	cohort	cohort	NOUN
aiua-6844	104	8	study	study	NOUN
aiua-6844	104	9	that	that	PRON
aiua-6844	104	10	involved	involve	VERB
aiua-6844	104	11	19.561	19.561	NUM
aiua-6844	104	12	japanese	japanese	ADJ
aiua-6844	104	13	men	man	NOUN
aiua-6844	104	14	from	from	ADP
aiua-6844	104	15	ohsaki	ohsaki	NOUN
aiua-6844	104	16	to	to	PART
aiua-6844	104	17	whom	whom	PRON
aiua-6844	104	18	was	be	AUX
aiua-6844	104	19	self	self	NOUN
aiua-6844	104	20	-	-	PUNCT
aiua-6844	104	21	administered	administer	VERB
aiua-6844	104	22	a	a	DET
aiua-6844	104	23	questionnaire	questionnaire	NOUN
aiua-6844	104	24	suggested	suggest	VERB
aiua-6844	104	25	that	that	SCONJ
aiua-6844	104	26	green	green	ADJ
aiua-6844	104	27	-	-	PUNCT
aiua-6844	104	28	tea	tea	NOUN
aiua-6844	104	29	intake	intake	NOUN
aiua-6844	104	30	did	do	AUX
aiua-6844	104	31	not	not	PART
aiua-6844	104	32	reduce	reduce	VERB
aiua-6844	104	33	pca	pca	NOUN
aiua-6844	104	34	(	(	PUNCT
aiua-6844	104	35	22	22	NUM
aiua-6844	104	36	)	)	PUNCT
aiua-6844	104	37	.	.	PUNCT
aiua-6844	105	1	on	on	ADP
aiua-6844	105	2	the	the	DET
aiua-6844	105	3	contrary	contrary	NOUN
aiua-6844	105	4	,	,	PUNCT
aiua-6844	105	5	a	a	DET
aiua-6844	105	6	case	case	NOUN
aiua-6844	105	7	-	-	PUNCT
aiua-6844	105	8	control	control	NOUN
aiua-6844	105	9	study	study	NOUN
aiua-6844	105	10	in	in	ADP
aiua-6844	105	11	china	china	PROPN
aiua-6844	105	12	found	find	VERB
aiua-6844	105	13	that	that	SCONJ
aiua-6844	105	14	green	green	ADJ
aiua-6844	105	15	-	-	PUNCT
aiua-6844	105	16	tea	tea	NOUN
aiua-6844	105	17	intake	intake	NOUN
aiua-6844	105	18	was	be	AUX
aiua-6844	105	19	associated	associate	VERB
aiua-6844	105	20	with	with	ADP
aiua-6844	105	21	a	a	DET
aiua-6844	105	22	lower	low	ADJ
aiua-6844	105	23	risk	risk	NOUN
aiua-6844	105	24	of	of	ADP
aiua-6844	105	25	prostate	prostate	NOUN
aiua-6844	105	26	cancer	cancer	NOUN
aiua-6844	105	27	(	(	PUNCT
aiua-6844	105	28	23	23	NUM
aiua-6844	105	29	)	)	PUNCT
aiua-6844	105	30	,	,	PUNCT
aiua-6844	105	31	whereas	whereas	SCONJ
aiua-6844	105	32	a	a	DET
aiua-6844	105	33	case	case	NOUN
aiua-6844	105	34	-	-	PUNCT
aiua-6844	105	35	control	control	NOUN
aiua-6844	105	36	study	study	NOUN
aiua-6844	105	37	in	in	ADP
aiua-6844	105	38	japan	japan	PROPN
aiua-6844	105	39	showed	show	VERB
aiua-6844	105	40	a	a	DET
aiua-6844	105	41	modest	modest	ADJ
aiua-6844	105	42	reduction	reduction	NOUN
aiua-6844	105	43	in	in	ADP
aiua-6844	105	44	pca	pca	PROPN
aiua-6844	105	45	(	(	PUNCT
aiua-6844	105	46	24	24	NUM
aiua-6844	105	47	)	)	PUNCT
aiua-6844	105	48	.	.	PUNCT
aiua-6844	106	1	borderline	borderline	NOUN
aiua-6844	106	2	results	result	NOUN
aiua-6844	106	3	were	be	AUX
aiua-6844	106	4	obtained	obtain	VERB
aiua-6844	106	5	also	also	ADV
aiua-6844	106	6	in	in	ADP
aiua-6844	106	7	a	a	DET
aiua-6844	106	8	randomized	randomized	ADJ
aiua-6844	106	9	,	,	PUNCT
aiua-6844	106	10	double	double	ADJ
aiua-6844	106	11	-	-	PUNCT
aiua-6844	106	12	blind	blind	ADJ
aiua-6844	106	13	,	,	PUNCT
aiua-6844	106	14	placebo	placebo	NOUN
aiua-6844	106	15	-	-	PUNCT
aiua-6844	106	16	controlled	control	VERB
aiua-6844	106	17	trial	trial	NOUN
aiua-6844	106	18	performed	perform	VERB
aiua-6844	106	19	in	in	ADP
aiua-6844	106	20	men	man	NOUN
aiua-6844	106	21	with	with	ADP
aiua-6844	106	22	pca	pca	NOUN
aiua-6844	106	23	scheduled	schedule	VERB
aiua-6844	106	24	to	to	PART
aiua-6844	106	25	undergo	undergo	VERB
aiua-6844	106	26	radical	radical	ADJ
aiua-6844	106	27	prostatectomy	prostatectomy	NOUN
aiua-6844	106	28	that	that	PRON
aiua-6844	106	29	received	receive	VERB
aiua-6844	106	30	daily	daily	ADV
aiua-6844	106	31	either	either	CCONJ
aiua-6844	106	32	a	a	DET
aiua-6844	106	33	drug	drug	NOUN
aiua-6844	106	34	containing	contain	VERB
aiua-6844	106	35	800	800	NUM
aiua-6844	106	36	mg	mg	PROPN
aiua-6844	106	37	green	green	ADJ
aiua-6844	106	38	tea	tea	NOUN
aiua-6844	106	39	catechins	catechin	NOUN
aiua-6844	106	40	or	or	CCONJ
aiua-6844	106	41	placebo	placebo	NOUN
aiua-6844	106	42	for	for	ADP
aiua-6844	106	43	3	3	NUM
aiua-6844	106	44	to	to	PART
aiua-6844	106	45	6	6	NUM
aiua-6844	106	46	weeks	week	NOUN
aiua-6844	106	47	before	before	ADP
aiua-6844	106	48	surgery	surgery	NOUN
aiua-6844	106	49	.	.	PUNCT
aiua-6844	107	1	results	result	NOUN
aiua-6844	107	2	of	of	ADP
aiua-6844	107	3	the	the	DET
aiua-6844	107	4	study	study	NOUN
aiua-6844	107	5	indicate	indicate	VERB
aiua-6844	107	6	that	that	SCONJ
aiua-6844	107	7	the	the	DET
aiua-6844	107	8	treatment	treatment	NOUN
aiua-6844	107	9	with	with	ADP
aiua-6844	107	10	green	green	ADJ
aiua-6844	107	11	tea	tea	NOUN
aiua-6844	107	12	catechins	catechin	NOUN
aiua-6844	107	13	resulted	result	VERB
aiua-6844	107	14	in	in	ADP
aiua-6844	107	15	favorable	favorable	ADJ
aiua-6844	107	16	but	but	CCONJ
aiua-6844	107	17	not	not	PART
aiua-6844	107	18	statistically	statistically	ADV
aiua-6844	107	19	significant	significant	ADJ
aiua-6844	107	20	changes	change	NOUN
aiua-6844	107	21	in	in	ADP
aiua-6844	107	22	serum	serum	NOUN
aiua-6844	107	23	psa	psa	NOUN
aiua-6844	107	24	as	as	ADV
aiua-6844	107	25	well	well	ADV
aiua-6844	107	26	as	as	ADP
aiua-6844	107	27	the	the	DET
aiua-6844	107	28	proportion	proportion	NOUN
aiua-6844	107	29	of	of	ADP
aiua-6844	107	30	subjects	subject	NOUN
aiua-6844	107	31	who	who	PRON
aiua-6844	107	32	had	have	VERB
aiua-6844	107	33	a	a	DET
aiua-6844	107	34	decrease	decrease	NOUN
aiua-6844	107	35	in	in	ADP
aiua-6844	107	36	gleason	gleason	PROPN
aiua-6844	107	37	score	score	NOUN
aiua-6844	107	38	between	between	ADP
aiua-6844	107	39	biopsy	biopsy	NOUN
aiua-6844	107	40	and	and	CCONJ
aiua-6844	107	41	surgical	surgical	ADJ
aiua-6844	107	42	specimens	specimen	NOUN
aiua-6844	107	43	(	(	PUNCT
aiua-6844	107	44	25	25	NUM
aiua-6844	107	45	)	)	PUNCT
aiua-6844	107	46	.	.	PUNCT
aiua-6844	108	1	a	a	DET
aiua-6844	108	2	phase	phase	NOUN
aiua-6844	108	3	ii	ii	NOUN
aiua-6844	108	4	trial	trial	NOUN
aiua-6844	108	5	aimed	aim	VERB
aiua-6844	108	6	to	to	PART
aiua-6844	108	7	estimate	estimate	VERB
aiua-6844	108	8	percentage	percentage	NOUN
aiua-6844	108	9	of	of	ADP
aiua-6844	108	10	patients	patient	NOUN
aiua-6844	108	11	with	with	ADP
aiua-6844	108	12	androgen	androgen	NOUN
aiua-6844	108	13	independent	independent	ADJ
aiua-6844	108	14	metastatic	metastatic	ADJ
aiua-6844	108	15	pca	pca	NOUN
aiua-6844	108	16	who	who	PRON
aiua-6844	108	17	sustained	sustain	VERB
aiua-6844	108	18	a	a	DET
aiua-6844	108	19	decline	decline	NOUN
aiua-6844	108	20	in	in	ADP
aiua-6844	108	21	psa	psa	NOUN
aiua-6844	108	22	level	level	NOUN
aiua-6844	108	23	with	with	ADP
aiua-6844	108	24	green	green	ADJ
aiua-6844	108	25	tea	tea	NOUN
aiua-6844	108	26	,	,	PUNCT
aiua-6844	108	27	showed	show	VERB
aiua-6844	108	28	its	its	PRON
aiua-6844	108	29	limited	limited	ADJ
aiua-6844	108	30	capability	capability	NOUN
aiua-6844	108	31	to	to	PART
aiua-6844	108	32	breakdown	breakdown	VERB
aiua-6844	108	33	psa	psa	VERB
aiua-6844	108	34	,	,	PUNCT
aiua-6844	108	35	although	although	SCONJ
aiua-6844	108	36	no	no	DET
aiua-6844	108	37	patient	patient	NOUN
aiua-6844	108	38	manifested	manifest	VERB
aiua-6844	108	39	a	a	DET
aiua-6844	108	40	tumor	tumor	NOUN
aiua-6844	108	41	response	response	NOUN
aiua-6844	108	42	during	during	ADP
aiua-6844	108	43	the	the	DET
aiua-6844	108	44	months	month	NOUN
aiua-6844	108	45	of	of	ADP
aiua-6844	108	46	treatment	treatment	NOUN
aiua-6844	108	47	(	(	PUNCT
aiua-6844	108	48	26	26	NUM
aiua-6844	108	49	)	)	PUNCT
aiua-6844	108	50	.	.	PUNCT
aiua-6844	109	1	another	another	DET
aiua-6844	109	2	prospective	prospective	ADJ
aiua-6844	109	3	clinical	clinical	ADJ
aiua-6844	109	4	trial	trial	NOUN
aiua-6844	109	5	for	for	ADP
aiua-6844	109	6	hormone	hormone	NOUN
aiua-6844	109	7	refractory	refractory	NOUN
aiua-6844	109	8	prostate	prostate	NOUN
aiua-6844	109	9	cancer	cancer	NOUN
aiua-6844	109	10	indicated	indicate	VERB
aiua-6844	109	11	minimal	minimal	ADJ
aiua-6844	109	12	clinical	clinical	ADJ
aiua-6844	109	13	activity	activity	NOUN
aiua-6844	109	14	of	of	ADP
aiua-6844	109	15	green	green	ADJ
aiua-6844	109	16	tea	tea	NOUN
aiua-6844	109	17	extract	extract	NOUN
aiua-6844	109	18	capsules	capsule	NOUN
aiua-6844	109	19	in	in	ADP
aiua-6844	109	20	15	15	NUM
aiua-6844	109	21	men	man	NOUN
aiua-6844	109	22	(	(	PUNCT
aiua-6844	109	23	27	27	NUM
aiua-6844	109	24	)	)	PUNCT
aiua-6844	109	25	.	.	PUNCT
aiua-6844	110	1	finally	finally	ADV
aiua-6844	110	2	,	,	PUNCT
aiua-6844	110	3	a	a	DET
aiua-6844	110	4	meta	meta	ADJ
aiua-6844	110	5	-	-	PUNCT
aiua-6844	110	6	analysis	analysis	NOUN
aiua-6844	110	7	indicated	indicate	VERB
aiua-6844	110	8	that	that	SCONJ
aiua-6844	110	9	consumption	consumption	NOUN
aiua-6844	110	10	of	of	ADP
aiua-6844	110	11	green	green	ADJ
aiua-6844	110	12	tea	tea	NOUN
aiua-6844	110	13	may	may	AUX
aiua-6844	110	14	have	have	VERB
aiua-6844	110	15	a	a	DET
aiua-6844	110	16	protective	protective	ADJ
aiua-6844	110	17	effect	effect	NOUN
aiua-6844	110	18	on	on	ADP
aiua-6844	110	19	pca	pca	PROPN
aiua-6844	110	20	in	in	ADP
aiua-6844	110	21	asian	asian	ADJ
aiua-6844	110	22	populations	population	NOUN
aiua-6844	110	23	,	,	PUNCT
aiua-6844	110	24	suggesting	suggest	VERB
aiua-6844	110	25	that	that	SCONJ
aiua-6844	110	26	further	further	ADJ
aiua-6844	110	27	prospective	prospective	ADJ
aiua-6844	110	28	cohort	cohort	NOUN
aiua-6844	110	29	studies	study	NOUN
aiua-6844	110	30	are	be	AUX
aiua-6844	110	31	needed	need	VERB
aiua-6844	110	32	to	to	PART
aiua-6844	110	33	obtain	obtain	VERB
aiua-6844	110	34	a	a	DET
aiua-6844	110	35	definitive	definitive	ADJ
aiua-6844	110	36	conclusion	conclusion	NOUN
aiua-6844	110	37	in	in	ADP
aiua-6844	110	38	this	this	DET
aiua-6844	110	39	field	field	NOUN
aiua-6844	110	40	,	,	PUNCT
aiua-6844	110	41	especially	especially	ADV
aiua-6844	110	42	with	with	ADP
aiua-6844	110	43	regard	regard	NOUN
aiua-6844	110	44	to	to	ADP
aiua-6844	110	45	the	the	DET
aiua-6844	110	46	protective	protective	ADJ
aiua-6844	110	47	role	role	NOUN
aiua-6844	110	48	of	of	ADP
aiua-6844	110	49	green	green	ADJ
aiua-6844	110	50	tea	tea	NOUN
aiua-6844	110	51	on	on	ADP
aiua-6844	110	52	pca	pca	PROPN
aiua-6844	110	53	across	across	ADP
aiua-6844	110	54	different	different	ADJ
aiua-6844	110	55	regions	region	NOUN
aiua-6844	110	56	apart	apart	ADV
aiua-6844	110	57	from	from	ADP
aiua-6844	110	58	asia	asia	PROPN
aiua-6844	110	59	(	(	PUNCT
aiua-6844	110	60	20	20	NUM
aiua-6844	110	61	)	)	PUNCT
aiua-6844	110	62	.	.	PUNCT
aiua-6844	111	1	it	it	PRON
aiua-6844	111	2	is	be	AUX
aiua-6844	111	3	known	know	VERB
aiua-6844	111	4	that	that	SCONJ
aiua-6844	111	5	inflammation	inflammation	NOUN
aiua-6844	111	6	plays	play	VERB
aiua-6844	111	7	an	an	DET
aiua-6844	111	8	important	important	ADJ
aiua-6844	111	9	role	role	NOUN
aiua-6844	111	10	in	in	ADP
aiua-6844	111	11	the	the	DET
aiua-6844	111	12	aetiology	aetiology	NOUN
aiua-6844	111	13	of	of	ADP
aiua-6844	111	14	prostate	prostate	NOUN
aiua-6844	111	15	cancer	cancer	NOUN
aiua-6844	111	16	(	(	PUNCT
aiua-6844	111	17	28	28	NUM
aiua-6844	111	18	)	)	PUNCT
aiua-6844	111	19	.	.	PUNCT
aiua-6844	112	1	on	on	ADP
aiua-6844	112	2	the	the	DET
aiua-6844	112	3	other	other	ADJ
aiua-6844	112	4	hand	hand	NOUN
aiua-6844	112	5	,	,	PUNCT
aiua-6844	112	6	several	several	ADJ
aiua-6844	112	7	in	in	ADP
aiua-6844	112	8	vitro	vitro	X
aiua-6844	112	9	and	and	CCONJ
aiua-6844	112	10	in	in	ADP
aiua-6844	112	11	vivo	vivo	ADJ
aiua-6844	112	12	studies	study	NOUN
aiua-6844	112	13	have	have	AUX
aiua-6844	112	14	shown	show	VERB
aiua-6844	112	15	that	that	SCONJ
aiua-6844	112	16	both	both	CCONJ
aiua-6844	112	17	green	green	ADJ
aiua-6844	112	18	tea	tea	NOUN
aiua-6844	112	19	and	and	CCONJ
aiua-6844	112	20	their	their	PRON
aiua-6844	112	21	catechins	catechin	NOUN
aiua-6844	112	22	may	may	AUX
aiua-6844	112	23	inhibit	inhibit	VERB
aiua-6844	112	24	carcinogenesis	carcinogenesis	NOUN
aiua-6844	112	25	during	during	ADP
aiua-6844	112	26	the	the	DET
aiua-6844	112	27	initiation	initiation	NOUN
aiua-6844	112	28	,	,	PUNCT
aiua-6844	112	29	promotion	promotion	NOUN
aiua-6844	112	30	and	and	CCONJ
aiua-6844	112	31	progression	progression	NOUN
aiua-6844	112	32	stages	stage	NOUN
aiua-6844	112	33	through	through	ADP
aiua-6844	112	34	many	many	ADJ
aiua-6844	112	35	mechanisms	mechanism	NOUN
aiua-6844	112	36	,	,	PUNCT
aiua-6844	112	37	including	include	VERB
aiua-6844	112	38	the	the	DET
aiua-6844	112	39	antioxidant	antioxidant	ADJ
aiua-6844	112	40	effects	effect	NOUN
aiua-6844	112	41	(	(	PUNCT
aiua-6844	112	42	29	29	NUM
aiua-6844	112	43	)	)	PUNCT
aiua-6844	112	44	.	.	PUNCT
aiua-6844	113	1	moreover	moreover	ADV
aiua-6844	113	2	,	,	PUNCT
aiua-6844	113	3	mukherjee	mukherjee	PROPN
aiua-6844	113	4	et	et	PROPN
aiua-6844	113	5	al	al	PROPN
aiua-6844	113	6	.	.	PROPN
aiua-6844	114	1	(	(	PUNCT
aiua-6844	114	2	30	30	NUM
aiua-6844	114	3	)	)	PUNCT
aiua-6844	114	4	reported	report	VERB
aiua-6844	114	5	that	that	SCONJ
aiua-6844	114	6	egcg	egcg	NOUN
aiua-6844	114	7	suppresses	suppress	VERB
aiua-6844	114	8	inflammation	inflammation	NOUN
aiua-6844	114	9	in	in	ADP
aiua-6844	114	10	prostate	prostate	NOUN
aiua-6844	114	11	cancer	cancer	NOUN
aiua-6844	114	12	cells	cell	NOUN
aiua-6844	114	13	,	,	PUNCT
aiua-6844	114	14	thus	thus	ADV
aiua-6844	114	15	reducing	reduce	VERB
aiua-6844	114	16	the	the	DET
aiua-6844	114	17	risk	risk	NOUN
aiua-6844	114	18	of	of	ADP
aiua-6844	114	19	pca	pca	PROPN
aiua-6844	114	20	.	.	PUNCT
aiua-6844	115	1	therefore	therefore	ADV
aiua-6844	115	2	,	,	PUNCT
aiua-6844	115	3	we	we	PRON
aiua-6844	115	4	speculate	speculate	VERB
aiua-6844	115	5	that	that	SCONJ
aiua-6844	115	6	the	the	DET
aiua-6844	115	7	significant	significant	ADJ
aiua-6844	115	8	reduction	reduction	NOUN
aiua-6844	115	9	of	of	ADP
aiua-6844	115	10	psa	psa	NOUN
aiua-6844	115	11	values	value	NOUN
aiua-6844	115	12	throughout	throughout	ADP
aiua-6844	115	13	the	the	DET
aiua-6844	115	14	one	one	NUM
aiua-6844	115	15	-	-	PUNCT
aiua-6844	115	16	year	year	NOUN
aiua-6844	115	17	study	study	NOUN
aiua-6844	115	18	,	,	PUNCT
aiua-6844	115	19	as	as	ADV
aiua-6844	115	20	well	well	ADV
aiua-6844	115	21	as	as	ADP
aiua-6844	115	22	the	the	DET
aiua-6844	115	23	not	not	PART
aiua-6844	115	24	significant	significant	ADJ
aiua-6844	115	25	decrease	decrease	NOUN
aiua-6844	115	26	of	of	ADP
aiua-6844	115	27	pca	pca	PROPN
aiua-6844	115	28	at	at	ADP
aiua-6844	115	29	the	the	DET
aiua-6844	115	30	6	6	NUM
aiua-6844	115	31	month	month	NOUN
aiua-6844	115	32	follow	follow	NOUN
aiua-6844	115	33	up	up	ADP
aiua-6844	115	34	,	,	PUNCT
aiua-6844	115	35	we	we	PRON
aiua-6844	115	36	observed	observe	VERB
aiua-6844	115	37	in	in	ADP
aiua-6844	115	38	our	our	PRON
aiua-6844	115	39	study	study	NOUN
aiua-6844	115	40	,	,	PUNCT
aiua-6844	115	41	could	could	AUX
aiua-6844	115	42	be	be	AUX
aiua-6844	115	43	linked	link	VERB
aiua-6844	115	44	to	to	ADP
aiua-6844	115	45	the	the	DET
aiua-6844	115	46	anti	anti	ADJ
aiua-6844	115	47	-	-	ADJ
aiua-6844	115	48	inflammatory	inflammatory	ADJ
aiua-6844	115	49	property	property	NOUN
aiua-6844	115	50	of	of	ADP
aiua-6844	115	51	green	green	ADJ
aiua-6844	115	52	tea	tea	NOUN
aiua-6844	115	53	.	.	PUNCT
aiua-6844	116	1	this	this	DET
aiua-6844	116	2	hypothesis	hypothesis	NOUN
aiua-6844	116	3	was	be	AUX
aiua-6844	116	4	also	also	ADV
aiua-6844	116	5	supported	support	VERB
aiua-6844	116	6	by	by	ADP
aiua-6844	116	7	a	a	DET
aiua-6844	116	8	recent	recent	ADJ
aiua-6844	116	9	open	open	ADJ
aiua-6844	116	10	label	label	NOUN
aiua-6844	116	11	,	,	PUNCT
aiua-6844	116	12	phase	phase	NOUN
aiua-6844	116	13	ii	ii	NOUN
aiua-6844	116	14	clinical	clinical	ADJ
aiua-6844	116	15	trial	trial	NOUN
aiua-6844	116	16	carried	carry	VERB
aiua-6844	116	17	out	out	ADP
aiua-6844	116	18	in	in	ADP
aiua-6844	116	19	113	113	NUM
aiua-6844	116	20	men	man	NOUN
aiua-6844	116	21	diagnosed	diagnose	VERB
aiua-6844	116	22	with	with	ADP
aiua-6844	116	23	prostate	prostate	NOUN
aiua-6844	116	24	cancer	cancer	NOUN
aiua-6844	116	25	randomized	randomize	VERB
aiua-6844	116	26	who	who	PRON
aiua-6844	116	27	received	receive	VERB
aiua-6844	116	28	six	six	NUM
aiua-6844	116	29	cups	cup	NOUN
aiua-6844	116	30	daily	daily	ADV
aiua-6844	116	31	of	of	ADP
aiua-6844	116	32	brewed	brew	VERB
aiua-6844	116	33	green	green	ADJ
aiua-6844	116	34	tea	tea	NOUN
aiua-6844	116	35	or	or	CCONJ
aiua-6844	116	36	brown	brown	ADJ
aiua-6844	116	37	tea	tea	NOUN
aiua-6844	116	38	or	or	CCONJ
aiua-6844	116	39	water	water	NOUN
aiua-6844	116	40	for	for	ADP
aiua-6844	116	41	three	three	NUM
aiua-6844	116	42	to	to	PART
aiua-6844	116	43	eight	eight	NUM
aiua-6844	116	44	weeks	week	NOUN
aiua-6844	116	45	prior	prior	ADV
aiua-6844	116	46	to	to	ADP
aiua-6844	116	47	radical	radical	ADJ
aiua-6844	116	48	prostatectomy	prostatectomy	NOUN
aiua-6844	116	49	(	(	PUNCT
aiua-6844	116	50	31	31	NUM
aiua-6844	116	51	)	)	PUNCT
aiua-6844	116	52	.	.	PUNCT
aiua-6844	117	1	in	in	ADP
aiua-6844	117	2	prostate	prostate	NOUN
aiua-6844	117	3	tissue	tissue	NOUN
aiua-6844	117	4	,	,	PUNCT
aiua-6844	117	5	henning	henning	NOUN
aiua-6844	117	6	et	et	PROPN
aiua-6844	117	7	al	al	PROPN
aiua-6844	117	8	.	.	PROPN
aiua-6844	117	9	found	find	VERB
aiua-6844	117	10	that	that	SCONJ
aiua-6844	117	11	green	green	ADJ
aiua-6844	117	12	tea	tea	NOUN
aiua-6844	117	13	consumption	consumption	NOUN
aiua-6844	117	14	led	lead	VERB
aiua-6844	117	15	to	to	ADP
aiua-6844	117	16	a	a	DET
aiua-6844	117	17	significant	significant	ADJ
aiua-6844	117	18	decrease	decrease	NOUN
aiua-6844	117	19	in	in	ADP
aiua-6844	117	20	nuclear	nuclear	ADJ
aiua-6844	117	21	immunostaining	immunostaining	NOUN
aiua-6844	117	22	of	of	ADP
aiua-6844	117	23	nuclear	nuclear	ADJ
aiua-6844	117	24	factor	factor	NOUN
aiua-6844	117	25	kappa	kappa	PROPN
aiua-6844	117	26	b	b	PROPN
aiua-6844	117	27	(	(	PUNCT
aiua-6844	117	28	nfκb	nfκb	NOUN
aiua-6844	117	29	)	)	PUNCT
aiua-6844	117	30	compared	compare	VERB
aiua-6844	117	31	to	to	ADP
aiua-6844	117	32	water	water	NOUN
aiua-6844	117	33	control	control	NOUN
aiua-6844	117	34	,	,	PUNCT
aiua-6844	117	35	which	which	PRON
aiua-6844	117	36	may	may	AUX
aiua-6844	117	37	reduce	reduce	VERB
aiua-6844	117	38	inflammatory	inflammatory	ADJ
aiua-6844	117	39	processes	process	NOUN
aiua-6844	117	40	that	that	PRON
aiua-6844	117	41	may	may	AUX
aiua-6844	117	42	contribute	contribute	VERB
aiua-6844	117	43	to	to	ADP
aiua-6844	117	44	prostate	prostate	NOUN
aiua-6844	117	45	cancerogenesis	cancerogenesis	NOUN
aiua-6844	117	46	.	.	PUNCT
aiua-6844	118	1	moreover	moreover	ADV
aiua-6844	118	2	,	,	PUNCT
aiua-6844	118	3	evidences	evidence	NOUN
aiua-6844	118	4	of	of	ADP
aiua-6844	118	5	both	both	DET
aiua-6844	118	6	systemic	systemic	ADJ
aiua-6844	118	7	antioxidant	antioxidant	ADJ
aiua-6844	118	8	effect	effect	NOUN
aiua-6844	118	9	(	(	PUNCT
aiua-6844	118	10	reduced	reduce	VERB
aiua-6844	118	11	urinary	urinary	ADJ
aiua-6844	118	12	8	8	NUM
aiua-6844	118	13	-	-	PUNCT
aiua-6844	118	14	hydroxydeoxyguanosine	hydroxydeoxyguanosine	NOUN
aiua-6844	118	15	)	)	PUNCT
aiua-6844	118	16	and	and	CCONJ
aiua-6844	118	17	small	small	ADJ
aiua-6844	118	18	but	but	CCONJ
aiua-6844	118	19	statistically	statistically	ADV
aiua-6844	118	20	significant	significant	ADJ
aiua-6844	118	21	decrease	decrease	NOUN
aiua-6844	118	22	in	in	ADP
aiua-6844	118	23	psa	psa	NOUN
aiua-6844	118	24	levels	level	NOUN
aiua-6844	118	25	were	be	AUX
aiua-6844	118	26	observed	observe	VERB
aiua-6844	118	27	.	.	PUNCT
aiua-6844	119	1	luts	luts	PROPN
aiua-6844	119	2	are	be	AUX
aiua-6844	119	3	a	a	DET
aiua-6844	119	4	complex	complex	NOUN
aiua-6844	119	5	of	of	ADP
aiua-6844	119	6	obstructive	obstructive	ADJ
aiua-6844	119	7	(	(	PUNCT
aiua-6844	119	8	intermittency	intermittency	NOUN
aiua-6844	119	9	flow	flow	NOUN
aiua-6844	119	10	issue	issue	NOUN
aiua-6844	119	11	,	,	PUNCT
aiua-6844	119	12	incomplete	incomplete	ADJ
aiua-6844	119	13	voiding	voiding	NOUN
aiua-6844	119	14	,	,	PUNCT
aiua-6844	119	15	weak	weak	ADJ
aiua-6844	119	16	urinary	urinary	ADJ
aiua-6844	119	17	stream	stream	NOUN
aiua-6844	119	18	)	)	PUNCT
aiua-6844	119	19	and	and	CCONJ
aiua-6844	119	20	irritative	irritative	ADJ
aiua-6844	119	21	(	(	PUNCT
aiua-6844	119	22	pollakiuria	pollakiuria	NOUN
aiua-6844	119	23	nocturia	nocturia	PROPN
aiua-6844	119	24	,	,	PUNCT
aiua-6844	119	25	urgency	urgency	NOUN
aiua-6844	119	26	and	and	CCONJ
aiua-6844	119	27	burning	burn	VERB
aiua-6844	119	28	during	during	ADP
aiua-6844	119	29	urination	urination	NOUN
aiua-6844	119	30	)	)	PUNCT
aiua-6844	119	31	symptoms	symptom	NOUN
aiua-6844	119	32	that	that	PRON
aiua-6844	119	33	affect	affect	VERB
aiua-6844	119	34	the	the	DET
aiua-6844	119	35	quality	quality	NOUN
aiua-6844	119	36	of	of	ADP
aiua-6844	119	37	life	life	NOUN
aiua-6844	119	38	and	and	CCONJ
aiua-6844	119	39	are	be	AUX
aiua-6844	119	40	quite	quite	ADV
aiua-6844	119	41	common	common	ADJ
aiua-6844	119	42	in	in	ADP
aiua-6844	119	43	men	man	NOUN
aiua-6844	119	44	over	over	ADP
aiua-6844	119	45	the	the	DET
aiua-6844	119	46	age	age	NOUN
aiua-6844	119	47	of	of	ADP
aiua-6844	119	48	60	60	NUM
aiua-6844	119	49	years	year	NOUN
aiua-6844	119	50	and	and	CCONJ
aiua-6844	119	51	in	in	ADP
aiua-6844	119	52	those	those	PRON
aiua-6844	119	53	with	with	ADP
aiua-6844	119	54	benign	benign	ADJ
aiua-6844	119	55	prostatic	prostatic	ADJ
aiua-6844	119	56	hyperplasia	hyperplasia	NOUN
aiua-6844	119	57	(	(	PUNCT
aiua-6844	119	58	32	32	NUM
aiua-6844	119	59	)	)	PUNCT
aiua-6844	119	60	.	.	PUNCT
aiua-6844	120	1	interestingly	interestingly	ADV
aiua-6844	120	2	,	,	PUNCT
aiua-6844	120	3	the	the	DET
aiua-6844	120	4	analysis	analysis	NOUN
aiua-6844	120	5	of	of	ADP
aiua-6844	120	6	micali_stesura	micali_stesura	NOUN
aiua-6844	120	7	seveso	seveso	NOUN
aiua-6844	120	8	28/09/17	28/09/17	PROPN
aiua-6844	120	9	10:18	10:18	NUM
aiua-6844	120	10	pagina	pagina	NOUN
aiua-6844	120	11	200	200	NUM
aiua-6844	120	12	questionnaires	questionnaire	NOUN
aiua-6844	120	13	administered	administer	VERB
aiua-6844	120	14	to	to	ADP
aiua-6844	120	15	subjects	subject	NOUN
aiua-6844	120	16	participating	participate	VERB
aiua-6844	120	17	in	in	ADP
aiua-6844	120	18	the	the	DET
aiua-6844	120	19	clinical	clinical	ADJ
aiua-6844	120	20	study	study	NOUN
aiua-6844	120	21	showed	show	VERB
aiua-6844	120	22	a	a	DET
aiua-6844	120	23	small	small	ADJ
aiua-6844	120	24	but	but	CCONJ
aiua-6844	120	25	not	not	PART
aiua-6844	120	26	significant	significant	ADJ
aiua-6844	120	27	improvement	improvement	NOUN
aiua-6844	120	28	of	of	ADP
aiua-6844	120	29	luts	luts	PROPN
aiua-6844	120	30	or	or	CCONJ
aiua-6844	120	31	qol	qol	PROPN
aiua-6844	120	32	scores	score	NOUN
aiua-6844	120	33	in	in	ADP
aiua-6844	120	34	the	the	DET
aiua-6844	120	35	green	green	ADJ
aiua-6844	120	36	teatreated	teatreate	VERB
aiua-6844	120	37	group	group	NOUN
aiua-6844	120	38	respect	respect	NOUN
aiua-6844	120	39	to	to	ADP
aiua-6844	120	40	the	the	DET
aiua-6844	120	41	control	control	NOUN
aiua-6844	120	42	one	one	NUM
aiua-6844	120	43	.	.	PUNCT
aiua-6844	121	1	this	this	DET
aiua-6844	121	2	finding	finding	NOUN
aiua-6844	121	3	supports	support	VERB
aiua-6844	121	4	the	the	DET
aiua-6844	121	5	hypothesis	hypothesis	NOUN
aiua-6844	121	6	that	that	SCONJ
aiua-6844	121	7	the	the	DET
aiua-6844	121	8	anti	anti	ADJ
aiua-6844	121	9	-	-	ADJ
aiua-6844	121	10	inflammatory	inflammatory	ADJ
aiua-6844	121	11	effect	effect	NOUN
aiua-6844	121	12	of	of	ADP
aiua-6844	121	13	green	green	ADJ
aiua-6844	121	14	tea	tea	NOUN
aiua-6844	121	15	catechins	catechin	NOUN
aiua-6844	121	16	both	both	PRON
aiua-6844	121	17	can	can	AUX
aiua-6844	121	18	determine	determine	VERB
aiua-6844	121	19	the	the	DET
aiua-6844	121	20	reduction	reduction	NOUN
aiua-6844	121	21	in	in	ADP
aiua-6844	121	22	blood	blood	NOUN
aiua-6844	121	23	levels	level	NOUN
aiua-6844	121	24	of	of	ADP
aiua-6844	121	25	psa	psa	NOUN
aiua-6844	121	26	and	and	CCONJ
aiua-6844	121	27	can	can	AUX
aiua-6844	121	28	relieve	relieve	VERB
aiua-6844	121	29	the	the	DET
aiua-6844	121	30	symptoms	symptom	NOUN
aiua-6844	121	31	of	of	ADP
aiua-6844	121	32	luts	lut	NOUN
aiua-6844	121	33	,	,	PUNCT
aiua-6844	121	34	thus	thus	ADV
aiua-6844	121	35	enhancing	enhance	VERB
aiua-6844	121	36	the	the	DET
aiua-6844	121	37	quality	quality	NOUN
aiua-6844	121	38	of	of	ADP
aiua-6844	121	39	life	life	NOUN
aiua-6844	121	40	.	.	PUNCT
aiua-6844	122	1	conclusions	conclusion	NOUN
aiua-6844	122	2	in	in	ADP
aiua-6844	122	3	recent	recent	ADJ
aiua-6844	122	4	decades	decade	NOUN
aiua-6844	122	5	,	,	PUNCT
aiua-6844	122	6	natural	natural	ADJ
aiua-6844	122	7	drugs	drug	NOUN
aiua-6844	122	8	gained	gain	VERB
aiua-6844	122	9	particular	particular	ADJ
aiua-6844	122	10	attention	attention	NOUN
aiua-6844	122	11	mainly	mainly	ADV
aiua-6844	122	12	because	because	SCONJ
aiua-6844	122	13	of	of	ADP
aiua-6844	122	14	their	their	PRON
aiua-6844	122	15	antioxidant	antioxidant	ADJ
aiua-6844	122	16	and	and	CCONJ
aiua-6844	122	17	anti	anti	ADJ
aiua-6844	122	18	-	-	ADJ
aiua-6844	122	19	inflammatory	inflammatory	ADJ
aiua-6844	122	20	activities	activity	NOUN
aiua-6844	122	21	exploitable	exploitable	VERB
aiua-6844	122	22	in	in	ADP
aiua-6844	122	23	the	the	DET
aiua-6844	122	24	prevention	prevention	NOUN
aiua-6844	122	25	of	of	ADP
aiua-6844	122	26	certain	certain	ADJ
aiua-6844	122	27	chronic	chronic	ADJ
aiua-6844	122	28	degenerative	degenerative	ADJ
aiua-6844	122	29	pathologies	pathology	NOUN
aiua-6844	122	30	(	(	PUNCT
aiua-6844	122	31	4	4	NUM
aiua-6844	122	32	,	,	PUNCT
aiua-6844	122	33	33	33	NUM
aiua-6844	122	34	-	-	SYM
aiua-6844	122	35	35	35	NUM
aiua-6844	122	36	)	)	PUNCT
aiua-6844	122	37	.	.	PUNCT
aiua-6844	123	1	however	however	ADV
aiua-6844	123	2	,	,	PUNCT
aiua-6844	123	3	the	the	DET
aiua-6844	123	4	increased	increase	VERB
aiua-6844	123	5	employment	employment	NOUN
aiua-6844	123	6	of	of	ADP
aiua-6844	123	7	alternative	alternative	ADJ
aiua-6844	123	8	and	and	CCONJ
aiua-6844	123	9	complementary	complementary	ADJ
aiua-6844	123	10	medicines	medicine	NOUN
aiua-6844	123	11	requires	require	VERB
aiua-6844	123	12	a	a	DET
aiua-6844	123	13	lot	lot	NOUN
aiua-6844	123	14	of	of	ADP
aiua-6844	123	15	attention	attention	NOUN
aiua-6844	123	16	from	from	ADP
aiua-6844	123	17	the	the	DET
aiua-6844	123	18	scientific	scientific	ADJ
aiua-6844	123	19	community	community	NOUN
aiua-6844	123	20	in	in	ADP
aiua-6844	123	21	order	order	NOUN
aiua-6844	123	22	to	to	PART
aiua-6844	123	23	evaluate	evaluate	VERB
aiua-6844	123	24	the	the	DET
aiua-6844	123	25	effectiveness	effectiveness	NOUN
aiua-6844	123	26	and	and	CCONJ
aiua-6844	123	27	safety	safety	NOUN
aiua-6844	123	28	of	of	ADP
aiua-6844	123	29	herbal	herbal	ADJ
aiua-6844	123	30	preparations	preparation	NOUN
aiua-6844	123	31	since	since	SCONJ
aiua-6844	123	32	studies	study	NOUN
aiua-6844	123	33	have	have	AUX
aiua-6844	123	34	cast	cast	VERB
aiua-6844	123	35	some	some	DET
aiua-6844	123	36	doubts	doubt	NOUN
aiua-6844	123	37	on	on	ADP
aiua-6844	123	38	whether	whether	SCONJ
aiua-6844	123	39	their	their	PRON
aiua-6844	123	40	use	use	NOUN
aiua-6844	123	41	is	be	AUX
aiua-6844	123	42	really	really	ADV
aiua-6844	123	43	producing	produce	VERB
aiua-6844	123	44	an	an	DET
aiua-6844	123	45	alternative	alternative	NOUN
aiua-6844	123	46	to	to	ADP
aiua-6844	123	47	synthetic	synthetic	ADJ
aiua-6844	123	48	drugs	drug	NOUN
aiua-6844	123	49	(	(	PUNCT
aiua-6844	123	50	5	5	NUM
aiua-6844	123	51	,	,	PUNCT
aiua-6844	123	52	36	36	NUM
aiua-6844	123	53	,	,	PUNCT
aiua-6844	123	54	37	37	NUM
aiua-6844	123	55	)	)	PUNCT
aiua-6844	123	56	.	.	PUNCT
aiua-6844	124	1	although	although	SCONJ
aiua-6844	124	2	numerous	numerous	ADJ
aiua-6844	124	3	in	in	ADP
aiua-6844	124	4	vitro	vitro	X
aiua-6844	124	5	and	and	CCONJ
aiua-6844	124	6	in	in	ADP
aiua-6844	124	7	vivo	vivo	ADJ
aiua-6844	124	8	studies	study	NOUN
aiua-6844	124	9	have	have	AUX
aiua-6844	124	10	suggested	suggest	VERB
aiua-6844	124	11	a	a	DET
aiua-6844	124	12	protective	protective	ADJ
aiua-6844	124	13	effect	effect	NOUN
aiua-6844	124	14	of	of	ADP
aiua-6844	124	15	green	green	ADJ
aiua-6844	124	16	-	-	PUNCT
aiua-6844	124	17	tea	tea	NOUN
aiua-6844	124	18	polyphenols	polyphenol	NOUN
aiua-6844	124	19	against	against	ADP
aiua-6844	124	20	development	development	NOUN
aiua-6844	124	21	of	of	ADP
aiua-6844	124	22	prostate	prostate	NOUN
aiua-6844	124	23	cancer	cancer	NOUN
aiua-6844	124	24	,	,	PUNCT
aiua-6844	124	25	to	to	ADP
aiua-6844	124	26	date	date	NOUN
aiua-6844	124	27	this	this	PRON
aiua-6844	124	28	has	have	AUX
aiua-6844	124	29	not	not	PART
aiua-6844	124	30	been	be	AUX
aiua-6844	124	31	unequivocally	unequivocally	ADV
aiua-6844	124	32	demonstrated	demonstrate	VERB
aiua-6844	124	33	in	in	ADP
aiua-6844	124	34	humans	human	NOUN
aiua-6844	124	35	.	.	PUNCT
aiua-6844	125	1	despite	despite	SCONJ
aiua-6844	125	2	the	the	DET
aiua-6844	125	3	small	small	ADJ
aiua-6844	125	4	number	number	NOUN
aiua-6844	125	5	of	of	ADP
aiua-6844	125	6	patients	patient	NOUN
aiua-6844	125	7	we	we	PRON
aiua-6844	125	8	enrolled	enrol	VERB
aiua-6844	125	9	and	and	CCONJ
aiua-6844	125	10	the	the	DET
aiua-6844	125	11	relatively	relatively	ADV
aiua-6844	125	12	short	short	ADJ
aiua-6844	125	13	duration	duration	NOUN
aiua-6844	125	14	of	of	ADP
aiua-6844	125	15	intervention	intervention	NOUN
aiua-6844	125	16	,	,	PUNCT
aiua-6844	125	17	results	result	NOUN
aiua-6844	125	18	of	of	ADP
aiua-6844	125	19	our	our	PRON
aiua-6844	125	20	clinical	clinical	ADJ
aiua-6844	125	21	trial	trial	NOUN
aiua-6844	125	22	indicate	indicate	VERB
aiua-6844	125	23	that	that	SCONJ
aiua-6844	125	24	green	green	ADJ
aiua-6844	125	25	tea	tea	NOUN
aiua-6844	125	26	catechins	catechin	NOUN
aiua-6844	125	27	do	do	AUX
aiua-6844	125	28	not	not	PART
aiua-6844	125	29	reduce	reduce	VERB
aiua-6844	125	30	the	the	DET
aiua-6844	125	31	chance	chance	NOUN
aiua-6844	125	32	of	of	ADP
aiua-6844	125	33	a	a	DET
aiua-6844	125	34	later	later	ADJ
aiua-6844	125	35	development	development	NOUN
aiua-6844	125	36	of	of	ADP
aiua-6844	125	37	pca	pca	PROPN
aiua-6844	125	38	in	in	ADP
aiua-6844	125	39	men	man	NOUN
aiua-6844	125	40	with	with	ADP
aiua-6844	125	41	hgpin	hgpin	NOUN
aiua-6844	125	42	.	.	PUNCT
aiua-6844	126	1	however	however	ADV
aiua-6844	126	2	,	,	PUNCT
aiua-6844	126	3	the	the	DET
aiua-6844	126	4	minor	minor	ADJ
aiua-6844	126	5	incidence	incidence	NOUN
aiua-6844	126	6	of	of	ADP
aiua-6844	126	7	new	new	ADJ
aiua-6844	126	8	diagnoses	diagnosis	NOUN
aiua-6844	126	9	of	of	ADP
aiua-6844	126	10	pca	pca	PROPN
aiua-6844	126	11	at	at	ADP
aiua-6844	126	12	6	6	NUM
aiua-6844	126	13	months	month	NOUN
aiua-6844	126	14	follow	follow	NOUN
aiua-6844	126	15	-	-	PUNCT
aiua-6844	126	16	up	up	NOUN
aiua-6844	126	17	(	(	PUNCT
aiua-6844	126	18	albeit	albeit	SCONJ
aiua-6844	126	19	not	not	PART
aiua-6844	126	20	statistically	statistically	ADV
aiua-6844	126	21	significant	significant	ADJ
aiua-6844	126	22	)	)	PUNCT
aiua-6844	126	23	and	and	CCONJ
aiua-6844	126	24	the	the	DET
aiua-6844	126	25	significant	significant	ADJ
aiua-6844	126	26	reduction	reduction	NOUN
aiua-6844	126	27	of	of	ADP
aiua-6844	126	28	psa	psa	NOUN
aiua-6844	126	29	levels	level	NOUN
aiua-6844	126	30	at	at	ADP
aiua-6844	126	31	both	both	DET
aiua-6844	126	32	6	6	NUM
aiua-6844	126	33	and	and	CCONJ
aiua-6844	126	34	12	12	NUM
aiua-6844	126	35	months	month	NOUN
aiua-6844	126	36	follow	follow	VERB
aiua-6844	126	37	-	-	PUNCT
aiua-6844	126	38	up	up	NOUN
aiua-6844	126	39	,	,	PUNCT
aiua-6844	126	40	associated	associate	VERB
aiua-6844	126	41	to	to	ADP
aiua-6844	126	42	the	the	DET
aiua-6844	126	43	quite	quite	ADV
aiua-6844	126	44	favourable	favourable	ADJ
aiua-6844	126	45	trend	trend	NOUN
aiua-6844	126	46	that	that	PRON
aiua-6844	126	47	we	we	PRON
aiua-6844	126	48	observed	observe	VERB
aiua-6844	126	49	in	in	ADP
aiua-6844	126	50	our	our	PRON
aiua-6844	126	51	clinical	clinical	ADJ
aiua-6844	126	52	trial	trial	NOUN
aiua-6844	126	53	(	(	PUNCT
aiua-6844	126	54	very	very	ADV
aiua-6844	126	55	limited	limited	ADJ
aiua-6844	126	56	adverse	adverse	ADJ
aiua-6844	126	57	effects	effect	NOUN
aiua-6844	126	58	and	and	CCONJ
aiua-6844	126	59	improvement	improvement	NOUN
aiua-6844	126	60	in	in	ADP
aiua-6844	126	61	luts	luts	PROPN
aiua-6844	126	62	and	and	CCONJ
aiua-6844	126	63	quality	quality	NOUN
aiua-6844	126	64	of	of	ADP
aiua-6844	126	65	life	life	NOUN
aiua-6844	126	66	)	)	PUNCT
aiua-6844	126	67	suggest	suggest	VERB
aiua-6844	126	68	that	that	SCONJ
aiua-6844	126	69	future	future	ADJ
aiua-6844	126	70	studies	study	NOUN
aiua-6844	126	71	with	with	ADP
aiua-6844	126	72	a	a	DET
aiua-6844	126	73	larger	large	ADJ
aiua-6844	126	74	cohort	cohort	NOUN
aiua-6844	126	75	of	of	ADP
aiua-6844	126	76	men	man	NOUN
aiua-6844	126	77	and	and	CCONJ
aiua-6844	126	78	longer	long	ADJ
aiua-6844	126	79	durations	duration	NOUN
aiua-6844	126	80	of	of	ADP
aiua-6844	126	81	interventions	intervention	NOUN
aiua-6844	126	82	are	be	AUX
aiua-6844	126	83	warranted	warrant	VERB
aiua-6844	126	84	.	.	PUNCT
aiua-6844	127	1	moreover	moreover	ADV
aiua-6844	127	2	,	,	PUNCT
aiua-6844	127	3	the	the	DET
aiua-6844	127	4	results	result	NOUN
aiua-6844	127	5	of	of	ADP
aiua-6844	127	6	our	our	PRON
aiua-6844	127	7	trial	trial	NOUN
aiua-6844	127	8	provide	provide	VERB
aiua-6844	127	9	a	a	DET
aiua-6844	127	10	glimpse	glimpse	NOUN
aiua-6844	127	11	of	of	ADP
aiua-6844	127	12	the	the	DET
aiua-6844	127	13	possibility	possibility	NOUN
aiua-6844	127	14	that	that	SCONJ
aiua-6844	127	15	the	the	DET
aiua-6844	127	16	green	green	ADJ
aiua-6844	127	17	tea	tea	NOUN
aiua-6844	127	18	catechins	catechin	NOUN
aiua-6844	127	19	might	might	AUX
aiua-6844	127	20	be	be	AUX
aiua-6844	127	21	useful	useful	ADJ
aiua-6844	127	22	,	,	PUNCT
aiua-6844	127	23	alone	alone	ADJ
aiua-6844	127	24	or	or	CCONJ
aiua-6844	127	25	in	in	ADP
aiua-6844	127	26	combination	combination	NOUN
aiua-6844	127	27	with	with	ADP
aiua-6844	127	28	other	other	ADJ
aiua-6844	127	29	drugs	drug	NOUN
aiua-6844	127	30	,	,	PUNCT
aiua-6844	127	31	for	for	ADP
aiua-6844	127	32	the	the	DET
aiua-6844	127	33	prevention	prevention	NOUN
aiua-6844	127	34	or	or	CCONJ
aiua-6844	127	35	treatment	treatment	NOUN
aiua-6844	127	36	of	of	ADP
aiua-6844	127	37	other	other	ADJ
aiua-6844	127	38	prostatic	prostatic	ADJ
aiua-6844	127	39	pathologies	pathology	NOUN
aiua-6844	127	40	.	.	PUNCT
aiua-6844	128	1	ethics	ethic	NOUN
aiua-6844	128	2	approval	approval	NOUN
aiua-6844	128	3	and	and	CCONJ
aiua-6844	128	4	consent	consent	NOUN
aiua-6844	128	5	to	to	PART
aiua-6844	128	6	participate	participate	VERB
aiua-6844	128	7	this	this	DET
aiua-6844	128	8	study	study	NOUN
aiua-6844	128	9	was	be	AUX
aiua-6844	128	10	approved	approve	VERB
aiua-6844	128	11	by	by	ADP
aiua-6844	128	12	the	the	DET
aiua-6844	128	13	modena	modena	PROPN
aiua-6844	128	14	ethic	ethic	PROPN
aiua-6844	128	15	committee	committee	PROPN
aiua-6844	128	16	(	(	PUNCT
aiua-6844	128	17	italy	italy	PROPN
aiua-6844	128	18	)	)	PUNCT
aiua-6844	128	19	on	on	ADP
aiua-6844	128	20	2007	2007	NUM
aiua-6844	128	21	-	-	PUNCT
aiua-6844	128	22	04	04	NUM
aiua-6844	128	23	-	-	SYM
aiua-6844	128	24	10	10	NUM
aiua-6844	128	25	(	(	PUNCT
aiua-6844	128	26	number	number	NOUN
aiua-6844	128	27	23/07	23/07	NUM
aiua-6844	128	28	)	)	PUNCT
aiua-6844	128	29	and	and	CCONJ
aiua-6844	128	30	carried	carry	VERB
aiua-6844	128	31	out	out	ADP
aiua-6844	128	32	in	in	ADP
aiua-6844	128	33	the	the	DET
aiua-6844	128	34	modena	modena	PROPN
aiua-6844	128	35	university	university	PROPN
aiua-6844	128	36	hospital	hospital	PROPN
aiua-6844	128	37	(	(	PUNCT
aiua-6844	128	38	italy	italy	PROPN
aiua-6844	128	39	)	)	PUNCT
aiua-6844	128	40	from	from	ADP
aiua-6844	128	41	may	may	PROPN
aiua-6844	128	42	2007	2007	NUM
aiua-6844	128	43	to	to	ADP
aiua-6844	128	44	february	february	PROPN
aiua-6844	128	45	2011	2011	NUM
aiua-6844	128	46	.	.	PUNCT
aiua-6844	129	1	all	all	DET
aiua-6844	129	2	volunteers	volunteer	NOUN
aiua-6844	129	3	have	have	AUX
aiua-6844	129	4	been	be	AUX
aiua-6844	129	5	properly	properly	ADV
aiua-6844	129	6	informed	inform	VERB
aiua-6844	129	7	about	about	ADP
aiua-6844	129	8	the	the	DET
aiua-6844	129	9	clinical	clinical	ADJ
aiua-6844	129	10	trial	trial	NOUN
aiua-6844	129	11	and	and	CCONJ
aiua-6844	129	12	signed	sign	VERB
aiua-6844	129	13	a	a	DET
aiua-6844	129	14	free	free	ADJ
aiua-6844	129	15	informed	inform	VERB
aiua-6844	129	16	consent	consent	NOUN
aiua-6844	129	17	form	form	NOUN
aiua-6844	129	18	.	.	PUNCT
aiua-6844	130	1	references	reference	NOUN
aiua-6844	130	2	1	1	NUM
aiua-6844	130	3	.	.	PUNCT
aiua-6844	130	4	bostwick	bostwick	PROPN
aiua-6844	130	5	dg	dg	PROPN
aiua-6844	130	6	,	,	PUNCT
aiua-6844	130	7	liu	liu	PROPN
aiua-6844	130	8	l	l	PROPN
aiua-6844	130	9	,	,	PUNCT
aiua-6844	130	10	brawer	brawer	PROPN
aiua-6844	130	11	mk	mk	PROPN
aiua-6844	130	12	,	,	PUNCT
aiua-6844	130	13	qian	qian	PROPN
aiua-6844	130	14	j.	j.	PROPN
aiua-6844	130	15	high	high	ADJ
aiua-6844	130	16	-	-	PUNCT
aiua-6844	130	17	grade	grade	NOUN
aiua-6844	130	18	prostatic	prostatic	ADJ
aiua-6844	130	19	intraepithelial	intraepithelial	ADJ
aiua-6844	130	20	neoplasia	neoplasia	NOUN
aiua-6844	130	21	.	.	PUNCT
aiua-6844	131	1	rev	rev	PROPN
aiua-6844	131	2	urol	urol	PROPN
aiua-6844	131	3	.	.	PUNCT
aiua-6844	131	4	2004	2004	NUM
aiua-6844	131	5	;	;	PUNCT
aiua-6844	132	1	6:171	6:171	NUM
aiua-6844	132	2	-	-	SYM
aiua-6844	132	3	179	179	NUM
aiua-6844	132	4	.	.	PUNCT
aiua-6844	133	1	2	2	X
aiua-6844	133	2	.	.	X
aiua-6844	133	3	paterniti	paterniti	PROPN
aiua-6844	133	4	i	i	PRON
aiua-6844	133	5	,	,	PUNCT
aiua-6844	133	6	cordaro	cordaro	PROPN
aiua-6844	133	7	m	m	PROPN
aiua-6844	133	8	,	,	PUNCT
aiua-6844	133	9	campolo	campolo	PROPN
aiua-6844	133	10	m	m	PROPN
aiua-6844	133	11	,	,	PUNCT
aiua-6844	133	12	et	et	PROPN
aiua-6844	133	13	al	al	PROPN
aiua-6844	133	14	.	.	PROPN
aiua-6844	133	15	neuroprotection	neuroprotection	NOUN
aiua-6844	133	16	by	by	ADP
aiua-6844	133	17	association	association	NOUN
aiua-6844	133	18	of	of	ADP
aiua-6844	133	19	palmitoylethanolamide	palmitoylethanolamide	NOUN
aiua-6844	133	20	with	with	ADP
aiua-6844	133	21	luteolin	luteolin	PROPN
aiua-6844	133	22	in	in	ADP
aiua-6844	133	23	experimental	experimental	PROPN
aiua-6844	133	24	alzheimer	alzheimer	PROPN
aiua-6844	133	25	's	's	PART
aiua-6844	133	26	disease	disease	NOUN
aiua-6844	133	27	models	model	NOUN
aiua-6844	133	28	:	:	PUNCT
aiua-6844	133	29	the	the	DET
aiua-6844	133	30	control	control	NOUN
aiua-6844	133	31	of	of	ADP
aiua-6844	133	32	neuroinflammation	neuroinflammation	NOUN
aiua-6844	133	33	.	.	PUNCT
aiua-6844	134	1	cns	cns	PROPN
aiua-6844	134	2	neurol	neurol	PROPN
aiua-6844	134	3	disord	disord	NOUN
aiua-6844	134	4	drug	drug	NOUN
aiua-6844	134	5	targets	target	NOUN
aiua-6844	134	6	.	.	PUNCT
aiua-6844	135	1	2014	2014	NUM
aiua-6844	135	2	;	;	PUNCT
aiua-6844	135	3	13:1530	13:1530	NUM
aiua-6844	135	4	-	-	SYM
aiua-6844	135	5	41	41	NUM
aiua-6844	135	6	.	.	PUNCT
aiua-6844	136	1	3	3	X
aiua-6844	136	2	.	.	X
aiua-6844	136	3	filocamo	filocamo	PROPN
aiua-6844	136	4	a	a	PRON
aiua-6844	136	5	,	,	PUNCT
aiua-6844	136	6	bisignano	bisignano	NOUN
aiua-6844	136	7	c	c	NOUN
aiua-6844	136	8	,	,	PUNCT
aiua-6844	136	9	ferlazzo	ferlazzo	VERB
aiua-6844	136	10	n	n	CCONJ
aiua-6844	136	11	,	,	PUNCT
aiua-6844	136	12	et	et	PROPN
aiua-6844	136	13	al	al	PROPN
aiua-6844	136	14	.	.	PUNCT
aiua-6844	137	1	in	in	ADP
aiua-6844	137	2	vitro	vitro	X
aiua-6844	137	3	effect	effect	NOUN
aiua-6844	137	4	of	of	ADP
aiua-6844	137	5	bergamot	bergamot	NOUN
aiua-6844	137	6	(	(	PUNCT
aiua-6844	137	7	citrus	citrus	PROPN
aiua-6844	137	8	bergamia	bergamia	PROPN
aiua-6844	137	9	)	)	PUNCT
aiua-6844	137	10	juice	juice	NOUN
aiua-6844	137	11	against	against	ADP
aiua-6844	137	12	caga	caga	NOUN
aiua-6844	137	13	-	-	PUNCT
aiua-6844	137	14	positive	positive	ADJ
aiua-6844	137	15	and	and	CCONJ
aiua-6844	137	16	-	-	PUNCT
aiua-6844	137	17	negative	negative	ADJ
aiua-6844	137	18	clinical	clinical	ADJ
aiua-6844	137	19	isolates	isolate	NOUN
aiua-6844	137	20	of	of	ADP
aiua-6844	137	21	helicobacter	helicobacter	NOUN
aiua-6844	137	22	pylori	pylori	NOUN
aiua-6844	137	23	.	.	PUNCT
aiua-6844	138	1	bmc	bmc	PROPN
aiua-6844	138	2	complement	complement	PROPN
aiua-6844	138	3	altern	altern	NOUN
aiua-6844	138	4	me	i	PRON
aiua-6844	138	5	.	.	PUNCT
aiua-6844	138	6	2015	2015	NUM
aiua-6844	138	7	;	;	PUNCT
aiua-6844	138	8	15:256	15:256	NUM
aiua-6844	138	9	.	.	NOUN
aiua-6844	139	1	4	4	NUM
aiua-6844	139	2	.	.	NUM
aiua-6844	139	3	marino	marino	PROPN
aiua-6844	139	4	a	a	NOUN
aiua-6844	139	5	,	,	PUNCT
aiua-6844	139	6	paterniti	paterniti	NOUN
aiua-6844	139	7	i	i	PRON
aiua-6844	139	8	,	,	PUNCT
aiua-6844	139	9	cordaro	cordaro	PROPN
aiua-6844	139	10	m	m	PROPN
aiua-6844	139	11	,	,	PUNCT
aiua-6844	139	12	et	et	PROPN
aiua-6844	139	13	al	al	PROPN
aiua-6844	139	14	.	.	PROPN
aiua-6844	139	15	role	role	NOUN
aiua-6844	139	16	of	of	ADP
aiua-6844	139	17	natural	natural	ADJ
aiua-6844	139	18	antioxidants	antioxidant	NOUN
aiua-6844	139	19	and	and	CCONJ
aiua-6844	139	20	potential	potential	ADJ
aiua-6844	139	21	use	use	NOUN
aiua-6844	139	22	of	of	ADP
aiua-6844	139	23	bergamot	bergamot	NOUN
aiua-6844	139	24	in	in	ADP
aiua-6844	139	25	treating	treat	VERB
aiua-6844	139	26	rheumatoid	rheumatoid	NOUN
aiua-6844	139	27	arthritis	arthritis	NOUN
aiua-6844	139	28	.	.	PUNCT
aiua-6844	140	1	pharmanutrition	pharmanutrition	NOUN
aiua-6844	140	2	.	.	PUNCT
aiua-6844	141	1	2015	2015	NUM
aiua-6844	141	2	;	;	PUNCT
aiua-6844	141	3	3:53	3:53	NUM
aiua-6844	141	4	-	-	SYM
aiua-6844	141	5	59	59	NUM
aiua-6844	141	6	.	.	PUNCT
aiua-6844	142	1	5	5	NUM
aiua-6844	142	2	.	.	X
aiua-6844	142	3	micali	micali	PROPN
aiua-6844	142	4	s	s	PROPN
aiua-6844	142	5	,	,	PUNCT
aiua-6844	142	6	isgro	isgro	ADP
aiua-6844	142	7	g	g	PROPN
aiua-6844	142	8	,	,	PUNCT
aiua-6844	142	9	bianchi	bianchi	NOUN
aiua-6844	142	10	g	g	PROPN
aiua-6844	142	11	,	,	PUNCT
aiua-6844	142	12	et	et	PROPN
aiua-6844	142	13	al	al	PROPN
aiua-6844	142	14	.	.	PROPN
aiua-6844	142	15	cranberry	cranberry	PROPN
aiua-6844	142	16	and	and	CCONJ
aiua-6844	142	17	recurrent	recurrent	ADJ
aiua-6844	142	18	cystitis	cystitis	NOUN
aiua-6844	142	19	:	:	PUNCT
aiua-6844	142	20	more	more	ADJ
aiua-6844	142	21	than	than	ADP
aiua-6844	142	22	marketing	marketing	NOUN
aiua-6844	142	23	?	?	PUNCT
aiua-6844	143	1	crit	crit	PROPN
aiua-6844	143	2	rev	rev	PROPN
aiua-6844	143	3	food	food	PROPN
aiua-6844	143	4	sci	sci	PROPN
aiua-6844	143	5	nutr	nutr	PROPN
aiua-6844	143	6	.	.	PROPN
aiua-6844	143	7	2014	2014	NUM
aiua-6844	143	8	;	;	PUNCT
aiua-6844	143	9	54:1063	54:1063	NUM
aiua-6844	143	10	-	-	SYM
aiua-6844	143	11	75	75	NUM
aiua-6844	143	12	.	.	PUNCT
aiua-6844	144	1	6	6	NUM
aiua-6844	144	2	.	.	X
aiua-6844	144	3	ferlazzo	ferlazzo	PROPN
aiua-6844	144	4	n	n	CCONJ
aiua-6844	144	5	,	,	PUNCT
aiua-6844	144	6	cirmi	cirmi	VERB
aiua-6844	144	7	s	s	PART
aiua-6844	144	8	,	,	PUNCT
aiua-6844	144	9	russo	russo	PROPN
aiua-6844	144	10	m	m	PROPN
aiua-6844	144	11	,	,	PUNCT
aiua-6844	144	12	et	et	PROPN
aiua-6844	144	13	al	al	PROPN
aiua-6844	144	14	.	.	PROPN
aiua-6844	144	15	nf	nf	PROPN
aiua-6844	144	16	-	-	PUNCT
aiua-6844	144	17	κb	κb	NOUN
aiua-6844	144	18	mediates	mediate	VERB
aiua-6844	144	19	the	the	DET
aiua-6844	144	20	antiproliferative	antiproliferative	NOUN
aiua-6844	144	21	and	and	CCONJ
aiua-6844	144	22	proapoptotic	proapoptotic	ADJ
aiua-6844	144	23	effects	effect	NOUN
aiua-6844	144	24	of	of	ADP
aiua-6844	144	25	bergamot	bergamot	NOUN
aiua-6844	144	26	juice	juice	NOUN
aiua-6844	144	27	in	in	ADP
aiua-6844	144	28	hepg2	hepg2	NOUN
aiua-6844	144	29	cells	cell	NOUN
aiua-6844	144	30	.	.	PUNCT
aiua-6844	145	1	life	life	PROPN
aiua-6844	145	2	sci	sci	PROPN
aiua-6844	145	3	.	.	PROPN
aiua-6844	145	4	2016	2016	NUM
aiua-6844	145	5	;	;	PUNCT
aiua-6844	145	6	146:81	146:81	NUM
aiua-6844	145	7	-	-	SYM
aiua-6844	145	8	91	91	NUM
aiua-6844	145	9	.	.	PUNCT
aiua-6844	146	1	7	7	X
aiua-6844	146	2	.	.	X
aiua-6844	146	3	navarra	navarra	PROPN
aiua-6844	146	4	m	m	PROPN
aiua-6844	146	5	,	,	PUNCT
aiua-6844	146	6	ferlazzo	ferlazzo	PROPN
aiua-6844	146	7	n	n	CCONJ
aiua-6844	146	8	,	,	PUNCT
aiua-6844	146	9	cirmi	cirmi	VERB
aiua-6844	146	10	s	s	PART
aiua-6844	146	11	,	,	PUNCT
aiua-6844	146	12	et	et	PROPN
aiua-6844	146	13	al	al	PROPN
aiua-6844	146	14	.	.	PUNCT
aiua-6844	147	1	effects	effect	NOUN
aiua-6844	147	2	of	of	ADP
aiua-6844	147	3	bergamot	bergamot	NOUN
aiua-6844	147	4	essential	essential	ADJ
aiua-6844	147	5	oil	oil	NOUN
aiua-6844	147	6	and	and	CCONJ
aiua-6844	147	7	its	its	PRON
aiua-6844	147	8	extractive	extractive	ADJ
aiua-6844	147	9	fractions	fraction	NOUN
aiua-6844	147	10	on	on	ADP
aiua-6844	147	11	sh	sh	PROPN
aiua-6844	147	12	-	-	PUNCT
aiua-6844	147	13	sy5y	sy5y	PROPN
aiua-6844	147	14	human	human	ADJ
aiua-6844	147	15	neuroblastoma	neuroblastoma	NOUN
aiua-6844	147	16	cell	cell	NOUN
aiua-6844	147	17	growth	growth	NOUN
aiua-6844	147	18	.	.	PUNCT
aiua-6844	148	1	j	j	PROPN
aiua-6844	148	2	pharm	pharm	PROPN
aiua-6844	148	3	pharmacol	pharmacol	PROPN
aiua-6844	148	4	.	.	PROPN
aiua-6844	148	5	2015	2015	NUM
aiua-6844	148	6	;	;	PUNCT
aiua-6844	148	7	67:1042	67:1042	NUM
aiua-6844	148	8	-	-	SYM
aiua-6844	148	9	53	53	NUM
aiua-6844	148	10	.	.	NOUN
aiua-6844	148	11	8	8	NUM
aiua-6844	148	12	.	.	PUNCT
aiua-6844	149	1	lee	lee	PROPN
aiua-6844	149	2	j	j	PROPN
aiua-6844	149	3	,	,	PUNCT
aiua-6844	149	4	demissie	demissie	PROPN
aiua-6844	149	5	k	k	PROPN
aiua-6844	149	6	,	,	PUNCT
aiua-6844	149	7	lu	lu	PROPN
aiua-6844	149	8	se	se	X
aiua-6844	149	9	,	,	PUNCT
aiua-6844	149	10	rhoads	rhoad	VERB
aiua-6844	149	11	gg	gg	PROPN
aiua-6844	149	12	.	.	PUNCT
aiua-6844	150	1	cancer	cancer	NOUN
aiua-6844	150	2	incidence	incidence	NOUN
aiua-6844	150	3	among	among	ADP
aiua-6844	150	4	korean	korean	ADJ
aiua-6844	150	5	-	-	PUNCT
aiua-6844	150	6	american	american	ADJ
aiua-6844	150	7	immigrants	immigrant	NOUN
aiua-6844	150	8	in	in	ADP
aiua-6844	150	9	the	the	DET
aiua-6844	150	10	united	united	PROPN
aiua-6844	150	11	states	states	PROPN
aiua-6844	150	12	and	and	CCONJ
aiua-6844	150	13	native	native	ADJ
aiua-6844	150	14	koreans	koreans	PROPN
aiua-6844	150	15	in	in	ADP
aiua-6844	150	16	south	south	PROPN
aiua-6844	150	17	korea	korea	PROPN
aiua-6844	150	18	.	.	PUNCT
aiua-6844	151	1	cancer	cancer	NOUN
aiua-6844	151	2	control	control	PROPN
aiua-6844	151	3	.	.	PUNCT
aiua-6844	152	1	2007	2007	NUM
aiua-6844	152	2	;	;	PUNCT
aiua-6844	152	3	14:78	14:78	NUM
aiua-6844	152	4	-	-	SYM
aiua-6844	152	5	85	85	NUM
aiua-6844	152	6	.	.	NOUN
aiua-6844	153	1	9	9	NUM
aiua-6844	153	2	.	.	X
aiua-6844	153	3	khan	khan	PROPN
aiua-6844	153	4	n	n	CCONJ
aiua-6844	153	5	,	,	PUNCT
aiua-6844	153	6	syed	syed	ADJ
aiua-6844	153	7	dn	dn	PROPN
aiua-6844	153	8	,	,	PUNCT
aiua-6844	153	9	ahmad	ahmad	PROPN
aiua-6844	153	10	n	n	CCONJ
aiua-6844	153	11	,	,	PUNCT
aiua-6844	153	12	et	et	PROPN
aiua-6844	153	13	al	al	PROPN
aiua-6844	153	14	.	.	PUNCT
aiua-6844	154	1	a	a	DET
aiua-6844	154	2	dietary	dietary	ADJ
aiua-6844	154	3	antioxidant	antioxidant	NOUN
aiua-6844	154	4	for	for	ADP
aiua-6844	154	5	health	health	NOUN
aiua-6844	154	6	promotion	promotion	NOUN
aiua-6844	154	7	.	.	PUNCT
aiua-6844	155	1	antioxid	antioxid	VERB
aiua-6844	155	2	redox	redox	NOUN
aiua-6844	155	3	signal	signal	NOUN
aiua-6844	155	4	.	.	PUNCT
aiua-6844	156	1	2013	2013	NUM
aiua-6844	156	2	;	;	PUNCT
aiua-6844	156	3	19:151	19:151	NUM
aiua-6844	156	4	-	-	SYM
aiua-6844	156	5	162	162	NUM
aiua-6844	156	6	.	.	PUNCT
aiua-6844	157	1	10	10	NUM
aiua-6844	157	2	.	.	PUNCT
aiua-6844	158	1	minciullo	minciullo	PROPN
aiua-6844	158	2	pl	pl	PROPN
aiua-6844	158	3	,	,	PUNCT
aiua-6844	158	4	inferrera	inferrera	PROPN
aiua-6844	158	5	a	a	PRON
aiua-6844	158	6	,	,	PUNCT
aiua-6844	158	7	navarra	navarra	PROPN
aiua-6844	158	8	m	m	PROPN
aiua-6844	158	9	,	,	PUNCT
aiua-6844	158	10	et	et	PROPN
aiua-6844	158	11	al	al	PROPN
aiua-6844	158	12	.	.	PROPN
aiua-6844	158	13	oxidative	oxidative	ADJ
aiua-6844	158	14	stress	stress	NOUN
aiua-6844	158	15	in	in	ADP
aiua-6844	158	16	benign	benign	ADJ
aiua-6844	158	17	prostatic	prostatic	ADJ
aiua-6844	158	18	hyperplasia	hyperplasia	NOUN
aiua-6844	158	19	:	:	PUNCT
aiua-6844	158	20	a	a	DET
aiua-6844	158	21	systematic	systematic	ADJ
aiua-6844	158	22	review	review	NOUN
aiua-6844	158	23	.	.	PUNCT
aiua-6844	159	1	urol	urol	PROPN
aiua-6844	159	2	int	int	PROPN
aiua-6844	159	3	.	.	PUNCT
aiua-6844	160	1	2015	2015	NUM
aiua-6844	160	2	;	;	PUNCT
aiua-6844	160	3	94:249	94:249	NUM
aiua-6844	160	4	-	-	SYM
aiua-6844	160	5	54	54	NUM
aiua-6844	160	6	.	.	PUNCT
aiua-6844	161	1	11	11	NUM
aiua-6844	161	2	.	.	PUNCT
aiua-6844	162	1	johnson	johnson	PROPN
aiua-6844	162	2	jj	jj	PROPN
aiua-6844	162	3	,	,	PUNCT
aiua-6844	162	4	bailey	bailey	PROPN
aiua-6844	162	5	hh	hh	PROPN
aiua-6844	162	6	,	,	PUNCT
aiua-6844	162	7	mukhtar	mukhtar	PROPN
aiua-6844	162	8	h.	h.	PROPN
aiua-6844	162	9	green	green	PROPN
aiua-6844	162	10	tea	tea	NOUN
aiua-6844	162	11	polyphenols	polyphenol	NOUN
aiua-6844	162	12	for	for	ADP
aiua-6844	162	13	prostate	prostate	NOUN
aiua-6844	162	14	cancer	cancer	NOUN
aiua-6844	162	15	chemoprevention	chemoprevention	NOUN
aiua-6844	162	16	:	:	PUNCT
aiua-6844	162	17	a	a	DET
aiua-6844	162	18	translational	translational	ADJ
aiua-6844	162	19	perspective	perspective	NOUN
aiua-6844	162	20	.	.	PUNCT
aiua-6844	163	1	phytomedicine	phytomedicine	NOUN
aiua-6844	163	2	.	.	PUNCT
aiua-6844	164	1	2010	2010	NUM
aiua-6844	164	2	;	;	PUNCT
aiua-6844	164	3	17:3	17:3	NUM
aiua-6844	164	4	-	-	SYM
aiua-6844	164	5	13	13	NUM
aiua-6844	164	6	.	.	PUNCT
aiua-6844	165	1	12	12	NUM
aiua-6844	165	2	.	.	PUNCT
aiua-6844	166	1	bettuzzi	bettuzzi	PROPN
aiua-6844	166	2	s	s	PROPN
aiua-6844	166	3	,	,	PUNCT
aiua-6844	166	4	brausi	brausi	PROPN
aiua-6844	166	5	m	m	PROPN
aiua-6844	166	6	,	,	PUNCT
aiua-6844	166	7	rizzi	rizzi	PROPN
aiua-6844	166	8	f	f	PROPN
aiua-6844	166	9	,	,	PUNCT
aiua-6844	166	10	et	et	PROPN
aiua-6844	166	11	al	al	PROPN
aiua-6844	166	12	.	.	PROPN
aiua-6844	166	13	chemoprevention	chemoprevention	PROPN
aiua-6844	166	14	of	of	ADP
aiua-6844	166	15	human	human	ADJ
aiua-6844	166	16	prostate	prostate	NOUN
aiua-6844	166	17	cancer	cancer	NOUN
aiua-6844	166	18	by	by	ADP
aiua-6844	166	19	oral	oral	ADJ
aiua-6844	166	20	administration	administration	NOUN
aiua-6844	166	21	of	of	ADP
aiua-6844	166	22	green	green	ADJ
aiua-6844	166	23	tea	tea	NOUN
aiua-6844	166	24	catechins	catechin	NOUN
aiua-6844	166	25	in	in	ADP
aiua-6844	166	26	volunteers	volunteer	NOUN
aiua-6844	166	27	with	with	ADP
aiua-6844	166	28	high	high	ADJ
aiua-6844	166	29	-	-	PUNCT
aiua-6844	166	30	grade	grade	NOUN
aiua-6844	166	31	prostate	prostate	NOUN
aiua-6844	166	32	intraepithelial	intraepithelial	ADJ
aiua-6844	166	33	neoplasia	neoplasia	NOUN
aiua-6844	166	34	:	:	PUNCT
aiua-6844	166	35	a	a	DET
aiua-6844	166	36	preliminary	preliminary	ADJ
aiua-6844	166	37	report	report	NOUN
aiua-6844	166	38	from	from	ADP
aiua-6844	166	39	a	a	DET
aiua-6844	166	40	one	one	NUM
aiua-6844	166	41	-	-	PUNCT
aiua-6844	166	42	year	year	NOUN
aiua-6844	166	43	proof	proof	NOUN
aiua-6844	166	44	-	-	PUNCT
aiua-6844	166	45	of	of	ADP
aiua-6844	166	46	-	-	PUNCT
aiua-6844	166	47	principle	principle	NOUN
aiua-6844	166	48	study	study	NOUN
aiua-6844	166	49	.	.	PUNCT
aiua-6844	167	1	cancer	cancer	NOUN
aiua-6844	167	2	research	research	NOUN
aiua-6844	167	3	.	.	PUNCT
aiua-6844	168	1	2006	2006	NUM
aiua-6844	168	2	;	;	PUNCT
aiua-6844	168	3	66:1234	66:1234	NOUN
aiua-6844	168	4	-	-	SYM
aiua-6844	168	5	40	40	NUM
aiua-6844	168	6	.	.	PUNCT
aiua-6844	168	7	13	13	NUM
aiua-6844	168	8	.	.	PUNCT
aiua-6844	169	1	brausi	brausi	PROPN
aiua-6844	169	2	m	m	PROPN
aiua-6844	169	3	,	,	PUNCT
aiua-6844	169	4	rizzi	rizzi	PROPN
aiua-6844	169	5	f	f	PROPN
aiua-6844	169	6	,	,	PUNCT
aiua-6844	169	7	bettuzzi	bettuzzi	PROPN
aiua-6844	169	8	s.	s.	PROPN
aiua-6844	169	9	chmorevention	chmorevention	PROPN
aiua-6844	169	10	of	of	ADP
aiua-6844	169	11	human	human	ADJ
aiua-6844	169	12	prostate	prostate	NOUN
aiua-6844	169	13	cancer	cancer	NOUN
aiua-6844	169	14	by	by	ADP
aiua-6844	169	15	green	green	ADJ
aiua-6844	169	16	tea	tea	NOUN
aiua-6844	169	17	catechins	catechin	NOUN
aiua-6844	169	18	:	:	PUNCT
aiua-6844	169	19	two	two	NUM
aiua-6844	169	20	years	year	NOUN
aiua-6844	169	21	later	later	ADV
aiua-6844	169	22	.	.	PUNCT
aiua-6844	170	1	a	a	DET
aiua-6844	170	2	follow	follow	NOUN
aiua-6844	170	3	up	up	ADP
aiua-6844	170	4	update	update	NOUN
aiua-6844	170	5	.	.	PUNCT
aiua-6844	171	1	eur	eur	PROPN
aiua-6844	171	2	urol	urol	PROPN
aiua-6844	171	3	.	.	PUNCT
aiua-6844	171	4	2008	2008	NUM
aiua-6844	171	5	;	;	PUNCT
aiua-6844	171	6	54:472	54:472	NUM
aiua-6844	171	7	-	-	SYM
aiua-6844	171	8	473	473	NUM
aiua-6844	171	9	.	.	PUNCT
aiua-6844	171	10	14	14	NUM
aiua-6844	171	11	.	.	PUNCT
aiua-6844	172	1	jacob	jacob	PROPN
aiua-6844	172	2	sa	sa	PROPN
aiua-6844	172	3	,	,	PUNCT
aiua-6844	172	4	khan	khan	PROPN
aiua-6844	172	5	tm	tm	PROPN
aiua-6844	172	6	,	,	PUNCT
aiua-6844	172	7	lee	lee	PROPN
aiua-6844	172	8	lh	lh	PROPN
aiua-6844	172	9	.	.	PUNCT
aiua-6844	173	1	the	the	DET
aiua-6844	173	2	effect	effect	NOUN
aiua-6844	173	3	of	of	ADP
aiua-6844	173	4	green	green	ADJ
aiua-6844	173	5	tea	tea	NOUN
aiua-6844	173	6	consumption	consumption	NOUN
aiua-6844	173	7	on	on	ADP
aiua-6844	173	8	prostate	prostate	NOUN
aiua-6844	173	9	cancer	cancer	NOUN
aiua-6844	173	10	risk	risk	NOUN
aiua-6844	173	11	and	and	CCONJ
aiua-6844	173	12	progression	progression	NOUN
aiua-6844	173	13	:	:	PUNCT
aiua-6844	173	14	a	a	DET
aiua-6844	173	15	systematic	systematic	ADJ
aiua-6844	173	16	review	review	NOUN
aiua-6844	173	17	.	.	PUNCT
aiua-6844	174	1	nutr	nutr	NOUN
aiua-6844	174	2	cancer	cancer	NOUN
aiua-6844	174	3	.	.	PUNCT
aiua-6844	175	1	2017	2017	NUM
aiua-6844	175	2	;	;	PUNCT
aiua-6844	175	3	69:353	69:353	NUM
aiua-6844	175	4	-	-	SYM
aiua-6844	175	5	364	364	NUM
aiua-6844	175	6	.	.	NOUN
aiua-6844	175	7	15	15	NUM
aiua-6844	175	8	.	.	PUNCT
aiua-6844	176	1	denis	denis	PROPN
aiua-6844	176	2	lj	lj	PROPN
aiua-6844	176	3	.	.	PUNCT
aiua-6844	177	1	future	future	ADJ
aiua-6844	177	2	implications	implication	NOUN
aiua-6844	177	3	for	for	ADP
aiua-6844	177	4	the	the	DET
aiua-6844	177	5	management	management	NOUN
aiua-6844	177	6	of	of	ADP
aiua-6844	177	7	benign	benign	ADJ
aiua-6844	177	8	prostatic	prostatic	ADJ
aiua-6844	177	9	hyperplasia	hyperplasia	NOUN
aiua-6844	177	10	.	.	PUNCT
aiua-6844	178	1	eur	eur	PROPN
aiua-6844	178	2	urol	urol	PROPN
aiua-6844	178	3	.	.	PUNCT
aiua-6844	178	4	1994	1994	NUM
aiua-6844	178	5	;	;	PUNCT
aiua-6844	178	6	25:29	25:29	NUM
aiua-6844	178	7	-	-	SYM
aiua-6844	178	8	34	34	NUM
aiua-6844	178	9	.	.	PUNCT
aiua-6844	178	10	16	16	NUM
aiua-6844	178	11	.	.	PUNCT
aiua-6844	179	1	grumann	grumann	PROPN
aiua-6844	179	2	m	m	PROPN
aiua-6844	179	3	,	,	PUNCT
aiua-6844	179	4	schlag	schlag	NOUN
aiua-6844	179	5	pm	pm	NOUN
aiua-6844	179	6	.	.	PUNCT
aiua-6844	179	7	assessment	assessment	NOUN
aiua-6844	179	8	of	of	ADP
aiua-6844	179	9	quality	quality	NOUN
aiua-6844	179	10	of	of	ADP
aiua-6844	179	11	life	life	NOUN
aiua-6844	179	12	in	in	ADP
aiua-6844	179	13	cancer	cancer	NOUN
aiua-6844	179	14	patients	patient	NOUN
aiua-6844	179	15	:	:	PUNCT
aiua-6844	179	16	complexity	complexity	NOUN
aiua-6844	179	17	,	,	PUNCT
aiua-6844	179	18	criticism	criticism	NOUN
aiua-6844	179	19	,	,	PUNCT
aiua-6844	179	20	challenges	challenge	NOUN
aiua-6844	179	21	.	.	PUNCT
aiua-6844	180	1	onkologie	onkologie	INTJ
aiua-6844	180	2	.	.	PUNCT
aiua-6844	181	1	2001	2001	NUM
aiua-6844	181	2	;	;	PUNCT
aiua-6844	181	3	24:10	24:10	NUM
aiua-6844	181	4	-	-	SYM
aiua-6844	181	5	5	5	NUM
aiua-6844	181	6	.	.	NUM
aiua-6844	181	7	17	17	NUM
aiua-6844	181	8	.	.	PUNCT
aiua-6844	182	1	villeneuve	villeneuve	PROPN
aiua-6844	182	2	pj	pj	PROPN
aiua-6844	182	3	,	,	PUNCT
aiua-6844	182	4	johnson	johnson	PROPN
aiua-6844	182	5	kc	kc	PROPN
aiua-6844	182	6	,	,	PUNCT
aiua-6844	182	7	kreiger	kreiger	PROPN
aiua-6844	182	8	n	n	CCONJ
aiua-6844	182	9	,	,	PUNCT
aiua-6844	182	10	mao	mao	PROPN
aiua-6844	182	11	y.	y.	PROPN
aiua-6844	182	12	risk	risk	NOUN
aiua-6844	182	13	factors	factor	NOUN
aiua-6844	182	14	for	for	ADP
aiua-6844	182	15	prostate	prostate	NOUN
aiua-6844	182	16	cancer	cancer	NOUN
aiua-6844	182	17	:	:	PUNCT
aiua-6844	182	18	results	result	NOUN
aiua-6844	182	19	from	from	ADP
aiua-6844	182	20	the	the	DET
aiua-6844	182	21	canadian	canadian	ADJ
aiua-6844	182	22	national	national	ADJ
aiua-6844	182	23	enhanced	enhance	VERB
aiua-6844	182	24	cancer	cancer	NOUN
aiua-6844	182	25	surveillance	surveillance	NOUN
aiua-6844	182	26	system	system	NOUN
aiua-6844	182	27	.	.	PUNCT
aiua-6844	183	1	cancer	cancer	NOUN
aiua-6844	183	2	cause	cause	VERB
aiua-6844	183	3	control	control	NOUN
aiua-6844	183	4	.	.	PUNCT
aiua-6844	184	1	1999	1999	NUM
aiua-6844	184	2	;	;	PUNCT
aiua-6844	185	1	10:355367	10:355367	X
aiua-6844	185	2	.	.	PUNCT
aiua-6844	186	1	18	18	NUM
aiua-6844	186	2	.	.	PUNCT
aiua-6844	187	1	kim	kim	PROPN
aiua-6844	187	2	hl	hl	PROPN
aiua-6844	187	3	,	,	PUNCT
aiua-6844	187	4	yang	yang	PROPN
aiua-6844	187	5	xj	xj	PROPN
aiua-6844	187	6	.	.	PUNCT
aiua-6844	188	1	prevalence	prevalence	NOUN
aiua-6844	188	2	of	of	ADP
aiua-6844	188	3	high	high	ADJ
aiua-6844	188	4	-	-	PUNCT
aiua-6844	188	5	grade	grade	NOUN
aiua-6844	188	6	prostatic	prostatic	ADJ
aiua-6844	188	7	intraepithelial	intraepithelial	ADJ
aiua-6844	188	8	neoplasia	neoplasia	NOUN
aiua-6844	188	9	and	and	CCONJ
aiua-6844	188	10	its	its	PRON
aiua-6844	188	11	relationship	relationship	NOUN
aiua-6844	188	12	to	to	PART
aiua-6844	188	13	serum	serum	VERB
aiua-6844	188	14	prostate	prostate	NOUN
aiua-6844	188	15	specific	specific	ADJ
aiua-6844	188	16	antigen	antigen	NOUN
aiua-6844	188	17	.	.	PUNCT
aiua-6844	189	1	int	int	PROPN
aiua-6844	189	2	braz	braz	PROPN
aiua-6844	189	3	j	j	PROPN
aiua-6844	189	4	urol	urol	PROPN
aiua-6844	189	5	2002	2002	NUM
aiua-6844	189	6	;	;	PUNCT
aiua-6844	189	7	28:413	28:413	NUM
aiua-6844	189	8	-	-	SYM
aiua-6844	189	9	417	417	NUM
aiua-6844	189	10	19	19	NUM
aiua-6844	189	11	.	.	PUNCT
aiua-6844	189	12	bostwick	bostwick	PROPN
aiua-6844	189	13	dg	dg	PROPN
aiua-6844	189	14	,	,	PUNCT
aiua-6844	189	15	qian	qian	PROPN
aiua-6844	189	16	j.	j.	PROPN
aiua-6844	189	17	atypical	atypical	PROPN
aiua-6844	189	18	adenomatous	adenomatous	ADJ
aiua-6844	189	19	hyperplasia	hyperplasia	NOUN
aiua-6844	189	20	pf	pf	ADP
aiua-6844	189	21	the	the	DET
aiua-6844	189	22	prostate	prostate	NOUN
aiua-6844	189	23	.	.	PUNCT
aiua-6844	190	1	relationship	relationship	NOUN
aiua-6844	190	2	with	with	ADP
aiua-6844	190	3	carcinoma	carcinoma	NOUN
aiua-6844	190	4	in	in	ADP
aiua-6844	190	5	217	217	NUM
aiua-6844	190	6	whole	whole	ADJ
aiua-6844	190	7	-	-	PUNCT
aiua-6844	190	8	mount	mount	NOUN
aiua-6844	190	9	radical	radical	ADJ
aiua-6844	190	10	prostatectomies	prostatectomy	NOUN
aiua-6844	190	11	.	.	PUNCT
aiua-6844	191	1	am	be	AUX
aiua-6844	191	2	j	j	PROPN
aiua-6844	191	3	surg	surg	NOUN
aiua-6844	191	4	pathol	pathol	NOUN
aiua-6844	191	5	1995	1995	NUM
aiua-6844	191	6	;	;	PUNCT
aiua-6844	191	7	19:506	19:506	NUM
aiua-6844	191	8	-	-	SYM
aiua-6844	191	9	518	518	NUM
aiua-6844	191	10	.	.	NOUN
aiua-6844	191	11	20	20	NUM
aiua-6844	191	12	.	.	PUNCT
aiua-6844	192	1	zheng	zheng	PROPN
aiua-6844	192	2	j	j	PROPN
aiua-6844	192	3	,	,	PUNCT
aiua-6844	192	4	yang	yang	PROPN
aiua-6844	192	5	b	b	PROPN
aiua-6844	192	6	,	,	PUNCT
aiua-6844	192	7	huang	huang	PROPN
aiua-6844	192	8	t	t	PROPN
aiua-6844	192	9	,	,	PUNCT
aiua-6844	192	10	et	et	PROPN
aiua-6844	192	11	al	al	PROPN
aiua-6844	192	12	.	.	PROPN
aiua-6844	193	1	green	green	ADJ
aiua-6844	193	2	tea	tea	NOUN
aiua-6844	193	3	and	and	CCONJ
aiua-6844	193	4	black	black	ADJ
aiua-6844	193	5	tea	tea	NOUN
aiua-6844	193	6	consumption	consumption	NOUN
aiua-6844	193	7	and	and	CCONJ
aiua-6844	193	8	prostate	prostate	NOUN
aiua-6844	193	9	cancer	cancer	NOUN
aiua-6844	193	10	risk	risk	NOUN
aiua-6844	193	11	:	:	PUNCT
aiua-6844	193	12	an	an	DET
aiua-6844	193	13	exploratory	exploratory	ADJ
aiua-6844	193	14	meta	meta	NOUN
aiua-6844	193	15	-	-	PUNCT
aiua-6844	193	16	analysis	analysis	NOUN
aiua-6844	193	17	of	of	ADP
aiua-6844	193	18	observational	observational	ADJ
aiua-6844	193	19	studies	study	NOUN
aiua-6844	193	20	.	.	PUNCT
aiua-6844	194	1	nutr	nutr	NOUN
aiua-6844	194	2	cancer	cancer	NOUN
aiua-6844	194	3	.	.	PUNCT
aiua-6844	195	1	2011	2011	NUM
aiua-6844	195	2	;	;	PUNCT
aiua-6844	195	3	63:663	63:663	NUM
aiua-6844	195	4	-	-	SYM
aiua-6844	195	5	72	72	NUM
aiua-6844	195	6	.	.	PUNCT
aiua-6844	195	7	21	21	NUM
aiua-6844	195	8	.	.	PUNCT
aiua-6844	196	1	montague	montague	PROPN
aiua-6844	196	2	ja	ja	PROPN
aiua-6844	196	3	,	,	PUNCT
aiua-6844	196	4	butler	butler	PROPN
aiua-6844	196	5	lm	lm	PROPN
aiua-6844	196	6	,	,	PUNCT
aiua-6844	196	7	wu	wu	PROPN
aiua-6844	196	8	ah	ah	INTJ
aiua-6844	196	9	,	,	PUNCT
aiua-6844	196	10	et	et	PROPN
aiua-6844	196	11	al	al	PROPN
aiua-6844	196	12	.	.	PROPN
aiua-6844	196	13	green	green	PROPN
aiua-6844	196	14	and	and	CCONJ
aiua-6844	196	15	black	black	ADJ
aiua-6844	196	16	tea	tea	NOUN
aiua-6844	196	17	intake	intake	NOUN
aiua-6844	196	18	in	in	ADP
aiua-6844	196	19	relation	relation	NOUN
aiua-6844	196	20	to	to	ADP
aiua-6844	196	21	prostate	prostate	NOUN
aiua-6844	196	22	cancer	cancer	NOUN
aiua-6844	196	23	risk	risk	NOUN
aiua-6844	196	24	among	among	ADP
aiua-6844	196	25	singapore	singapore	PROPN
aiua-6844	196	26	chinese	chinese	PROPN
aiua-6844	196	27	.	.	PUNCT
aiua-6844	197	1	cancer	cancer	NOUN
aiua-6844	197	2	causes	cause	VERB
aiua-6844	197	3	control	control	NOUN
aiua-6844	197	4	.	.	PUNCT
aiua-6844	198	1	2012	2012	NUM
aiua-6844	198	2	;	;	PUNCT
aiua-6844	198	3	23:1635	23:1635	PROPN
aiua-6844	198	4	-	-	SYM
aiua-6844	198	5	41	41	NUM
aiua-6844	198	6	.	.	PUNCT
aiua-6844	199	1	22	22	NUM
aiua-6844	199	2	.	.	PUNCT
aiua-6844	200	1	kikuchi	kikuchi	PROPN
aiua-6844	200	2	n	n	CCONJ
aiua-6844	200	3	,	,	PUNCT
aiua-6844	200	4	ohmori	ohmori	PROPN
aiua-6844	200	5	k	k	PROPN
aiua-6844	200	6	,	,	PUNCT
aiua-6844	200	7	shimazu	shimazu	PROPN
aiua-6844	200	8	t	t	PROPN
aiua-6844	200	9	,	,	PUNCT
aiua-6844	200	10	et	et	PROPN
aiua-6844	200	11	al	al	PROPN
aiua-6844	200	12	.	.	PUNCT
aiua-6844	201	1	no	no	DET
aiua-6844	201	2	association	association	NOUN
aiua-6844	201	3	between	between	ADP
aiua-6844	201	4	201archivio	201archivio	PROPN
aiua-6844	201	5	italiano	italiano	NOUN
aiua-6844	201	6	di	di	X
aiua-6844	201	7	urologia	urologia	PROPN
aiua-6844	201	8	e	e	PROPN
aiua-6844	201	9	andrologia	andrologia	NOUN
aiua-6844	201	10	2017	2017	NUM
aiua-6844	201	11	;	;	PUNCT
aiua-6844	201	12	89	89	NUM
aiua-6844	201	13	,	,	PUNCT
aiua-6844	201	14	3	3	NUM
aiua-6844	201	15	green	green	ADJ
aiua-6844	201	16	tea	tea	NOUN
aiua-6844	201	17	catechins	catechin	NOUN
aiua-6844	201	18	in	in	ADP
aiua-6844	201	19	hg	hg	ADJ
aiua-6844	201	20	-	-	ADJ
aiua-6844	201	21	pin	pin	ADJ
aiua-6844	201	22	patients	patient	NOUN
aiua-6844	201	23	micali_stesura	micali_stesura	PROPN
aiua-6844	201	24	seveso	seveso	VERB
aiua-6844	201	25	28/09/17	28/09/17	PROPN
aiua-6844	201	26	10:18	10:18	NUM
aiua-6844	201	27	pagina	pagina	NOUN
aiua-6844	201	28	201	201	NUM
aiua-6844	201	29	archivio	archivio	NOUN
aiua-6844	201	30	italiano	italiano	X
aiua-6844	201	31	di	di	X
aiua-6844	201	32	urologia	urologia	PROPN
aiua-6844	201	33	e	e	PROPN
aiua-6844	201	34	andrologia	andrologia	NOUN
aiua-6844	201	35	2017	2017	NUM
aiua-6844	201	36	;	;	PUNCT
aiua-6844	201	37	89	89	NUM
aiua-6844	201	38	,	,	PUNCT
aiua-6844	201	39	3	3	NUM
aiua-6844	201	40	s.	s.	PROPN
aiua-6844	201	41	micali	micali	PROPN
aiua-6844	201	42	,	,	PUNCT
aiua-6844	201	43	a.	a.	NOUN
aiua-6844	201	44	territo	territo	PROPN
aiua-6844	201	45	,	,	PUNCT
aiua-6844	201	46	g.m	g.m	PROPN
aiua-6844	201	47	.	.	PROPN
aiua-6844	201	48	pirola	pirola	PROPN
aiua-6844	201	49	,	,	PUNCT
aiua-6844	201	50	n.	n.	PROPN
aiua-6844	201	51	ferrari	ferrari	PROPN
aiua-6844	201	52	,	,	PUNCT
aiua-6844	201	53	m.c	m.c	PROPN
aiua-6844	201	54	.	.	PROPN
aiua-6844	201	55	sighinolfi	sighinolfi	PROPN
aiua-6844	201	56	,	,	PUNCT
aiua-6844	201	57	e.	e.	PROPN
aiua-6844	201	58	martorana	martorana	PROPN
aiua-6844	201	59	,	,	PUNCT
aiua-6844	201	60	m.	m.	NOUN
aiua-6844	201	61	navarra	navarra	PROPN
aiua-6844	201	62	,	,	PUNCT
aiua-6844	201	63	g.	g.	PROPN
aiua-6844	201	64	bianchi	bianchi	PROPN
aiua-6844	201	65	202	202	NUM
aiua-6844	201	66	green	green	ADJ
aiua-6844	201	67	tea	tea	NOUN
aiua-6844	201	68	and	and	CCONJ
aiua-6844	201	69	prostate	prostate	NOUN
aiua-6844	201	70	cancer	cancer	NOUN
aiua-6844	201	71	risk	risk	NOUN
aiua-6844	201	72	in	in	ADP
aiua-6844	201	73	japanese	japanese	ADJ
aiua-6844	201	74	men	man	NOUN
aiua-6844	201	75	:	:	PUNCT
aiua-6844	201	76	the	the	DET
aiua-6844	201	77	ohsaki	ohsaki	NOUN
aiua-6844	201	78	cohort	cohort	NOUN
aiua-6844	201	79	study	study	NOUN
aiua-6844	201	80	.	.	PUNCT
aiua-6844	202	1	br	br	PROPN
aiua-6844	202	2	j	j	PROPN
aiua-6844	202	3	cancer	cancer	NOUN
aiua-6844	202	4	.	.	PUNCT
aiua-6844	203	1	2006	2006	NUM
aiua-6844	203	2	;	;	PUNCT
aiua-6844	203	3	95:371	95:371	NUM
aiua-6844	203	4	-	-	SYM
aiua-6844	203	5	373	373	NUM
aiua-6844	203	6	.	.	PUNCT
aiua-6844	204	1	23	23	NUM
aiua-6844	204	2	.	.	PUNCT
aiua-6844	205	1	jian	jian	PROPN
aiua-6844	205	2	l	l	PROPN
aiua-6844	205	3	,	,	PUNCT
aiua-6844	205	4	xie	xie	PROPN
aiua-6844	205	5	lp	lp	PROPN
aiua-6844	205	6	,	,	PUNCT
aiua-6844	205	7	lee	lee	PROPN
aiua-6844	205	8	ah	ah	INTJ
aiua-6844	205	9	,	,	PUNCT
aiua-6844	205	10	binns	binns	PROPN
aiua-6844	205	11	cw	cw	NOUN
aiua-6844	205	12	.	.	PROPN
aiua-6844	205	13	protective	protective	ADJ
aiua-6844	205	14	effect	effect	NOUN
aiua-6844	205	15	of	of	ADP
aiua-6844	205	16	green	green	ADJ
aiua-6844	205	17	tea	tea	NOUN
aiua-6844	205	18	against	against	ADP
aiua-6844	205	19	prostate	prostate	NOUN
aiua-6844	205	20	cancer	cancer	NOUN
aiua-6844	205	21	:	:	PUNCT
aiua-6844	205	22	a	a	DET
aiua-6844	205	23	case	case	NOUN
aiua-6844	205	24	-	-	PUNCT
aiua-6844	205	25	control	control	NOUN
aiua-6844	205	26	study	study	NOUN
aiua-6844	205	27	in	in	ADP
aiua-6844	205	28	southeast	southeast	PROPN
aiua-6844	205	29	china	china	PROPN
aiua-6844	205	30	.	.	PUNCT
aiua-6844	206	1	int	int	PROPN
aiua-6844	206	2	j	j	PROPN
aiua-6844	206	3	cancer	cancer	NOUN
aiua-6844	206	4	.	.	PUNCT
aiua-6844	207	1	2004	2004	NUM
aiua-6844	207	2	;	;	PUNCT
aiua-6844	207	3	108:130	108:130	NOUN
aiua-6844	207	4	-	-	SYM
aiua-6844	207	5	135	135	NUM
aiua-6844	207	6	.	.	PUNCT
aiua-6844	207	7	24	24	NUM
aiua-6844	207	8	.	.	PUNCT
aiua-6844	208	1	sonoda	sonoda	PROPN
aiua-6844	208	2	t	t	PROPN
aiua-6844	208	3	,	,	PUNCT
aiua-6844	208	4	nagata	nagata	PROPN
aiua-6844	208	5	y	y	PROPN
aiua-6844	208	6	,	,	PUNCT
aiua-6844	208	7	mori	mori	PROPN
aiua-6844	208	8	m	m	PROPN
aiua-6844	208	9	,	,	PUNCT
aiua-6844	208	10	et	et	PROPN
aiua-6844	208	11	al	al	PROPN
aiua-6844	208	12	.	.	PUNCT
aiua-6844	209	1	a	a	DET
aiua-6844	209	2	case	case	NOUN
aiua-6844	209	3	-	-	PUNCT
aiua-6844	209	4	control	control	NOUN
aiua-6844	209	5	study	study	NOUN
aiua-6844	209	6	of	of	ADP
aiua-6844	209	7	diet	diet	NOUN
aiua-6844	209	8	and	and	CCONJ
aiua-6844	209	9	prostate	prostate	NOUN
aiua-6844	209	10	cancer	cancer	NOUN
aiua-6844	209	11	in	in	ADP
aiua-6844	209	12	japan	japan	PROPN
aiua-6844	209	13	:	:	PUNCT
aiua-6844	209	14	possible	possible	ADJ
aiua-6844	209	15	protective	protective	ADJ
aiua-6844	209	16	effect	effect	NOUN
aiua-6844	209	17	of	of	ADP
aiua-6844	209	18	traditional	traditional	ADJ
aiua-6844	209	19	japanese	japanese	ADJ
aiua-6844	209	20	diet	diet	NOUN
aiua-6844	209	21	.	.	PUNCT
aiua-6844	210	1	cancer	cancer	PROPN
aiua-6844	210	2	sci	sci	PROPN
aiua-6844	210	3	.	.	PROPN
aiua-6844	210	4	2004	2004	NUM
aiua-6844	210	5	;	;	PUNCT
aiua-6844	210	6	95:238	95:238	NUM
aiua-6844	210	7	-	-	SYM
aiua-6844	210	8	42	42	NUM
aiua-6844	210	9	.	.	PUNCT
aiua-6844	211	1	25	25	NUM
aiua-6844	211	2	.	.	PUNCT
aiua-6844	212	1	nguyen	nguyen	PROPN
aiua-6844	212	2	mm	mm	PROPN
aiua-6844	212	3	,	,	PUNCT
aiua-6844	212	4	ahmann	ahmann	PROPN
aiua-6844	212	5	fr	fr	PROPN
aiua-6844	212	6	,	,	PUNCT
aiua-6844	212	7	nagle	nagle	PROPN
aiua-6844	212	8	rb	rb	PROPN
aiua-6844	212	9	,	,	PUNCT
aiua-6844	212	10	et	et	PROPN
aiua-6844	212	11	al	al	PROPN
aiua-6844	212	12	.	.	PROPN
aiua-6844	212	13	randomized	randomize	VERB
aiua-6844	212	14	,	,	PUNCT
aiua-6844	212	15	double	double	ADJ
aiua-6844	212	16	bind	bind	NOUN
aiua-6844	212	17	,	,	PUNCT
aiua-6844	212	18	placebo	placebo	NOUN
aiua-6844	212	19	controlled	control	VERB
aiua-6844	212	20	trial	trial	NOUN
aiua-6844	212	21	of	of	ADP
aiua-6844	212	22	polyphenon	polyphenon	NOUN
aiua-6844	212	23	e	e	PROPN
aiua-6844	212	24	in	in	ADP
aiua-6844	212	25	prostate	prostate	NOUN
aiua-6844	212	26	cancer	cancer	NOUN
aiua-6844	212	27	patients	patient	NOUN
aiua-6844	212	28	before	before	ADP
aiua-6844	212	29	prostatectomy	prostatectomy	ADV
aiua-6844	212	30	:	:	PUNCT
aiua-6844	212	31	evaluation	evaluation	NOUN
aiua-6844	212	32	of	of	ADP
aiua-6844	212	33	potential	potential	ADJ
aiua-6844	212	34	chemopreventive	chemopreventive	ADJ
aiua-6844	212	35	activities	activity	NOUN
aiua-6844	212	36	.	.	PUNCT
aiua-6844	213	1	cancer	cancer	NOUN
aiua-6844	213	2	prev	prev	X
aiua-6844	213	3	res	re	NOUN
aiua-6844	213	4	.	.	PUNCT
aiua-6844	213	5	2012	2012	NUM
aiua-6844	213	6	;	;	PUNCT
aiua-6844	214	1	5:190	5:190	NUM
aiua-6844	214	2	-	-	SYM
aiua-6844	214	3	298	298	NUM
aiua-6844	214	4	.	.	NOUN
aiua-6844	214	5	26	26	NUM
aiua-6844	214	6	.	.	PUNCT
aiua-6844	215	1	jatoi	jatoi	PROPN
aiua-6844	215	2	a	a	PROPN
aiua-6844	215	3	,	,	PUNCT
aiua-6844	215	4	ellison	ellison	PROPN
aiua-6844	215	5	n	n	PRON
aiua-6844	215	6	,	,	PUNCT
aiua-6844	215	7	burch	burch	PROPN
aiua-6844	215	8	pa	pa	PROPN
aiua-6844	215	9	,	,	PUNCT
aiua-6844	215	10	et	et	PROPN
aiua-6844	215	11	al	al	PROPN
aiua-6844	215	12	.	.	PUNCT
aiua-6844	216	1	a	a	DET
aiua-6844	216	2	phase	phase	NOUN
aiua-6844	216	3	ii	ii	NOUN
aiua-6844	216	4	trial	trial	NOUN
aiua-6844	216	5	of	of	ADP
aiua-6844	216	6	green	green	ADJ
aiua-6844	216	7	tea	tea	NOUN
aiua-6844	216	8	in	in	ADP
aiua-6844	216	9	the	the	DET
aiua-6844	216	10	treatment	treatment	NOUN
aiua-6844	216	11	of	of	ADP
aiua-6844	216	12	patiens	patien	NOUN
aiua-6844	216	13	with	with	ADP
aiua-6844	216	14	androgen	androgen	NOUN
aiua-6844	216	15	independent	independent	ADJ
aiua-6844	216	16	metastatic	metastatic	ADJ
aiua-6844	216	17	prostate	prostate	NOUN
aiua-6844	216	18	carcinoma	carcinoma	NOUN
aiua-6844	216	19	.	.	PUNCT
aiua-6844	217	1	cancer	cancer	NOUN
aiua-6844	217	2	.	.	PUNCT
aiua-6844	218	1	2003	2003	NUM
aiua-6844	218	2	;	;	PUNCT
aiua-6844	218	3	97:1142	97:1142	NUM
aiua-6844	218	4	-	-	SYM
aiua-6844	218	5	6	6	NUM
aiua-6844	218	6	.	.	NOUN
aiua-6844	218	7	27	27	NUM
aiua-6844	218	8	.	.	PUNCT
aiua-6844	219	1	choan	choan	NOUN
aiua-6844	219	2	e	e	NOUN
aiua-6844	219	3	,	,	PUNCT
aiua-6844	219	4	segal	segal	PROPN
aiua-6844	219	5	r	r	PROPN
aiua-6844	219	6	,	,	PUNCT
aiua-6844	219	7	jonker	jonker	PROPN
aiua-6844	219	8	d	d	PROPN
aiua-6844	219	9	,	,	PUNCT
aiua-6844	219	10	et	et	PROPN
aiua-6844	219	11	al	al	PROPN
aiua-6844	219	12	.	.	PUNCT
aiua-6844	220	1	a	a	DET
aiua-6844	220	2	prospective	prospective	ADJ
aiua-6844	220	3	clinical	clinical	ADJ
aiua-6844	220	4	trial	trial	NOUN
aiua-6844	220	5	of	of	ADP
aiua-6844	220	6	green	green	ADJ
aiua-6844	220	7	tea	tea	NOUN
aiua-6844	220	8	for	for	ADP
aiua-6844	220	9	hormone	hormone	NOUN
aiua-6844	220	10	refractory	refractory	NOUN
aiua-6844	220	11	prostate	prostate	NOUN
aiua-6844	220	12	cancer	cancer	NOUN
aiua-6844	220	13	:	:	PUNCT
aiua-6844	220	14	an	an	DET
aiua-6844	220	15	evaluation	evaluation	NOUN
aiua-6844	220	16	of	of	ADP
aiua-6844	220	17	the	the	DET
aiua-6844	220	18	complementary	complementary	ADJ
aiua-6844	220	19	/	/	SYM
aiua-6844	220	20	alternative	alternative	NOUN
aiua-6844	220	21	therapy	therapy	NOUN
aiua-6844	220	22	approach	approach	NOUN
aiua-6844	220	23	.	.	PUNCT
aiua-6844	221	1	urol	urol	PROPN
aiua-6844	221	2	oncol	oncol	PROPN
aiua-6844	221	3	.	.	PUNCT
aiua-6844	222	1	2005	2005	NUM
aiua-6844	222	2	;	;	PUNCT
aiua-6844	222	3	23:108	23:108	NUM
aiua-6844	222	4	-	-	SYM
aiua-6844	222	5	113	113	NUM
aiua-6844	222	6	.	.	PUNCT
aiua-6844	223	1	28	28	NUM
aiua-6844	223	2	.	.	X
aiua-6844	224	1	yli	yli	NOUN
aiua-6844	224	2	-	-	NOUN
aiua-6844	224	3	hemminki	hemminki	PROPN
aiua-6844	224	4	th	th	NOUN
aiua-6844	224	5	,	,	PUNCT
aiua-6844	224	6	laurila	laurila	PROPN
aiua-6844	224	7	m	m	PROPN
aiua-6844	224	8	,	,	PUNCT
aiua-6844	224	9	auvinen	auvinen	PROPN
aiua-6844	224	10	a	a	PROPN
aiua-6844	224	11	,	,	PUNCT
aiua-6844	224	12	et	et	PROPN
aiua-6844	224	13	al	al	PROPN
aiua-6844	224	14	.	.	PROPN
aiua-6844	224	15	histological	histological	ADJ
aiua-6844	224	16	inflammation	inflammation	NOUN
aiua-6844	224	17	and	and	CCONJ
aiua-6844	224	18	risk	risk	NOUN
aiua-6844	224	19	of	of	ADP
aiua-6844	224	20	subsequent	subsequent	ADJ
aiua-6844	224	21	prostate	prostate	NOUN
aiua-6844	224	22	cancer	cancer	NOUN
aiua-6844	224	23	among	among	ADP
aiua-6844	224	24	men	man	NOUN
aiua-6844	224	25	with	with	ADP
aiua-6844	224	26	initially	initially	ADV
aiua-6844	224	27	elevated	elevate	VERB
aiua-6844	224	28	serum	serum	NOUN
aiua-6844	224	29	prostate	prostate	NOUN
aiua-6844	224	30	-	-	PUNCT
aiua-6844	224	31	specific	specific	ADJ
aiua-6844	224	32	antigen	antigen	NOUN
aiua-6844	224	33	(	(	PUNCT
aiua-6844	224	34	psa	psa	NOUN
aiua-6844	224	35	)	)	PUNCT
aiua-6844	224	36	concentration	concentration	NOUN
aiua-6844	224	37	in	in	ADP
aiua-6844	224	38	the	the	DET
aiua-6844	224	39	finnish	finnish	ADJ
aiua-6844	224	40	prostate	prostate	NOUN
aiua-6844	224	41	cancer	cancer	NOUN
aiua-6844	224	42	screening	screen	VERB
aiua-6844	224	43	trial	trial	NOUN
aiua-6844	224	44	.	.	PUNCT
aiua-6844	225	1	bju	bju	NOUN
aiua-6844	225	2	int	int	PROPN
aiua-6844	225	3	.	.	PUNCT
aiua-6844	226	1	2013	2013	NUM
aiua-6844	226	2	;	;	PUNCT
aiua-6844	226	3	112:735	112:735	NUM
aiua-6844	226	4	-	-	PUNCT
aiua-6844	226	5	41	41	NUM
aiua-6844	226	6	.	.	PUNCT
aiua-6844	226	7	29	29	NUM
aiua-6844	226	8	.	.	PUNCT
aiua-6844	227	1	lambert	lambert	PROPN
aiua-6844	227	2	jd	jd	PROPN
aiua-6844	227	3	,	,	PUNCT
aiua-6844	227	4	elias	elias	PROPN
aiua-6844	227	5	rj	rj	PROPN
aiua-6844	227	6	.	.	PUNCT
aiua-6844	228	1	the	the	DET
aiua-6844	228	2	antioxidant	antioxidant	ADJ
aiua-6844	228	3	and	and	CCONJ
aiua-6844	228	4	pro	pro	ADJ
aiua-6844	228	5	-	-	ADJ
aiua-6844	228	6	oxidant	oxidant	ADJ
aiua-6844	228	7	activities	activity	NOUN
aiua-6844	228	8	of	of	ADP
aiua-6844	228	9	green	green	ADJ
aiua-6844	228	10	tea	tea	NOUN
aiua-6844	228	11	polyphenols	polyphenol	NOUN
aiua-6844	228	12	:	:	PUNCT
aiua-6844	228	13	a	a	DET
aiua-6844	228	14	role	role	NOUN
aiua-6844	228	15	in	in	ADP
aiua-6844	228	16	cancer	cancer	NOUN
aiua-6844	228	17	prevention	prevention	NOUN
aiua-6844	228	18	.	.	PUNCT
aiua-6844	229	1	arch	arch	PROPN
aiua-6844	229	2	biochem	biochem	PROPN
aiua-6844	229	3	biophys	biophy	NOUN
aiua-6844	229	4	.	.	PUNCT
aiua-6844	230	1	2010	2010	NUM
aiua-6844	230	2	;	;	PUNCT
aiua-6844	230	3	501:65	501:65	NUM
aiua-6844	230	4	-	-	SYM
aiua-6844	230	5	72	72	NUM
aiua-6844	230	6	.	.	PUNCT
aiua-6844	231	1	30	30	NUM
aiua-6844	231	2	.	.	PUNCT
aiua-6844	232	1	mukherjee	mukherjee	PROPN
aiua-6844	232	2	s	s	PROPN
aiua-6844	232	3	,	,	PUNCT
aiua-6844	232	4	siddiqui	siddiqui	PROPN
aiua-6844	232	5	ma	ma	PROPN
aiua-6844	232	6	,	,	PUNCT
aiua-6844	232	7	dayal	dayal	PROPN
aiua-6844	232	8	s	s	PROPN
aiua-6844	232	9	,	,	PUNCT
aiua-6844	232	10	et	et	PROPN
aiua-6844	232	11	al	al	PROPN
aiua-6844	232	12	.	.	PUNCT
aiua-6844	233	1	epigallocatechin-3gallate	epigallocatechin-3gallate	PROPN
aiua-6844	233	2	suppresses	suppress	VERB
aiua-6844	233	3	proinflammatory	proinflammatory	ADJ
aiua-6844	233	4	cytokines	cytokine	NOUN
aiua-6844	233	5	and	and	CCONJ
aiua-6844	233	6	chemokines	chemokine	NOUN
aiua-6844	233	7	induced	induce	VERB
aiua-6844	233	8	by	by	ADP
aiua-6844	233	9	toll	toll	NOUN
aiua-6844	233	10	-	-	PUNCT
aiua-6844	233	11	like	like	ADJ
aiua-6844	233	12	receptor	receptor	NOUN
aiua-6844	233	13	9	9	NUM
aiua-6844	233	14	agonists	agonist	NOUN
aiua-6844	233	15	in	in	ADP
aiua-6844	233	16	prostate	prostate	NOUN
aiua-6844	233	17	cancer	cancer	NOUN
aiua-6844	233	18	cells	cell	NOUN
aiua-6844	233	19	.	.	PUNCT
aiua-6844	234	1	j	j	PROPN
aiua-6844	234	2	inflamm	inflamm	PROPN
aiua-6844	234	3	res	res	PROPN
aiua-6844	234	4	.	.	PUNCT
aiua-6844	234	5	2014	2014	NUM
aiua-6844	234	6	;	;	PUNCT
aiua-6844	234	7	7:89	7:89	NUM
aiua-6844	234	8	-	-	SYM
aiua-6844	234	9	101	101	NUM
aiua-6844	234	10	.	.	PUNCT
aiua-6844	235	1	31	31	NUM
aiua-6844	235	2	.	.	PUNCT
aiua-6844	236	1	henning	henning	PROPN
aiua-6844	236	2	sm	sm	PROPN
aiua-6844	236	3	,	,	PUNCT
aiua-6844	236	4	wang	wang	PROPN
aiua-6844	236	5	p	p	PROPN
aiua-6844	236	6	,	,	PUNCT
aiua-6844	236	7	said	say	VERB
aiua-6844	236	8	jw	jw	PROPN
aiua-6844	236	9	,	,	PUNCT
aiua-6844	236	10	et	et	PROPN
aiua-6844	236	11	al	al	PROPN
aiua-6844	236	12	.	.	PROPN
aiua-6844	236	13	randomized	randomize	VERB
aiua-6844	236	14	clinical	clinical	ADJ
aiua-6844	236	15	trial	trial	NOUN
aiua-6844	236	16	of	of	ADP
aiua-6844	236	17	brewed	brew	VERB
aiua-6844	236	18	green	green	ADJ
aiua-6844	236	19	and	and	CCONJ
aiua-6844	236	20	black	black	ADJ
aiua-6844	236	21	tea	tea	NOUN
aiua-6844	236	22	in	in	ADP
aiua-6844	236	23	men	man	NOUN
aiua-6844	236	24	with	with	ADP
aiua-6844	236	25	prostate	prostate	NOUN
aiua-6844	236	26	cancer	cancer	NOUN
aiua-6844	236	27	prior	prior	ADV
aiua-6844	236	28	to	to	ADP
aiua-6844	236	29	prostatectomy	prostatectomy	NOUN
aiua-6844	236	30	.	.	PUNCT
aiua-6844	237	1	the	the	DET
aiua-6844	237	2	prostate	prostate	NOUN
aiua-6844	237	3	.	.	PUNCT
aiua-6844	237	4	2015	2015	NUM
aiua-6844	237	5	;	;	PUNCT
aiua-6844	237	6	75:550	75:550	NUM
aiua-6844	237	7	-	-	SYM
aiua-6844	237	8	559	559	NUM
aiua-6844	237	9	.	.	PUNCT
aiua-6844	237	10	32	32	NUM
aiua-6844	237	11	.	.	PUNCT
aiua-6844	238	1	marberger	marberger	PROPN
aiua-6844	238	2	m.	m.	PROPN
aiua-6844	238	3	medical	medical	PROPN
aiua-6844	238	4	management	management	NOUN
aiua-6844	238	5	of	of	ADP
aiua-6844	238	6	lower	low	ADJ
aiua-6844	238	7	urinary	urinary	ADJ
aiua-6844	238	8	tract	tract	NOUN
aiua-6844	238	9	symptoms	symptom	NOUN
aiua-6844	238	10	in	in	ADP
aiua-6844	238	11	men	man	NOUN
aiua-6844	238	12	with	with	ADP
aiua-6844	238	13	benign	benign	ADJ
aiua-6844	238	14	prostatic	prostatic	ADJ
aiua-6844	238	15	enlargement	enlargement	NOUN
aiua-6844	238	16	.	.	PUNCT
aiua-6844	239	1	adv	adv	INTJ
aiua-6844	239	2	ther	ther	ADV
aiua-6844	239	3	.	.	PUNCT
aiua-6844	240	1	2013	2013	NUM
aiua-6844	240	2	;	;	PUNCT
aiua-6844	240	3	30:309	30:309	NUM
aiua-6844	240	4	-	-	SYM
aiua-6844	240	5	19	19	NUM
aiua-6844	240	6	.	.	NOUN
aiua-6844	240	7	33	33	NUM
aiua-6844	240	8	.	.	PUNCT
aiua-6844	241	1	ferlazzo	ferlazzo	PROPN
aiua-6844	241	2	n	n	CCONJ
aiua-6844	241	3	,	,	PUNCT
aiua-6844	241	4	cirmi	cirmi	VERB
aiua-6844	241	5	s	s	PART
aiua-6844	241	6	,	,	PUNCT
aiua-6844	241	7	calapai	calapai	PROPN
aiua-6844	241	8	g	g	PROPN
aiua-6844	241	9	,	,	PUNCT
aiua-6844	241	10	et	et	PROPN
aiua-6844	241	11	al	al	PROPN
aiua-6844	241	12	.	.	PUNCT
aiua-6844	242	1	anti	anti	ADJ
aiua-6844	242	2	-	-	ADJ
aiua-6844	242	3	inflammatory	inflammatory	ADJ
aiua-6844	242	4	activity	activity	NOUN
aiua-6844	242	5	of	of	ADP
aiua-6844	242	6	citrus	citrus	NOUN
aiua-6844	242	7	bergamia	bergamia	NOUN
aiua-6844	242	8	derivatives	derivative	NOUN
aiua-6844	242	9	:	:	PUNCT
aiua-6844	242	10	where	where	SCONJ
aiua-6844	242	11	do	do	AUX
aiua-6844	242	12	we	we	PRON
aiua-6844	242	13	stand	stand	VERB
aiua-6844	242	14	?	?	PUNCT
aiua-6844	243	1	molecules	molecule	NOUN
aiua-6844	243	2	.	.	PUNCT
aiua-6844	244	1	2016	2016	NUM
aiua-6844	244	2	;	;	PUNCT
aiua-6844	244	3	21:1273	21:1273	NUM
aiua-6844	244	4	.	.	PROPN
aiua-6844	245	1	34	34	NUM
aiua-6844	245	2	.	.	PUNCT
aiua-6844	246	1	ferlazzo	ferlazzo	PROPN
aiua-6844	246	2	n	n	CCONJ
aiua-6844	246	3	,	,	PUNCT
aiua-6844	246	4	visalli	visalli	PROPN
aiua-6844	246	5	g	g	PROPN
aiua-6844	246	6	,	,	PUNCT
aiua-6844	246	7	cirmi	cirmi	VERB
aiua-6844	246	8	s	s	PART
aiua-6844	246	9	,	,	PUNCT
aiua-6844	246	10	et	et	PROPN
aiua-6844	246	11	al	al	PROPN
aiua-6844	246	12	.	.	PROPN
aiua-6844	246	13	natural	natural	ADJ
aiua-6844	246	14	iron	iron	NOUN
aiua-6844	246	15	chelators	chelator	NOUN
aiua-6844	246	16	:	:	PUNCT
aiua-6844	246	17	protective	protective	ADJ
aiua-6844	246	18	role	role	NOUN
aiua-6844	246	19	in	in	ADP
aiua-6844	246	20	a549	a549	PROPN
aiua-6844	246	21	cells	cell	NOUN
aiua-6844	246	22	of	of	ADP
aiua-6844	246	23	flavonoids	flavonoid	NOUN
aiua-6844	246	24	-	-	PUNCT
aiua-6844	246	25	rich	rich	ADJ
aiua-6844	246	26	extracts	extract	NOUN
aiua-6844	246	27	of	of	ADP
aiua-6844	246	28	citrus	citrus	NOUN
aiua-6844	246	29	juices	juice	NOUN
aiua-6844	246	30	in	in	ADP
aiua-6844	246	31	fe(3+)-induced	fe(3+)-induce	VERB
aiua-6844	246	32	oxidative	oxidative	ADJ
aiua-6844	246	33	stress	stress	NOUN
aiua-6844	246	34	.	.	PUNCT
aiua-6844	247	1	environ	environ	PROPN
aiua-6844	247	2	toxicol	toxicol	PROPN
aiua-6844	247	3	pharmacol	pharmacol	PROPN
aiua-6844	247	4	.	.	PROPN
aiua-6844	248	1	2016	2016	NUM
aiua-6844	248	2	;	;	PUNCT
aiua-6844	248	3	43:248	43:248	NUM
aiua-6844	248	4	-	-	SYM
aiua-6844	248	5	56	56	NUM
aiua-6844	248	6	.	.	NOUN
aiua-6844	248	7	35	35	NUM
aiua-6844	248	8	.	.	PUNCT
aiua-6844	249	1	currò	currò	PROPN
aiua-6844	249	2	m	m	PROPN
aiua-6844	249	3	,	,	PUNCT
aiua-6844	249	4	risitano	risitano	PROPN
aiua-6844	249	5	r	r	NOUN
aiua-6844	249	6	,	,	PUNCT
aiua-6844	249	7	ferlazzo	ferlazzo	PROPN
aiua-6844	249	8	n	n	CCONJ
aiua-6844	249	9	,	,	PUNCT
aiua-6844	249	10	et	et	PROPN
aiua-6844	249	11	al	al	PROPN
aiua-6844	249	12	.	.	PROPN
aiua-6844	249	13	citrus	citrus	PROPN
aiua-6844	249	14	bergamia	bergamia	PROPN
aiua-6844	249	15	juice	juice	PROPN
aiua-6844	249	16	extract	extract	NOUN
aiua-6844	249	17	attenuates	attenuate	VERB
aiua-6844	249	18	β	β	NOUN
aiua-6844	249	19	-	-	NOUN
aiua-6844	249	20	amyloid	amyloid	NOUN
aiua-6844	249	21	-	-	PUNCT
aiua-6844	249	22	induced	induce	VERB
aiua-6844	249	23	pro	pro	ADJ
aiua-6844	249	24	-	-	ADJ
aiua-6844	249	25	inflammatory	inflammatory	ADJ
aiua-6844	249	26	activation	activation	NOUN
aiua-6844	249	27	of	of	ADP
aiua-6844	249	28	thp-1	thp-1	PUNCT
aiua-6844	249	29	cells	cell	NOUN
aiua-6844	249	30	through	through	ADP
aiua-6844	249	31	mapk	mapk	NOUN
aiua-6844	249	32	and	and	CCONJ
aiua-6844	249	33	ap-1	ap-1	ADV
aiua-6844	249	34	pathways	pathway	NOUN
aiua-6844	249	35	.	.	PUNCT
aiua-6844	250	1	sci	sci	PROPN
aiua-6844	250	2	rep	rep	PROPN
aiua-6844	250	3	.	.	PROPN
aiua-6844	250	4	2016	2016	NUM
aiua-6844	250	5	;	;	PUNCT
aiua-6844	250	6	6:20809	6:20809	X
aiua-6844	250	7	.	.	X
aiua-6844	251	1	36	36	NUM
aiua-6844	251	2	.	.	PUNCT
aiua-6844	251	3	cirmi	cirmi	PROPN
aiua-6844	251	4	s	s	PART
aiua-6844	251	5	,	,	PUNCT
aiua-6844	251	6	ferlazzo	ferlazzo	PROPN
aiua-6844	251	7	n	n	CCONJ
aiua-6844	251	8	,	,	PUNCT
aiua-6844	251	9	lombardo	lombardo	PROPN
aiua-6844	251	10	ge	ge	PROPN
aiua-6844	251	11	,	,	PUNCT
aiua-6844	251	12	et	et	PROPN
aiua-6844	252	1	al	al	PROPN
aiua-6844	252	2	.	.	PROPN
aiua-6844	252	3	chemopreventive	chemopreventive	ADJ
aiua-6844	252	4	agents	agent	NOUN
aiua-6844	252	5	and	and	CCONJ
aiua-6844	252	6	inhibitors	inhibitor	NOUN
aiua-6844	252	7	of	of	ADP
aiua-6844	252	8	cancer	cancer	NOUN
aiua-6844	252	9	hallmarks	hallmark	NOUN
aiua-6844	252	10	:	:	PUNCT
aiua-6844	252	11	may	may	AUX
aiua-6844	252	12	citrus	citrus	VERB
aiua-6844	252	13	offer	offer	VERB
aiua-6844	252	14	new	new	ADJ
aiua-6844	252	15	perspectives	perspective	NOUN
aiua-6844	252	16	?	?	PUNCT
aiua-6844	253	1	nutrients	nutrient	NOUN
aiua-6844	253	2	.	.	PUNCT
aiua-6844	254	1	2016	2016	NUM
aiua-6844	254	2	;	;	PUNCT
aiua-6844	254	3	8:698	8:698	NUM
aiua-6844	254	4	.	.	PUNCT
aiua-6844	255	1	37	37	NUM
aiua-6844	255	2	.	.	PUNCT
aiua-6844	255	3	cirmi	cirmi	PROPN
aiua-6844	255	4	s	s	PART
aiua-6844	255	5	,	,	PUNCT
aiua-6844	255	6	ferlazzo	ferlazzo	PROPN
aiua-6844	255	7	n	n	CCONJ
aiua-6844	255	8	,	,	PUNCT
aiua-6844	255	9	lombardo	lombardo	PROPN
aiua-6844	255	10	ge	ge	PROPN
aiua-6844	255	11	,	,	PUNCT
aiua-6844	255	12	et	et	PROPN
aiua-6844	255	13	al	al	PROPN
aiua-6844	255	14	.	.	PROPN
aiua-6844	255	15	neurodegenerative	neurodegenerative	ADJ
aiua-6844	255	16	diseases	disease	NOUN
aiua-6844	255	17	:	:	PUNCT
aiua-6844	255	18	might	might	AUX
aiua-6844	255	19	citrus	citrus	VERB
aiua-6844	255	20	flavonoids	flavonoid	NOUN
aiua-6844	255	21	play	play	VERB
aiua-6844	255	22	a	a	DET
aiua-6844	255	23	protective	protective	ADJ
aiua-6844	255	24	role	role	NOUN
aiua-6844	255	25	?	?	PUNCT
aiua-6844	256	1	molecules	molecule	NOUN
aiua-6844	256	2	.	.	PUNCT
aiua-6844	257	1	2016	2016	NUM
aiua-6844	257	2	;	;	PUNCT
aiua-6844	257	3	21:1312	21:1312	NUM
aiua-6844	257	4	.	.	PUNCT
aiua-6844	257	5	correspondence	correspondence	NOUN
aiua-6844	257	6	salvatore	salvatore	PROPN
aiua-6844	257	7	micali	micali	PROPN
aiua-6844	257	8	,	,	PUNCT
aiua-6844	257	9	md	md	PROPN
aiua-6844	257	10	salvatore.micali@unimore.it	salvatore.micali@unimore.it	PROPN
aiua-6844	257	11	territo	territo	PROPN
aiua-6844	257	12	angelo	angelo	PROPN
aiua-6844	257	13	,	,	PUNCT
aiua-6844	257	14	md	md	PROPN
aiua-6844	257	15	territoangelo@tiscali.it	territoangelo@tiscali.it	PROPN
aiua-6844	257	16	pirola	pirola	PROPN
aiua-6844	257	17	giacomo	giacomo	PROPN
aiua-6844	257	18	maria	maria	PROPN
aiua-6844	257	19	,	,	PUNCT
aiua-6844	257	20	md	md	PROPN
aiua-6844	257	21	gmo.pirola@gmail.com	gmo.pirola@gmail.com	PROPN
aiua-6844	257	22	ferrari	ferrari	PROPN
aiua-6844	257	23	nancy	nancy	PROPN
aiua-6844	257	24	,	,	PUNCT
aiua-6844	257	25	md	md	PROPN
aiua-6844	257	26	nancyferrari@virgilio.it	nancyferrari@virgilio.it	VERB
aiua-6844	257	27	sighinolfi	sighinolfi	PROPN
aiua-6844	257	28	maria	maria	PROPN
aiua-6844	257	29	chiara	chiara	PROPN
aiua-6844	257	30	,	,	PUNCT
aiua-6844	257	31	md	md	PROPN
aiua-6844	257	32	sighinolfic@yahoo.com	sighinolfic@yahoo.com	PROPN
aiua-6844	257	33	martorana	martorana	PROPN
aiua-6844	257	34	eugenio	eugenio	PROPN
aiua-6844	257	35	,	,	PUNCT
aiua-6844	257	36	md	md	PROPN
aiua-6844	257	37	eugeniomartorana@libero.it	eugeniomartorana@libero.it	PROPN
aiua-6844	257	38	bianchi	bianchi	PROPN
aiua-6844	257	39	giampaolo	giampaolo	NOUN
aiua-6844	257	40	,	,	PUNCT
aiua-6844	257	41	md	md	PROPN
aiua-6844	257	42	bianchi.giampaolo@unimore.it	bianchi.giampaolo@unimore.it	NOUN
aiua-6844	257	43	bagiovara	bagiovara	PROPN
aiua-6844	257	44	hospital	hospital	NOUN
aiua-6844	257	45	,	,	PUNCT
aiua-6844	257	46	university	university	NOUN
aiua-6844	257	47	of	of	ADP
aiua-6844	257	48	modena	modena	PROPN
aiua-6844	257	49	and	and	CCONJ
aiua-6844	257	50	reggio	reggio	PROPN
aiua-6844	257	51	emilia	emilia	PROPN
aiua-6844	257	52	via	via	PROPN
aiua-6844	257	53	pietro	pietro	PROPN
aiua-6844	257	54	giardini	giardini	PROPN
aiua-6844	257	55	,	,	PUNCT
aiua-6844	257	56	1355	1355	NUM
aiua-6844	257	57	,	,	PUNCT
aiua-6844	257	58	modena	modena	PROPN
aiua-6844	257	59	,	,	PUNCT
aiua-6844	257	60	i-41126	i-41126	PROPN
aiua-6844	257	61	,	,	PUNCT
aiua-6844	257	62	italy	italy	PROPN
aiua-6844	257	63	michele	michele	PROPN
aiua-6844	257	64	navarra	navarra	PROPN
aiua-6844	257	65	,	,	PUNCT
aiua-6844	257	66	md	md	PROPN
aiua-6844	257	67	(	(	PUNCT
aiua-6844	257	68	corresponding	correspond	VERB
aiua-6844	257	69	author	author	NOUN
aiua-6844	257	70	)	)	PUNCT
aiua-6844	257	71	mnavarra@unime.it	mnavarra@unime.it	PROPN
aiua-6844	257	72	department	department	PROPN
aiua-6844	257	73	of	of	ADP
aiua-6844	257	74	chemical	chemical	PROPN
aiua-6844	257	75	,	,	PUNCT
aiua-6844	257	76	biological	biological	ADJ
aiua-6844	257	77	,	,	PUNCT
aiua-6844	257	78	pharmaceutical	pharmaceutical	ADJ
aiua-6844	257	79	and	and	CCONJ
aiua-6844	257	80	environmental	environmental	ADJ
aiua-6844	257	81	sciences	science	NOUN
aiua-6844	257	82	,	,	PUNCT
aiua-6844	257	83	university	university	PROPN
aiua-6844	257	84	of	of	ADP
aiua-6844	257	85	messina	messina	PROPN
aiua-6844	257	86	viale	viale	PROPN
aiua-6844	257	87	annunziata	annunziata	PROPN
aiua-6844	257	88	,	,	PUNCT
aiua-6844	257	89	i-98168	i-98168	PROPN
aiua-6844	257	90	,	,	PUNCT
aiua-6844	257	91	messina	messina	PROPN
aiua-6844	257	92	,	,	PUNCT
aiua-6844	257	93	italy	italy	PROPN
aiua-6844	257	94	micali_stesura	micali_stesura	PROPN
aiua-6844	257	95	seveso	seveso	VERB
aiua-6844	257	96	28/09/17	28/09/17	PROPN
aiua-6844	257	97	10:18	10:18	NUM
aiua-6844	257	98	pagina	pagina	NOUN
aiua-6844	257	99	202	202	NUM